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ABSTRACT 
 
Iron-sulfur (Fe-S) clusters are ubiquitous protein cofactors that are required for 
some of the most important reactions in nature, including nitrogen fixation, oxidative 
phosphorylation, and photosynthesis. Multiple biosynthetic pathways have evolved for 
assembling Fe-S clusters and delivering them to protein targets. The ISC (Iron-Sulfur 
Cluster assembly) pathway is found in many prokaryotes and in eukaryotic mitochondria. 
A central component of the pathway is a cysteine desulfurase, which uses a pyridoxal 
phosphate (PLP) cofactor to convert cysteine to alanine and functions as a sulfur source. 
The scaffold protein IscU combines this sulfur with ferrous iron and electrons to 
synthesize Fe-S clusters. The Fe-S clusters can then be transferred to acceptor proteins 
such as the monothiol glutaredoxins (Grx4 in bacteria, GRX5 in humans) and ferredoxin 
(Fdx). The chaperone co-chaperone pair (HscA-HscB) accelerate cluster transfer reactions 
from holo-IscU to Grx4 and Fdx. In eukaryotes, Fe-S cluster biosynthesis is stimulated by 
frataxin (FXN), which is associated with the neurodegenerative disease Friedreich’s ataxia 
(FRDA). To gain a mechanistic understanding into these processes, we employed stopped-
flow kinetic analysis and developed visible circular dichroism, fluorescence reporter, and 
radioactivity-based assays. Importantly, we develop the first complete functional assay in 
which Fe-S clusters are built and then transferred to a target protein. Here, studies will be 
presented that show (1) FXN accelerates specific steps in the PLP-associated chemistry of 
the cysteine desulfurase, interprotein sulfur transfer, and intermediate Fe-S cluster 
formation on the scaffold protein; (2) a FXN suppressor mutant identified on the scaffold 
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protein functions differently than FXN, accelerating cluster transfer from the scaffold 
protein to GRX5; (3) glutaredoxin functions as an intermediate carrier in cluster transfer 
reactions from IscU to apo acceptor proteins Fdx and HcaC; and (4) chaperones accelerate 
cluster transfer reactions from IscU to Grx4 and do not appear to assist in the folding or 
unfolding of the target proteins. Overall, this work provides new mechanistic insight into 
specific steps of Fe-S cluster assembly and transfer and may provide new opportunities 
for drug discovery to treat FRDA.  
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CHAPTER I  
INTRODUCTION 
Iron sulfur clusters are one of the earliest protein cofactors used by living systems 
[1]. They are abundant in diverse life forms from prokaryotes (i.e. E. coli) to eukaryotes 
ranging from yeast to humans [2]. Iron can switch between oxidation states of +3 and +2 
which enables iron-sulfur clusters to accept or donate electrons in complex enzymatic 
reactions [3]. In addition, iron-sulfur clusters can exist in different stoichiometries, flexible 
geometries and have a wide range of reduction potentials. These properties make them 
well-suited to participate in wide variety of processes like electron-transfer, substrate 
activation and gene regulation [4-6]. Hence, multiple biosynthetic pathways have evolved 
for the assembly of iron-sulfur clusters and their delivery to different Fe-S containing 
proteins [7-9]. Though widely studied, mechanistic details of the cluster biosynthesis and 
delivery process remain poorly understood along with the protein-protein interactions 
involved therein. 
Iron-sulfur Clusters 
Fe-S clusters consist of ferrous or ferric ions coordinated by bridging sulfide and, 
typically cysteine thiolates from proteins. However, histidine, aspartate, serine and amides 
from protein backbone have also been observed to serve as ligands [10]. Different forms 
of iron-sulfur clusters are observed in Nature with distinct properties and functions (Fig. 
1.1). Though, [2Fe-2S] and [4Fe-4S] are the most common forms, additional iron sulfur 
clusters with varying number of iron and sulfides such as [3Fe-4S], [4Fe-3S], [5Fe-5S] 
and [8Fe-7S] are also known. 
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Figure 1.1. Iron-sulfur cluster protein cofactors found in nature. Orange and yellow 
spheres represent iron and sulfur ions, respectively. The small blue sphere in the Mo-Fe-
S-Carbide is a molybdenum ion and the green center ion is a carbide. The green spheres 
in the CODH/ACS metal complexes are nickel ions and the grey sphere is a zinc ion (this 
is inactive form of the enzyme. The active form contains Ni2+ instead of Zn2+). 
Coordinating cysteine ligands are shown. 
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Clusters bound to metal ions other than iron are also found in Nature. For example, 
carbon monoxide dehydrogenase has two separate iron-sulfur clusters coupled to a Ni ion 
[11]. Nitrogenase harbors a Mo-Fe-S cluster that consists of one Mo, seven Fe, a carbide, 
and nine sulfide ions, and is bound with a molecule of homo-citrate [12]. Many enzymes 
rely on ferredoxin, which typically contain a [2Fe-2S] cluster, to channel electrons into or 
out of their active site and catalyze chemical reactions [13]. [4Fe-4S] clusters pair with S-
adenosylmethionine to catalyze an array of chemical reactions in the radical-SAM 
superfamily [14]. DNA binding proteins, such as IscR, bind Fe-S clusters as negative 
feedback transcriptional regulators [15]. More recently, DNA repair enzymes have been 
implicated in using Fe-S clusters to sense DNA damage [16]. The wide variety of functions 
for Fe-S proteins requires a robust Fe-S cluster maturation system that can incorporate 
clusters into hundreds of different protein targets that can tailor their orientations, ligands, 
redox properties and substrate access [17].  
Iron-sulfur Cluster Biosynthesis Pathways 
Though iron sulfur clusters can readily self-assemble from free sulfide and iron 
[18], it is non-feasible to use this as an in vivo strategy for their formation due to the toxic 
effects of free iron and sulfide [19]. Hence, several multi-component pathways were 
evolved to ensure regulated iron-sulfur cluster biosynthesis in cells. Defects in these 
pathways result in complications including iron trafficking problems, mitochondrial 
dysfunction and onset of several diseases [20]. Four biosynthetic pathways known as NIF, 
ISC, SUF and CIA have been identified. The first pathway to be discovered was NIF 
(Nitrogen Fixation Pathway). NIF is found in prokaryotes and is associated with cluster 
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biosynthesis for nitrogenase [7]. The Iron sulfur cluster assembly pathway (ISC), the 
second pathway discovered, is present in both prokaryotes and eukaryotic mitochondria. 
It is responsible for iron sulfur cluster biogenesis for multiple targets under normal growth 
conditions [21]. Another specialized pathway in prokaryotes is sulfur mobilization 
pathway (SUF) which often functions to assemble clusters under conditions of oxidative 
stress [8]. Eukaryotes also have cytosolic iron-sulfur protein assembly pathway (CIA) that 
is involved in maturation of iron-sulfur protein clusters in the nucleus and cytosol which 
is fundamentally different than the other pathways and will not be discussed here [9]. The 
NIF, ISC and SUF pathways are similar in having a cysteine desulfurase enzyme that 
converts cysteine to alanine thereby providing the sulfur required for cluster assembly and 
a scaffold protein on which the cluster is assembled (Fig. 1.2). Chemically, the cluster 
assembly reaction can be represented as: 
2 L-cysteine + 2 Fe2+ + 2 e-  [2Fe-2S]2+ + 2 L-alanine 
The source of iron and electrons for the reaction remains controversial with many 
possible candidates suggested in the literature. These pathways are essential and hence 
knock-outs are lethal except in case of organisms with multiple operative pathways. For 
example, E. coli contains both SUF and ISC pathways and deletion of one system is not 
lethal. However, in humans, impaired cluster biosynthesis in the mitochondria, which only 
has the ISC pathway, leads to several disorders like Friedreich’s ataxia, sideroblastic 
anemia and myopathy [22]. Hence, a deeper mechanistic understanding of ISC pathway 
would facilitate targeting the diseases resulting from defects associated with cluster 
assembly machinery. 
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Figure 1.2. Operon structure of Fe-S biosynthetic systems. NIF, ISC, and SUF operons 
are shown for Azotobacter vinelandii (Av), Escherichia coli (Ec), and Thermotoga 
maritima (Tm). Cysteine desulfurases are indicated by solid gray genes. U-type scaffold 
proteins/domains are indicated by white genes. Reproduced with permission from 
Bandyopadhyay S, Chandramouli K, Johnson MK. 2008. Biochem Soc Trans. 36 (Pt 6), 
1112-9. [193] The Biochemical Society. 
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ISC Pathway 
The ISC pathway is the only pathway shared between humans and prokaryotes. In 
E. coli, most of the genes for the pathway are encoded in a single operon [21]. The operon 
encodes genes for IscS, IscU, HscA, HscB, IscA, Fdx, IscR and IscX. IscS is cysteine 
desulfurase that converts cysteine to alanine and provides sulfur for cluster assembly. IscU 
is the scaffold protein on which [2Fe-2S] and possibly [4Fe-4S] clusters are assembled 
[23]. Electrons required for cluster synthesis may be provided by Fdx [24]. IscA has been 
proposed to function as an iron donor and as an alternate scaffold protein responsible for 
synthesis of [2Fe-2S] and [4Fe-4S] clusters [25]. HscA-HscB form the chaperone/co-
chaperone pair that have been shown to accelerate the cluster transfer from IscU to apo-
Fdx [26] IscS is cysteine desulfurase that converts cysteine to alanine and provides sulfur 
for cluster assembly. IscU is the scaffold protein on which [2Fe-2S] and possibly [4Fe-
4S] clusters are assembled [23]. Electrons required for cluster synthesis may be provided 
by Fdx [24]. IscA has been proposed to function as an iron donor and as an alternate 
scaffold protein responsible for synthesis of [2Fe-2S] and [4Fe-4S] clusters [25]. HscA-
HscB form the chaperone/co-chaperone pair that have been shown to accelerate the cluster 
transfer from IscU to apo-Fdx [26]. IscR acts as the negative feedback regulator for the 
ISC operon [27]. IscX is suggested to be an iron-donor or to have regulatory role [28, 29]. 
Additional proteins outside the ISC operon are also involved in cluster biosynthesis via 
the ISC pathway. For example, monothiol glutaredoxins function in the cluster transfer 
process [30] and frataxin (FXN) has been shown to be crucial in cluster biosynthesis for 
eukaryotes [31].  
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Major Players in ISC Pathway 
IscS is PLP dependent cysteine desulfurase that converts L-cysteine to L-alanine 
and generates a persulfide intermediate on an absolutely conserved cysteine residues that 
resides on a mobile loop near the active site [32]. The persulfide can be transferred to the 
scaffold protein, IscU, for cluster synthesis or cleaved by reductants like DTT to generate 
sulfide for monitoring cysteine desulfurase activity. Importantly, cleavage of the 
persulfide with reductants generates sulfide, which can readily combine with iron in a 
chemical reaction, and can seriously cripple the ability to monitor physiological 
(enzymatic) reactions using in vitro Fe-S assembly assays.  
IscU serves as the scaffold protein for cluster assembly. The Fe-S cluster is ligated 
by three conserved cysteine residues from IscU. The identity of the physiologically 
relevant fourth ligand is still unclear [33-35]. Fe-S clusters can be assembled on IscU in 
the presence of IscS, iron and cysteine. A crystal structure of a [2Fe-2S] cluster bound to 
the IscU-IscS complex revealed the cluster can be ligated by the three cysteines from IscU 
and the mobile loop cysteine of IscS [36]. There is also evidence of [2Fe-2S] cluster bound 
by cysteine residues of the two subunits in an IscU dimer [23]. In spite of this available 
information, the identity of the species responsible for transferring the clusters to 
downstream apo-acceptors is still not clear. In addition, although IscU clearly functions 
as the scaffold to build Fe-S clusters, the order of events, including whether iron or sulfur 
is incorporated first, has not been firmly established. 
Fdx is a [2Fe-2S] containing protein which is believed to behave as an electron 
source for the cluster biosynthesis. This stems from the observation that reduced 
 8 
 
ferredoxin is oxidized in the presence of IscS and cysteine leading them to propose 
formation of persulfide radical in the process as there was no exogenous iron present [24]. 
There have been multiple studies on interaction of Fdx with other proteins.  Ferredoxin 
and IscU have been shown to independently bind to IscS [24, 191].  NMR data show that 
conformation of IscU was perturbed on addition of Fdx into IscU-IscS complex. This data 
could be interpreted as dissociation of IscU from IscS in presence of Fdx or 
conformational change of iscU in presence of Fdx due to the formation of a ternary 
complex. Another puzzling observation is the competition of CyaY and Fdx for binding 
to IscS [192]. The significance of the interactions remains unclear.  
HscA is an ATPase and belongs to the Hsp70 (Heat Shock Protein 70) class of 
proteins but differs from its homologues like DnaK in having high 'substrate' specificity 
and selectively binding to specific client proteins [37]. Substrates for the chaperones are 
defined as proteins that bind in a nucleotide-dependent manner, have different affinities 
for different nucleotide-bound forms, and undergo conformational changes upon binding. 
HscA recognizes and binds IscU, the only substrate currently known, via a highly 
conserved LPPVK motif [38]. The basal ATPase activity of HscA is low but enhanced 
synergistically in the presence of IscU and HscB. HscB is a co-chaperone that recruits 
IscU and has recognition motifs for both HscA and IscU. Details of the mechanism by 
which the chaperones accelerate cluster transfer are poorly understood. The working 
model is that ATP-bound HscA binds to IscU with low affinity (T-state) and hydrolysis 
of ATP to ADP causes a conformational change on HscA, which leads to tighter binding 
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of ADP-bound HscA (D-state) to IscU and facilitates cluster transfer to the apo-acceptor 
[39] (Fig. 1.3). 
Glutaredoxins have been proposed to function in Fe-S cluster storage, transfer and 
sensing [40]. Monothiol glutaredoxins (Grx4) are known to bind [2Fe-2S], [3Fe-4S] and 
[4Fe-4S] clusters [41]. Preliminary evidence supports monothiol glutaredoxins as 
intermediate cluster carriers that function downstream of IscU in cluster biosynthesis 
[144]. 
Frataxin (FXN) plays an important role in cluster biosynthesis as evident from 
FXN deletion phenotypes resulting in iron accumulation in mitochondria, increased 
oxidative stress and loss of activity of Fe-S enzymes [42]. Proposals for the role of FXN 
include an iron chaperone [43], iron donor for Fe-S cluster and heme biosynthesis [44] 
and detoxification of ROS [45]. Strong evidence was later obtained to support the role of 
FXN as an allosteric activator for the cysteine desulfurase in the presence of ISCU2 [31]. 
Comparison of Bacterial & Eukaryotic ISC Machinery 
As the ISC pathway is conserved between prokaryotes and eukaryotes, homology 
is expected between the analogous components in E. coli. Human cysteine desulfurase 
(NFS1) is 59% identical to IscS, ISCU2 (human scaffold protein) is 70% identical to E. 
coli IscU and CyaY (FXN homolog in E.coli) is 20% identical to human FXN [46]. In 
spite of the high sequence identities, there are many functional differences between the 
proteins in the E. coli and human pathways. For example, eukaryotic NFS1 by itself has 
very low basal activity as compared to IscS and requires an accessory protein ISD11 for 
its structural stability and exists as an NFS1-ISD11 complex (SD) [47]. FXN acts as an  
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Figure 1.3. Model of chaperone-dependent acceleration of cluster transfer from 
holo-IscU to apo-Fdx. HscA has differential affinities for holo-IscU in ATP and ADP 
bound states. ATP hydrolysis to ADP is coupled to cluster transfer from holo-IscU. 
Adapted with permission from Hoff, K.G., J.J. Silberg, and L.E. Vickery, Proc Natl Acad 
Sci USA, 2000. 97(14), 790-5. [39] 
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allosteric activator of cysteine desulfurase whereas CyaY, the bacterial homolog, is 
observed to inhibit cluster assembly on IscU. It has been observed that the functional 
difference of FXN and CyaY are dependent on the identity of cysteine desulfurase [46]. 
Both FXN and CyaY inhibit the rate of cluster assembly in assays containing the bacterial 
cysteine desulfurase, IscS, whereas they both accelerate the rate of cluster assembly in 
assays containing the human cysteine desulfurase complex, SD [46]. This is consistent 
with the recent discovery that the eukaryotic cysteine desulfurase complex exhibits a 
fundamentally different architecture compared to the IscS dimer [48, 49]. However, the 
mechanistic details of FXN activation and CyaY inhibition remain unclear. 
Proteins Involved in Cluster Transfer 
The next step of the cluster biogenesis is transfer of the cluster assembled on IscU 
to the downstream apo-acceptors (Fig. 1.4). The process needs to be highly fine-tuned for 
a multitude of reasons. First, iron-sulfur cluster intermediates need to be protected to 
prevent non-specific and possibly toxic side reactions. Moreover, ensuring specificity is 
critical as the ligating residues of different acceptors are amenable to coordinating other 
Fe-S cluster stoichiometries ([2Fe-2S] vs. [4Fe-4S] cluster) and metal ions (Cu and Zn in 
particular).  
Monothiol glutaredoxins have been shown to accept clusters from holo-IscU in a 
chaperone-dependent fashion [50]. Cluster transfer from holo-glutaredoxin to apo 
ferredoxin has also been demonstrated [51]. Monothiol glutaredoxins have been proposed 
to function as intermediate cluster carriers for redistribution of clusters or as cluster-
storage proteins [30]. Monothiol glutaredoxins also form cluster bound heterodimeric-
 12 
 
complexes with proteins like BolA [52] and Fra2 [53] which seem to function in iron 
regulation at the cellular level [54, 55]. 
Another class of proteins involved in cluster transfer are A-type proteins like IscA, 
SufA and NfuA. IscA can accept clusters from IscU [56] and reductively couple two [2Fe-
2S] clusters to generate a [4Fe-4S] clusters [57]. IscA is also capable of transferring [2Fe-
2S] and [4Fe-4S] clusters to several cluster targets [58]. Although mechanistic details are 
poorly understood, knockout studies of IscA show impaired levels of [4Fe-4S] proteins 
[59] pointing towards a role of IscA in assembly of [4Fe-4S] proteins. Glutaredoxins can 
transfer clusters to IscA [60] suggesting their involvement in transfer of [4Fe-4S] clusters 
to targets as well. 
Chaperones accelerate cluster transfer from IscU to apo-acceptors in an ATP-
dependent fashion [38]. HscB is the co-chaperone generally accepted to be responsible for 
recruiting IscU to HscA by forming a complex with IscU [39]. However, recent in vivo 
findings suggested that HscB is only required for cluster transfer to targets with a semi-
conserved LYR amino acid motif  [61]. Recently, HscB has been shown to reduce the rate 
of cluster assembly on IscU under some conditions [62] which has been suggested to 
support a CD-silent slow transferring holo-IscU:HscB complex. Yeast studies showed that 
IscS and HscB compete for binding IscU [63] whereas  studies performed in E. coli 
demonstrate simultaneous binding of HscB and IscS to IscU [64]. HscA is an ATPase 
which selectively binds IscU via a LPPVK recognition motif in a nucleotide-dependent 
manner. The ATP-bound T-state has low affinity for IscU whereas after hydrolysis, the 
ADP-bound D-state binds IscU with stronger affinity. Though IscU is the only known  
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Figure 1.4. Model for the ISC cluster assembly and transfer pathway. A [2Fe-2S] 
cluster is synthesized on IscU in the presence of IscS, cysteine, ferrous iron, and 
reducing equivalents. The [2Fe-2S] cluster is then transferred to the intermediate 
cluster carrier protein, Grx4, in a reaction accelerated by chaperones (HscA-HscB) 
and dependent on in MgATP. [2Fe-2S]-Grx4 can then transfer the cluster to terminal 
apo-acceptor targets like ferredoxin in a reaction that may also be chaperone 
dependent. Grx4 can also transfer clusters to IscA, which apparently matures and 
delivers [4Fe-4S] clusters to appropriate targets. 
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client protein known for HscA, many studies have reported interaction of HscA with apo-
acceptors like glutaredoxin and apo-BioB [65, 66]. 
In Vitro Study of Cluster Biosynthesis: Challenges and Strategies 
The study of cluster biosynthesis poses many challenges at a technical level. For 
example, most in vitro studies have traditionally used reductants like DTT as a source of 
electrons in cluster assembly assays. Unfortunately, we now know these reagents initiate 
thiol-mediated cluster redistribution [67]. Another challenge is the study of cluster transfer 
from one protein to another using UV spectra as the different holo-proteins exhibit 
virtually identical spectra. Using CD spectroscopy is an effective alternative but has 
limitations, including low sensitivity and a high sample requirement and a requirement of 
data deconvolution gets very complicated for experiments with multi-component cluster-
binding species. A novel fluorescence quenching assay developed in our lab addresses 
some of these issues. Proteins can be labeled with fluorophores, which report on cluster 
content even in the presence of other cluster binding proteins [59]. While the roles of many 
proteins remain unknown or controversial, along with the mechanistic details involved, a 
stepwise analysis of their effect on individual step(s) of cluster biosynthesis process is 
needed. For this, the entire process of biosynthesis is sub-divided into different steps like 
cysteine desulfurase activity, sulfur transfer, cluster synthesis and cluster transfer (Fig. 
1.5). 
Current Work and Future Directions 
Many studies have been carried out to better understand the process of cluster 
transfer and the roles of different components therein but we are still faced with many 
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unanswered questions and need to re-evaluate some of the previous results in light of 
recent discoveries.  
Glutaredoxin. Although, holo-Grx4 has been shown to transfer iron-sulfur cluster to apo-
Fdx, the reaction was carried out in presence of DTT, a reductant that has been shown to 
mediate non-physiological thiol-mediated redistribution of clusters [67], strongly 
suggesting a need for a re-evaluation of this effect. Additionally, the intermediacy of 
glutaredoxin in the cluster transfer from scaffold protein to apo-acceptors like ferredoxin 
in a one-pot reaction has not been demonstrated. Moreover, the ability of monothiol 
glutaredoxin to transfer clusters to other apo-targets like HcaC has not yet been explored. 
Chaperones. At this point, the mechanistic details of chaperone-assisted cluster transfer 
from IscU to downstream acceptors have more questions than answers. For example, 
HscA-HscB have been found to be disposable under certain growth conditions [68], 
raising the possibility of operation of an alternate cluster transfer pathway not utilizing 
chaperones in vivo. Cluster transfer from IscU to glutaredoxin is accelerated in the 
presence of chaperones in DTT-independent manner [50]. However, all the studies that 
have been carried out demonstrating chaperone-dependent acceleration of direct cluster 
transfer from IscU to ferredoxin have been done in presence of DTT which necessitates 
re-evaluation of the results. Further investigation is required to test if there are two 
alternate pathways operative in the process of cluster transfer with one being glutaredoxin-
mediated transfer from IscU to apo-Fdx and the other being chaperone-dependent direct 
transfer from IscU to apo-Fdx. Moreover, the requirement of the LYR motif on-apo 
acceptors for targeting by HscB is inconsistent with in vitro observations where 
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Figure 1.5. Different steps in  eukaryotic ISC cluster biosynthesis pathway. 
The overall process of cluster biosynthesis in humans was divided into four broad 
steps. 
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chaperones accelerate the rate of cluster transfer to glutaredoxin and apo-ferredoxin, as 
neither of the protein contains the LYR motif. The mechanism of partitioning between the 
process of cluster assembly and transfer is poorly understood. The competition between 
IscS and HscB for IscU binding in yeast and the contrasting formation of a three-protein 
complex in bacteria further raises the possibility that the mechanisms are different in 
bacteria and eukaryotes. Chaperones have been shown to accelerate cluster transfer from 
IscU to glutaredoxin and apo-Fdx but the effect of chaperones on cluster transfer from 
glutaredoxin to apo-acceptors, such as ferredoxin, have not been studied. Moreover, the 
mechanistic details of how HscA binding to holo-IscU facilitate cluster transfer to apo-
protein are poorly understood. It has also not been tested whether there is a functional 
relevance of the interaction between HscA and apo-acceptors like glutatredoxin and apo-
BioB with the possibility that HscA has functions in addition to binding IscU.  
In this work, we focused on optimizing and developing assays that assist a step-
wise analysis of iron-sulfur cluster biogenesis (Chapter II and IV), and permit the study of 
cluster delivery to terminal apo-targets. We investigate the role of CyaY (bacterial 
homolog of FXN, chapter III) frataxin (Chapter IV), glutaredoxin (chapter V) and 
chaperones (chapter VI) in cluster assembly and transfer. This work has helped us to gain 
some important insights on mechanism of cluster transfer from holo-IscU to apo-acceptors 
and the glutaredoxin and chaperone-dependence therein.  
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CHAPTER II 
FRATAXIN ACCELERATES [2FE-2S] CLUSTER FORMATION ON THE HUMAN 
FE-S COMPLEX1 
Introduction 
Proteins containing iron−sulfur (Fe−S) clusters are involved in many critical 
functions in cells, including oxidative respiration, DNA replication and repair, and 
cofactor biosynthesis [2]. Sophisticated Fe−S assembly pathways synthesize and deliver 
Fe−S clusters to apo-target proteins [9, 22, 69-71]. These O2-sensitive pathways involve 
more than a dozen proteins and require six substrates to generate the simplest (i.e., [2Fe-
2S]) cluster. Numerous protein complexes are assembled and disassembled during cluster 
formation and transfer reactions. Because of this complexity, assays for investigating the 
mechanistic enzymology of these pathways have had to simplify this process by including 
non-physiological reagents and by monitoring partial reactions. An additional challenge 
is that iron and sulfide can undergo competing non-enzymatic Fe−S cluster self-assembly 
(spontaneous formation of discrete species similar to biological Fe−S clusters) [72] and 
Fe−S mineralization chemistry. The resulting Fe−S material can also undergo ligand 
exchange and cluster conversion reactions [73]. It is important to elucidate the factors that 
partition between biosynthetic and competing side reactions and to understand the types 
                                                 
1 Reprinted with permission from “Frataxin Accelerates [2Fe-2S] Cluster Formation on the Human Fe−S 
Assembly Complex” by Nicholas G. Fox, Deepika Das, Mrinmoy Chakrabarti, Paul A. Lindahl, David P. 
Barondeau, 2015. Biochemistry, 54, 3880-3889. Copyright 2015 American Chemical Society. 
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and properties of Fe−S species that are being generated. The mitochondrial eukaryotic 
Fe−S biosynthetic pathway builds Fe−S clusters from the substrates L-cysteine, iron, and 
reducing equivalents, homologous to the chemistry of the prokaryotic ISC pathway. 
Cysteine desulfurase (human NFS1 or bacterial IscS) catalyzes the PLP-dependent 
conversion of L-cysteine to L-alanine, while generating a persulfide species on a mobile 
loop cysteine residue that delivers a sulfane sulfur to the Fe−S catalytic protein (human 
ISCU2 or bacterial IscU) [74, 75]. Cysteine desulfurase activity is often measured by 
intercepting this persulfide species using reductive thiol-cleaving reagents and 
quantitating the generated sulfide [74-76]. Human NFS1 forms a tight complex with 
ISD11 (the SD complex) that includes two NFS1 and possibly four ISD11 subunits [77]. 
ISD11 is a eukaryotic protein that stabilizes cysteine desulfurase and may help position 
the mobile loop cysteine for attack of the substrate [47, 78]. Possible electron donors for 
in vivo Fe−S cluster formation and/or transfer include glutathione (GSH) and NADPH 
with the ferredoxin/ferredoxin reductase system [79-81]. Notably, in vitro Fe−S cluster 
assembly reactions often use a surrogate electron donor such as dithiothreitol (DTT). Once 
the Fe−S clusters are assembled, chaperone and Fe−S carrier proteins facilitate the transfer 
of the intact Fe−S clusters from the Fe−S assembly complex to target proteins [65, 82, 
83].  
Depletion of human frataxin (FXN) is associated with the loss of Fe−S cluster 
enzyme activities and the development of the neurodegenerative disease Friedreich’s 
ataxia (FRDA) [84]. FXN binds to an ∼160 kDa complex consisting of NFS1, ISD11, and 
ISCU2 proteins (named SDU) to form the SDUF complex [31, 77]. FXN was initially 
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proposed to function as an iron donor for Fe−S cluster biosynthesis largely because of its 
ability to weakly bind iron [43, 85, 86]. Subsequently, FXN was shown to stimulate the 
activity of the cysteine desulfurase component of the SDUF complex (kcat is ∼10-fold 
higher for SDUF than for SDU), suggesting a role as an allosteric effector [31, 33, 87].  
Notably, FXN variants encoded by FRDA missense mutations have compromised 
abilities to bind and stimulate the activities of the Fe−S assembly complex [88]. Recent 
Mössbauer studies suggest that the mouse SDU complex assembles [2Fe-2S] clusters and 
that the SDUF complex synthesizes [4Fe-4S] clusters [89]. This result is puzzling because 
an IscU molecule in the SDUF complex would not be expected to dimerize (a requirement 
for the reductive coupling model of [4Fe-4S] cluster formation) [23] without a significant 
conformational change compared to the prokaryotic IscS−IscU structure. In addition, 
proteins previously implicated in [4Fe-4S] cluster formation [59] were not added during 
the reaction, and the putative [4Fe-4S] cluster was EPR silent under both oxidized and 
reduced conditions.  
The objectives of this study were to elucidate the formation kinetics and types of 
Fe−S clusters synthesized by the human Fe−S assembly complex under different 
experimental conditions. Previous kinetic assays for Fe−S cluster formation used the 
surrogate electron donor DTT and followed the increase in absorbance at 456 nm due to 
S → Fe charge transfer bands [31, 90-92]. This wavelength is characteristic of an 
absorbance peak for [2Fe-2S] clusters, but other Fe−S species, including [4Fe-4S] 
clusters, also absorb at that wavelength. Under these assay conditions, the SDUF complex 
exhibits activity ∼25-fold higher than that of the SDU complex [31]. However, the nature 
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of the Fe−S species produced during these assembly reactions were not determined. In this 
work, different electron donation systems were used for Fe−S cluster assembly reactions 
and the products of these reactions were established using electronic absorbance, circular 
dichroism, and Mössbauer spectroscopies [73]. Together, they reveal new details of the 
Fe−S cluster assembly reaction on the SDUF complex and of competing Fe−S cluster 
conversion and mineralization chemistry that have implications for the mechanism and 
study of Fe−S cluster biosynthesis. 
Results 
Fe−S cluster assembly reaction components were prepared anaerobically in a 
glovebox and combined in an anaerobic cuvette that was sealed with a rubber septum and 
removed from the glovebox for activity measurements. Activity assays were initiated by 
injecting L-cysteine into the sealed cuvette using a gastight syringe. We employed two 
types of Fe−S assembly assay conditions, called standard and DTT-free (see Materials and 
Methods), that differed in their electron donation systems. We first investigated the Fe−S 
cluster assembly reaction for the SDUF complex (with an SD: ISCU2: FXN molar ratio 
of 1:3:3) under standard assay conditions, which included substrates Fe2+ and L-cysteine, 
and electron donor DTT. After 1 h, the reaction mixture exhibited a broad peak with a 
maximum at 400 nm that is characteristic of [4Fe-4S] clusters [93] (Fig. 2.1A). In addition, 
the absorbance for the entire visible region increased with time. The origin of the general 
absorbance increase at all wavelengths was unclear, but was consistent with an increase 
in light scattering The absorbance at 400 nm increased rapidly and then more slowly in a 
second linear phase of the reaction (Fig. 2.1B). The rate and magnitude of the absorbance 
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Figure 2.1. SDUF complex generates Fe−S species under standard conditions 
with spectroscopic properties similar to those of [4Fe-4S] clusters. (A) 
Absorbance spectrum of the SDUF reaction mixture 45 s (bottom), 2.8 min, and 1 h 
(top) after the reaction was initiated. (B) Kinetics of the assembly assay reaction 
monitored by absorbance at 400 nm (black) and CD ellipticity at 430 nm (red). The 
absorbance was adjusted to zero at 0 min. (C) CD spectra of the reaction mixture 
recorded at 0 (black), 20 (red), 40 (green), and 90 (blue) min. (D) CD spectra of an 
equivalent reaction mixture as in C except that it included 10 mM EDTA and 
excluded Fe2+. Spectra were recorded at 0 (black), 10 (red), 20 (green), and 40 (blue) 
min. 
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changes depended on the concentration of Fe2+ (data not shown) The lack of a plateau 
region indicates that more than one reaction occurred and/or that more than one species 
formed. None of the spectra recorded, even at the earlier reaction times, showed 
absorbance features typical of a [2Fe-2S] cluster. The corresponding CD spectra exhibited 
a feature at 420 nm that was largely invariant with time (Fig. 2.1C). This feature was 
assigned to the PLP cofactor, as a similar peak was observed for the human SD complex 
and E. coli IscS that lack iron−sulfur clusters. The intensity of a second CD peak at 300 
nm decreased with time. 
The iron independence of this second feature (Fig. 2.1D) suggested that it was also 
due to the PLP cofactor and not due to an Fe−S cluster. Moreover, these features were 
inconsistent with the strong [2Fe-2S] cluster-dependent CD signals observed at 330 and 
430 nm exhibited by bacterial IscU [34, 83, 94] and human ISCU2 [33]. Rather, they 
suggested the formation of [4Fe-4S] clusters, which have negligible UV−visible CD 
intensity compared to that of [2Fe-2S] clusters [56, 95]. These features could also be due 
to other Fe−S species (such as an Fe−S mineral) that exhibit similar absorbance and CD 
spectroscopic properties. 
We repeated the Fe−S cluster assembly reaction under standard conditions in the 
absence of FXN (SDU complex with an SD:ISCU2 molar ratio of 1:3). As previously 
reported [31], the absorbance increase at 456 nm for the SDU complex was significantly 
slower than that of the SDUF complex. The plot was linear and was not maximized during 
the time frame of the experiment (Fig. 2.2A, black line). Early time points for the SDU 
reaction revealed spectral absorption features typical of a [2Fe-2S] cluster Fig. 2.2B).  
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Figure 2.2. SDU complex generates [2Fe-2S] clusters under standard 
conditions. (A) Comparison of the change in absorbance at 456 nm for the SDU 
(black) and SDUF (red) complexes. (B) Absorbance spectrum for the SDU reaction 
mixture recorded at 5, 10, 30, and 60 min. The small arrow at 456 nm highlights the 
formation of [2Fe-2S] clusters at early times, while the arrow at 400 nm highlights 
features similar to those of the SDUF reaction (Figure 2.1A) at later times. (C) CD 
spectra recorded for the SDU reaction at 0 (black), 20 (red), 40 (green), and 90 (blue) 
min. The features at 330 and 430 nm are assigned to [2Fe-2S]-ISCU2. (D) Time-
dependent changes in 330 nm ellipticity for a separate SDU reaction under standard 
conditions. 
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The formation of a [2Fe-2S] cluster was further supported by the development of a strong 
CD signal with peaks at 330 and 430 nm that are characteristic of [2Fe-2S]-IscU (Fig. 
2.2C). Absorbance features centered at 400 nm and an overall increase at all wavelengths 
(Fig. 2.2B) developed at later times, similar to those produced by SDUF reactions. Time-
dependent changes in the 330 nm CD signal of a separate SDU sample under standard 
conditions were monitored. The signal plateaued after ∼30 min and then decreased back 
to the initial ellipticity value (Fig. 2.2D). This is consistent with the SDU complex 
generating a [2Fe-2S] cluster that converts into a different species lacking a significant 
CD signature. The cluster conversion chemistry appears to vary with cysteine desulfurase 
activity and the amount of sulfide produced (see below). Overall, these results suggest that 
multiple species are generated in Fe−S assembly reactions under standard conditions. 
Fe−S cluster assembly reactions under standard conditions generate high-molecular 
weight species (HMWS). Human SDU and SDUF complexes were isolated and 
characterized from similar assembly reactions. Standard reaction conditions were used 
(except for higher protein concentrations), and products were analyzed by anaerobic 
analytical size-exclusion chromatography. A brown species eluted in the column void 
volume (at ∼9 mL) when either SDU (Fig. 2.3A) or SDUF (Fig. 2.3B) complexes were 
used. SD, SDU, and SDUF complexes eluted at ∼12 mL, and uncomplexed ISCU2 and 
FXN eluted at ∼16 mL. Forming this HMWS required Fe2+, L-cysteine, and the assembly 
complex. The reaction was accelerated by DTT (data not shown). Sodium dodecyl sulfate 
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Figure 2.3. HMWS formation during Fe−S cluster assembly reactions 
under standard conditions. Size-exclusion chromatogram, monitored at 
A280, of reaction mixtures involving (A) SDU and (B) SDUF under complete 
standard conditions (brown) but lacking cysteine (green), Fe2+ (blue), or both 
cysteine and Fe2+ (black). SDS−PAGE of fractions from Fe−S cluster 
assembly reactions involving (C) SDU and (D) SDUF. Fractions 9 (void), 12 
(native SD, SDU, and SDUF), and 16 mL (uncomplexed ISCU2 and FXN) 
from anaerobic S-200 columns were analyzed by SDS−PAGE. The gel was 
stained with Coomassie Blue. Migration positions of NSF1, ISCU2, FXN, and 
ISD11 are shown. 
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−polyacrylamide gel electrophoresis (SDS−PAGE) analysis of fractions containing SDU 
(Fig. 2.3C) and SDUF (Fig. 2.3D) indicated that the HMWS (fraction 9 in each case) 
contained SD and ISCU2. Most of the iron and sulfide added in the reaction mixture eluted 
with the HMWS. More iron and sulfide (9 Fe2+ and 10 S2− atoms per SDU assuming a 
1:2:1 stoichiometry [77]) were found in the HMWS fraction for the SDUF reaction than 
expected for a standard biological Fe−S cluster. A similar Fe−S cluster associated HMWS 
could be generated in control reactions (Fig. 2.4) using either the SD complex or E. coli 
IscS in the absence of the scaffold protein (human ISCU2 or E. coli IscU). As the 
ISCU2/IscU protein is required for biological Fe−S cluster assembly, this suggests that 
HMWS formation is an off-pathway process that competes with the physiological Fe−S 
cluster assembly pathway under these assay conditions.  
HMWS are solubilized Fe−S mineral species. We generated 57Fe-labeled HMWS to 
investigate it by Mössbauer spectroscopy. The 5 K spectrum was composed of unresolved 
magnetic material and a quadrupole doublet (Fig. 2.5A). At 100 K, the magnetic material 
collapsed into a doublet with δ =0.37 mm/s, ΔEQ = 0.67 mm/s, and Γ = 0.55 mm/s (Fig. 
2.5B). HMWS prepared from similar SDUF or other SD reactions displayed some spectral 
variability, suggesting multiple species. The Mössbauer magnetic properties and 
parameters along with the absence of an EPR signal (with or without added dithionite) for 
the HMWS are inconsistent with [2Fe-2S] or [4Fe-4S] clusters. Instead, they indicate an 
Fe−S mineral (see Discussion).  
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Figure 2.4. Elution profile of Fe-S assembly reaction. The solutions show that 
cysteine desulfurase generates HMWS during Fe-S assembly reactions under scaled 
up Standard conditions. Reaction mixtures including (A) human SD or (B) E. coli 
IscS and DTT, Fe2+, and L-cysteine were incubated for 45 min at 12 ° C. The samples 
were then separately applied to an anaerobic S-200 column and monitored by 
absorbance at 280 nm. The HMWS and cysteine desulfurase elute in fractions 8-12, 
and 12-14, respectively. 
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Figure 2.5. Mössbauer spectra of the HMWS mineral. The HMWS was 
generated with the SD complex under standard conditions and isolated from the 
void volume fractions of the S-200 column. Low-field (0.05 T) Mössbauer spectra 
were recorded at (A) 5 and (B) 100 K. The solid red line overlaying the data is a 
simulation of the quadrupole doublet due to the HMWS. 
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Formation and reaction properties of HMWS. Next, we attempted to minimize 
formation of the HMWS material. We considered whether cysteine desulfurase catalyzed 
L-cysteine turnover and generated sulfide during HMWS formation. That sulfide could 
then be used in Fe−S cluster self-assembly or Fe−S mineralization. Consistent with this 
role, sulfide could be substituted for L-cysteine (Fig. 2.6A, red line). However, alkylation 
of the cysteine residues of NFS1 eliminated HMWS formation even in the presence of 
sulfide and ferrous ions (Fig. 2.6A, green line). This suggests that NFS1 plays an 
additional role in HMWS formation, e.g., as a scaffold for assembling or solubilizing an 
Fe−S species. We then explored what reagent limits product formation for Fe−S cluster 
assembly reactions using SDUF under standard conditions (Fig. 2.6B). The Fe−S mineral 
is likely responsible for the increase in both the 400 nm absorbance and the apparent light 
scattering. The reaction started to plateau at ∼15 min, but adding L-cysteine at that point 
caused an abrupt rise in absorbance. This suggested that Fe−S mineral formation was 
limited due to depleted cysteine/sulfide, and that more of this material formed once extra 
cysteine was added. We wondered whether HMWS could function as a substrate for the 
chemical reconstitution of apo-target proteins. To test this, the SDUF reaction under 
standard conditions was repeated with a molar excess of the [2Fe-2S] cluster acceptor 
protein apo-FDX1. The reaction was analyzed by size-exclusion chromatography. An 
Fe−S cluster was incorporated into apo-FDX1 while less HMWS formed (Fig. 2.6C). 
Incorporation of mixtures under DTT-free conditions had features characteristic of a [2Fe-
2S] cluster, rather than the broad absorption at 400 nm that was due primarily to HMWS 
in reaction mixtures that contained DTT (Fig. 2.1A). In addition, the general increase in 
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Figure 2.6. Formation conditions and reaction properties of HMWS. (A) Size-
exclusion chromatogram, monitored at A280, of the SDUF complex incubated with 
DTT and S2− (black), Fe2+ and S2− (red), or Fe2+ and S2− using an SDUF complex in 
which NSF1 had been alkylated (green). (B) Kinetics of SDUF Fe−S cluster 
assembly reaction under standard conditions spiked (arrow) with 100 μM L-cysteine 
show that the plateau in 400 nm absorbance is due to depletion of cysteine/sulfide. 
(C) Size-exclusion chromatogram, monitored at A405, of the reaction mixture 
involving the SDUF complex in the absence (black) or presence (red) of apo-FDX1. 
(D) Size-exclusion chromatogram, monitored by absorbance at A405, of the isolated 
HMWS with (red) or without (black) added apo-FDX1. 
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absorption at all wavelengths that was attributed to light scattering from Fe−S mineral 
formation was diminished. To evaluate whether HMWS were also formed, a separate 
SDUF Fe−S cluster assembly reaction was analyzed after incubation for 1.5 h by size-
exclusion chromatography. Peaks that absorb at 405 nm for SDUF complex and the 
uncomplexed ISCU2 were detected (Fig. 2.7C), but not for HMWS or low molecular 
weight species (LMWS). At longer (>2h) time points, an absorbance peak near 400 nm 
developed along with general increase in absorbance at all wavelengths (Fig. 2.7D) that 
was consistent with Fe−S cluster-associated HMWS formation. Initial formation of 
HMWS (Figure 2.7C, shoulder at 10−11 mL) was confirmed for the 3.5 h sample. Thus, 
the DTT-free reactions delayed and suppressed the rate of HMWS formation compared to 
standard reactions. This can be rationalized by differences in the ability of cysteine and 
DTT to release the sulfide from a persulfide intermediate on the assembly complex. 
Generation of sulfide by cysteine (DTT-free assays) occurs through an intermolecular 
reaction, whereas the sulfide released by DTT (standard assays) involves an entropically 
favored intramolecular reaction that forms a disulfide-bonded six-membered ring. 
Sulfide converts [2Fe-2S] clusters to HMWS. Under standard conditions, the assembly 
reaction with SDUF failed to generate [2Fe-2S] CD signals (Fig. 2.1C), whereas with 
SDU, a [2Fe-2S] CD signal developed and then slowly decayed (Fig. 2.2D). We 
hypothesized that sulfide, which was generated rapidly for SDUF reactions and slowly for 
SDU reactions [31], reacted with synthesized [2Fe-2S] clusters to form HMWS. To test 
this, an assembly reaction involving SDU and DTT-free conditions was used to generate  
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Figure 2.7. Fe−S cluster assembly reactions under DTT-free conditions 
generate [2Fe-2S] clusters and delay HMWS formation. (A) Absorbance 
spectra for SDU-catalyzed Fe−S assembly reaction after 0 (black), 30 (red), 60 
(green), and 90 (blue) min. (B) Same for the SDUF-catalyzed reaction (same color 
coding, no 90 min spectrum). (C) Size-exclusion chromatogram, monitored at A405, 
of the SDUF Fe−S cluster assembly reaction after 1.5 (black) and 3.5 h (red). (D) 
Absorbance spectra for the reaction in panel C after 0 (black), 2 (green), 3.5 (red), 
and 5 (blue) h. 
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[2Fe-2S] clusters (Fig. 2.8A). Addition of Na2S immediately and dramatically decreased 
the magnitude of the [2Fe-2S] cluster signal (Fig. 2.8B). Lower concentrations of Na2S 
resulted in partial signal loss, whereas higher concentrations completely eliminated the 
signal (leaving only the PLP CD feature). The addition of sulfide also resulted in an overall 
increase in absorbance at all wavelengths. The CD and absorbance features are similar to 
those observed in SDUF reactions under standard conditions and suggest that bisulfide 
reacts with [2Fe-2S] cluster intermediates to generate HMWS. Thus, Fe−S cluster 
assembly reactions that generate bisulfide are prone to competing reactions for the 
synthesis and degradation of [2Fe-2S] clusters (see Discussion).  
FXN binding accelerates [2Fe-2S] cluster formation on ISCU2. Using DTT-free 
conditions that minimize the competing HMWS pathway, we assessed the role of FXN in 
the kinetics of [2Fe-2S] cluster formation. SDU- and SDUF catalyzed reactions were 
monitored by both absorption (panels A and B of Fig. 2.7, respectively) and CD (panels 
A and B of 2.9, respectively) spectroscopies. Strong absorbance and CD signals due to 
[2Fe-2S]-ISCU2 developed in both reactions, but the rates of formation were significantly 
more rapid in the SDUF-catalyzed reactions. Fitting the linear regions of the absorbance 
and CD kinetic traces (panels C and D of Fig. 2.9, respectively) revealed that FXN 
enhanced the rate of [2Fe-2S]-ISCU2 cluster formation by a factor of nearly 3. The 
addition of FXN increased the rate of absorbance change from 4.7 × 10−4 mM/min (R2 = 
0.99) to 13.4 × 10−4 mM/min (R2 = 0.99) (assuming an extinction coefficient of 4.58 mM−1 
cm−1 at 456 nm [23]). Notably, the absorbance increase did not plateau for either reaction, 
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Figure 2.8. Sulfide degrades [2Fe-2S] clusters bound to ISCU2. (A) Development 
of the [2Fe-2S] cluster CD signal after 0 (black), 30 (red), 60 (green), and 90 (blue) 
min for the SDU complex under DTT-free conditions. (B) Addition of 0 μM (black), 
250 μM (red), 500 μM (green), and 1 mM (blue) Na2S to the mixture for the completed 
reaction (90 min) from panel A. 
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Figure 2.9. FXN accelerates [2Fe-2S] cluster formation. (A) CD spectra of an 
SDU-catalyzed Fe−S cluster assembly reaction mixture after 0 (black), 30 (red), 
60 (green), and 90 (blue) min. (B) CD spectra of an SDUF-catalyzed Fe−S 
assembly reaction mixture after 0 (black), 30 (red), and 60 (green) min. (C) 
Absorbance at 456 nm vs time of reaction for SDU-catalyzed (blue) and SDUF 
catalyzed (red) reactions (shown in Figure 2.6A, B). (D) CD intensity at 330 nm 
vs time of reaction for SDU-catalyzed (blue) and SDUF-catalyzed (red) 
reactions. Bars are replicate errors from three experiments. 
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consistent with the initial formation of [2Fe-2S] clusters and the generation of HMWS at 
later times (Fig.2.7C, D). In contrast, the CD intensity is more specific for protein-bound 
[2Fe-2S]2+ clusters. Addition of FXN increased the rate of CD signal growth from 0.40 × 
10−4 mM/min (R2 =0.99) to 0.97 × 10−4 mM/min (R2 = 0.99). The CD ellipticity at 330 
nm plateaued at ∼20 mdeg after ∼30 min for the SDUF reaction and after ∼100 min for 
the SDU reaction (Fig. 2.9D). The ∼20 mdeg value corresponds to a [2Fe-2S] cluster 
concentration of ∼30 μM [83], the concentration of ISCU2 used in these experiments. 
Thus, the plateau in the CD intensity is consistent with the reaction halting after all of the 
ISCU2 in the solution became bound with [2Fe-2S] clusters. These data also indicate that 
these [2Fe-2S] clusters are not converted to another Fe−S species. Notably, alternate 
species such as Fe−S minerals [4Fe-4S] clusters [56, 95] and [2Fe-2S] clusters associated 
with small molecules rather than proteins [96] do not significantly contribute to this region 
of the CD spectrum. Overall, these data demonstrate that adding FXN to the SDU complex 
increases the rate at which the complex synthesizes [2Fe-2S] clusters on ISCU2. 
Discussion 
Experiments to identify reaction intermediates and elucidate mechanistic details of 
biosynthetic pathways often rely on monitoring reaction progress with kinetic 
measurements. This is challenging for Fe−S cluster biosynthesis researchers because the 
substrates (iron, cysteine, and reducing equivalents) and byproducts (sulfide) also undergo 
competing non-enzymatic Fe−S cluster self-assembly [72] and mineralization chemistry. 
Additionally, the synthesized Fe−S clusters are capable of undergoing ligand exchange 
and cluster conversion reactions [73]. These competing reactions complicate the 
 38 
 
interpretation of results and limit mechanistic insight. It is therefore important to elucidate 
factors that partition reaction intermediates between these competing pathways and to 
understand the types and properties of Fe−S species that are being generated. Here we 
have identified conditions that favor pathways that intercept intermediates in Fe−S cluster 
biosynthesis. We have shown how to minimize this competing pathway by limiting sulfide 
generation and have provided insight into the reaction chemistry associated with human 
Fe−S cluster biosynthesis. Fe−S cluster assembly reactions under standard conditions 
generated products with absorbance and CD properties consistent with [4Fe-4S] clusters. 
The generation of [4Fe-4S] clusters is consistent with a recent proposal for the murine Fe− 
S biosynthetic system in which FXN was proposed to have a role in generating [4Fe-4S] 
cluster intermediates on the assembly complex [89]. However, Mössbauer and 
biochemical studies revealed that reactions for the human assembly complex under similar 
conditions generate Fe−S mineral or high molecular weight species (HMWS) and not 
[4Fe-4S] clusters. The HMWS are an iron-, sulfide-, and protein-containing material that 
exhibits Mössbauer spectra with a quadrupole doublet that is similar to those of Fe−S 
minerals such as pyrite (δ = 0.25−0.43 mm/s, and ΔEQ = 0.61−0.66 mm/s). The Mössbauer 
parameters of the HMWS doublet are also similar to those assigned to [2Fe-2S]-GSH (δ 
= 0.393 mm/s, and ΔEQ = 0.676 mm/s) [96]. However, the spectroscopic properties of 
HMWS are not consistent with well-characterized [2Fe-2S]2+ or [4Fe-4S]2+ clusters. The 
former clusters generally have δ = 0.25−0.30 mm/s and ΔEQ = 0.7−0.8 mm/s. [4Fe-4S]2+ 
clusters have δ = 0.44−0.46 mm/s and ΔEQ = 0.6−1.5 mm/ s. Another important difference 
is that the HMWS exhibit magnetic hyperfine interactions (rather than a doublet) at low 
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temperatures. This spectral feature collapses into the doublet at higher temperatures. This 
behavior is distinctly different from those of S = 0 [2Fe-2S]2+ or [4Fe-4S]2+ clusters that 
exhibit doublets at both low and high temperatures. Also, the HMWS lack an S = 1/2 EPR 
signal (with or without added dithionite). Fe−S cluster-associated HMWS have been 
generated during chemical reconstitution of [4Fe-4S] cluster-containing radical SAM 
enzymes [97]. Standard in vitro Fe−S assembly reactions generate HMWS by intercepting 
persulfide and [2Fe-2S] cluster intermediates. In humans, a persulfide intermediate on the 
NFS1 component of the assembly complex is generated (Fig. 2.10, reaction A) and 
transferred to ISCU2 (Fig. 2.10, reaction B) as an initiating step in Fe−S cluster 
biosynthesis [33]. Addition of iron and reducing equivalents converts the terminal sulfur 
of this persulfide species into the bridging sulfur of a [2Fe-2S] cluster ( Fig. 2.10, reaction 
C) [33]. Transfer of the [2Fe-2S] cluster intermediate to a target protein completes the 
catalytic cycle for the assembly complex (Fig. 2.10, reaction D). Nucleophilic reagents 
such as surrogate electron donor DTT and the substrate cysteine can attack or intercept 
protein-bound persulfide intermediates to produce sulfide ions (Figure 2.10, reaction E). 
Subsequent reaction of sulfide (or bisulfide) with iron and the assembly complex generates 
HMWS (Figure 2.10, reaction F). Sulfide also appears to be capable of reacting with [2Fe-
2S] intermediates and forming HMWS (Fig. 2.10, reaction G), a process that may be 
accelerated by the addition of FXN. Similar thiol-based extrusion of [2Fe-2S] clusters 
from proteins has been reported [67, 98]. The two separate paths for forming HMWS are 
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Figure 2.10. Model for competing Fe−S cluster biosynthesis and mineralization 
pathways. (A) Generation of a persulfide intermediate on NFS1. (B) Transfer of sulfur 
from NFS1 to ISCU2. (C) Catalytic synthesis of a [2Fe-2S] cluster intermediate. (D) 
Transfer of the [2Fe-2S] cluster to apo target proteins. (E) Interception of the 
persulfide intermediate with reductive thiol reagents to produce sulfide. (F) 
Combination of sulfide, iron, and the assembly complex (not shown) to form HMWS. 
(G) Degradation of [2Fe-2S] intermediates by sulfide to form HMWS. (H) Chemical 
reconstitution of apo target protein by HMWS. FXN accelerates [2Fe-2S] cluster 
formation (green arrows) by the human Fe−S assembly complex. 
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supported by recent kinetic studies of SDUC35AF and SDUC61AF complexes that exhibit 
nativelike cysteine desulfurase activities but compromised Fe−S assembly activities under 
standard conditions [33]. The slow increase in absorbance for SDUC35AF and SDUC61AF 
complexes compared to that of native SDUF is likely due to a functional persulfide 
cleavage pathway (Fig. 2.10, reactions E and F) but compromised biosynthetic route 
(Fig.2.10, reactions A−C and G) to HMWS. The ISCU2 variants for the SDUC35AF and 
SDUC61AF complexes have mutations in the conserved cysteines used for cluster 
biosynthesis. These different routes to HMWS may correspond to the initial rapid 
(biosynthetic route) and secondary slow linear (persulfide cleavage route) changes in 
absorbance under standard conditions. Overall, these results indicate that Fe−S cluster 
assembly assays under standard (DTT-containing) conditions may be qualitatively 
informative (representing primarily the enzymatic [2Fe-2S] biosynthesis and degradation 
pathway) but are not quantitatively meaningful for measuring the rate of [2Fe-2S] cluster 
synthesis by the assembly complex.  
We elucidated details of the human Fe−S cluster biosynthetic process by 
identifying reaction conditions that minimize the competing non-enzymatic pathways and 
by monitoring reaction progress with spectroscopic methods that are uniquely sensitive to 
[2Fe-2S] clusters bound to proteins. Previously, human FXN was shown to stimulate the 
cysteine desulfurase activity (10-fold higher kcat for sulfide production) [31] and facilitate 
the accumulation of persulfide species on ISCU2 [33]. Here, we explored the kinetics of 
[2Fe-2S] cluster formation under DTT-free conditions. Addition of FXN accelerated the 
rate of development for [2Fe-2S] CD features and resulted in approximately one [2Fe-2S] 
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cluster per ISCU2 molecule. We show by Mössbauer spectroscopy and liquid 
chromatography that, under similar conditions, [2Fe-2S] clusters are present on 
uncomplexed ISCU2. Together, these results support a model in which FXN accelerates 
[2Fe-2S] cluster formation on the SDUF complex (green arrows in Fig. 2.10, presumably 
using cysteine as the electron donor) [73]. This conclusion is supported by recent in vitro 
studies of a primarily Saccharomyces cerevisiae system in which the rate of formation for 
a [2Fe-2S]-Isu1 CD signal was dependent on the addition of Yfh1 (FXN homologue) [81]. 
Interestingly, the addition of the presumed physiological electron donation system (FDX2, 
ferredoxin reductase, and NADPH) or non-physiological electron donor DTT resulted in 
similar rates for the development of the [2Fe-2S]-Isu1 CD signal in the yeast system. This 
is in contrast to the human system in which the addition of DTT eliminates the [2Fe-2S]-
ISCU2 CD signal. Thus, there are fundamental differences in the response of the human 
and yeast in vitro systems to surrogate electron donor DTT. In the future, these in vitro 
studies need to be expanded to evaluate complete cluster synthesis and transfer reactions 
that include chaperones, intermediate carrier proteins, and different Fe−S target proteins.  
In summary, we have provided new details of competing pathways for Fe−S 
cluster biosynthesis and Fe−S mineralization. The partitioning of reaction intermediates 
complicates the interpretation of in vitro Fe−S assembly results. Deconvoluting the 
enzymatic and mineralization processes is challenging as there appears to be multiple 
partitioning branch points, comparable formation kinetics (both ultimately depend on 
cysteine turnover by NFS1), overlapping absorbance properties, products that co-elute on 
desalting columns, and similar abilities to transfer (Fig. 2.10, reaction D) or chemically 
 43 
 
reconstitute (Fig. 2.10, reaction H) Fe−S clusters on target proteins. In these cases, 
performing reactions under conditions that minimize off-pathway reactions and 
monitoring the kinetics with multiple interrelated spectroscopic methods may be required 
to elucidate mechanistic details for the assembly and/or transfer of Fe−S clusters. 
Together, our current and previous [31, 33] results are consistent with yeast studies [81, 
99] and indicate that FXN accelerates a rate-limiting sulfur transfer step in [2Fe-2S] 
cluster synthesis for the human Fe−S assembly complex. Our study also tells a cautionary 
tale of the complexities of Fe−S chemistry that could easily mislead unsuspecting 
researchers who study Fe−S cluster assembly or chemically reconstitute recombinant 
Fe−S proteins. 
Materials and Methods 
Protein expression and purification. NFS1-ISD11 (named SD), ISCU2, and FXN were 
purified as described previously [31]. The SDUF complex exhibited a cysteine desulfurase 
activity of 11 mol of sulfide (mol of PLP)−1min−1, which is similar to reported values [31, 
46]. Briefly, plasmids that contain the genes for human SD, ISCU2, and FXN were 
individually transformed into BL21(DE3) cells. Cells were grown at 37 °C until an OD600 
of 0.6 was achieved. Protein expression was induced with either 0.5 mM (ISCU2 and 
FXN) or 0.1 mM (SD) IPTG; the temperature was reduced to 16 °C, and the cells were 
harvested 16 h later. Plasmid PET9 encoding human ferredoxin (FDX1, gift of J. Markley) 
was transformed into Escherichia coli BL21(DE3) cells and grown at 37 °C until an OD600 
of 0.6 was reached. Expression was induced with 0.4 mM IPTG, 1 mM cysteine, and 0.1 
mg/mL ferric ammonium citrate, and the cells were harvested 16 h later. Buffer A [50 mM 
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HEPES (pH 7.8) and 250 mM NaCl] was used for all experiments unless otherwise stated. 
The cells were lysed by sonication, and the soluble proteins were loaded onto an anion 
exchange column (26/20 POROS 50HQ, Applied Biosystems) and eluted with a linear 
gradient from 0 to 1000 mM NaCl in 50 mM Tris (pH 7.5). Fractions containing FDX1 
were further purified on a Sephacryl S100 (26/60, GE Healthcare) size-exclusion column 
equilibrated in 50 mM Tris (pH 7.4) and 50 mM NaCl. Apo-FDX1 was prepared by 
incubating purified FDX1 with 10 mM DTT, adding 10% trichloroacetic acid on ice for 
10 min, pelleting the sample, rinsing the pellet twice with water, and resuspending the 
pellet anaerobically in 50 mM Tris (pH 8.0) and 250 mM NaCl. Anaerobic experiments 
were performed in an Mbraun glovebox at ∼12 °C with an argon atmosphere and <1 ppm 
O2 as monitored by a Teledyne model 310 analyzer.  
Fe−S cluster formation assays. The Fe−S cluster assembly assay mixtures under two 
experimental conditions (standard and DTT-free) were prepared anaerobically and 
transferred to a 1 cm path length anaerobic cuvette for UV−visible (Agilent UV−visible 
8453) and circular dichroism (CD) (Chirascan) data collection at 20 °C. Standard assay 
conditions include 10 μM SD, 30 μM ISCU2, 30 μM FXN with 4 mM D, L-DTT, 100 μM 
L-cysteine, and either 250 or 400 μM Fe(NH4)2(SO4)2. Final volumes were 250 μL for 
UV−visible based and 200 or 400 μL for CD-based assays. DTT-free conditions were the 
same as standard conditions except that (a) the L-cysteine concentration was increased to 
1 mM, (b) samples lacked DTT, and (c) the Fe(NH4)2(SO4)2 concentration was decreased 
from 400 to 250 μM. The initial linear regions for the SDU and SDUF reactions under 
DTT-free conditions were fit using KaleidaGraph (Synergy Software). For the sulfide 
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addition experiments, the development of the [2Fe-2S] cluster using 50 μM ISCU2 was 
monitored with anaerobic CD spectroscopy under DTT-free conditions. Once the CD 
signal at 330 nm had been maximized (indicating the development of the [2Fe-2S] 
species), aliquots of a Na2S stock solution were added to final Na2S concentrations of 250, 
500, and 1000 μM and the CD spectra were immediately measured. 
 Protein assembly state analysis. Sample mixtures of 50 μM SD and 150 μM ISCU2 with 
(SDUF) or without (SDU) 150 μM FXN were incubated anaerobically for 20 min at 10 
°C with 1.5 mM DTT, 500 μM Fe(NH4)2(SO4)2, and 500 μM L-cysteine (complete reaction 
conditions). Additional reactions lacking DTT, Fe(NH4)2(SO4)2 and/or L-cysteine were 
also prepared. Samples were applied to an anaerobic S-200 column (Superdex 200 10/300 
GL, GE Healthcare) equilibrated with buffer A. In a second set of experiments, NFS1 was 
alkylated by incubating 50 μM SD with 1 mM iodoacetamide for 1 h at 12 °C and 
quenched with 10 mM L-cysteine. Modification of NFS1 residue C381 was confirmed by 
mass spectrometry. Alkylated or nonalkylated SD was reacted for 15 min at 12 °C with 
50 μM ISCU2, 50 μM FXN, 200 μM Fe(NH4)2(SO4)2, 1.5 mM DTT, and 200 μM Na2S 
(final concentrations, 0.2−0.5 mL reaction volume) and applied to the S-200 column. In a 
third set of experiments, 100 μM SDUF (final concentration) was prepared by mixing 100 
μM SD, 300 μM ISCU2, 300 μM FXN, 1 mM Fe(NH4)2(SO4)2, and 3 mM DTT in the 
presence and absence of 500 μM apo-FDX1. The reaction was initiated with 1 mM L-
cysteine (final concentration, 0.2−0.5 mL reaction volume). After reacting for 45 min at 
12 °C, the solution was applied to an S-200 column. The reaction without apo-FDX1 was 
repeated, and the high-molecular weight species (HMWS) was isolated from fractions of 
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the S-200 column. The HMWS sample was split, and half was incubated for 10 min with 
4 mM DTT. The other half was incubated for 40 min with 500 μM apo-FDX1 and 4 mM 
DTT. Samples were then reapplied to an S-200 column. Calibration with molecular weight 
standards confirmed that the protein samples eluted at volumes corresponding to their 
known molecular masses. Sulfide production was measured using a methylene blue assay 
[31, 100, 101]. Iron was quantified by the ferrozine assay [102-104]. 
Mössbauer analysis of HMWS. Mössbauer samples of HMWS were prepared by 
reacting 600 μM SD or SDUF with 6 mM L-cysteine, 6 mM 57ferric citrate, and 1.8 mM 
DTT for 45 min at 12 °C, and isolating the HMWS using an S-200 column equilibrated in 
buffer A. Mössbauer spectra were recorded using a model MS4 WRC spectrometer (See 
Co., Edina, MN) at 0.05 T applied parallel to the γ radiation. Spectra were analyzed using 
WMOSS software (SEE Co.). Parameters are quoted relative to α-Fe foil at 298 K. 
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CHAPTER III 
CYAY INHIBITS CLUSTER FORMATION ON ISCU BY SLOWING DOWN 
SULFUR TRANSFER FROM ISCS TO ISCU 
Introduction 
Iron sulfur clusters are essential protein cofactors for most living organisms in all 
three domains of life [69]. They play crucial roles in electron transport, catalysis, 
regulation of gene expression, iron homeostasis etc. [6, 105]. Hence, iron sulfur cluster 
biosynthesis needs to be very tightly regulated. In prokaryotes, three iron sulfur cluster 
biosynthesis pathways are known – 1) Nitrogen fixation (NIF) [106, 107], 2) Iron sulfur 
cluster assembly (ISC) [108-110] and 3) Sulfur Formation pathway (SUF) [111]. Among 
these, ISC pathway is the housekeeping pathway and operates under ‘normal’ growth 
conditions. On the other hand, NIF and SUF are more specialized systems. NIF is used 
exclusively to synthesize iron sulfur clusters on nitrogenase whereas SUF is employed to 
make iron sulfur cluster under oxidative stress and limited iron conditions [112]. ISC 
pathway is also the only pathway that is shared between prokaryotes and eukaryotes. 
Therefore, the proteins involved in ISC pathway are highly conserved. In E. coli, ISC 
operon encodes genes for IscR (iron sulfur cluster containing transcriptional regulator), 
IscS (cysteine desulfurase) [113], IscU (scaffold protein) [23, 114], IscA (alternate 
scaffold/iron donor) [115-117], HscB (co-chaperone) [83, 118], HscA (chaperone) [83, 
119], Fdx (putative electron donor) [120, 121] and IscX (effector) [28, 122]. 
The mechanism of iron sulfur cluster biosynthesis is also very well conserved 
across prokaryotes and eukaryotes. IscU is the scaffold protein on which the cluster is 
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assembled. IscS is a PLP dependent cysteine desulfurase that provides the sulfur to 
scaffold protein IscU in the form of a persulfide via an absolutely conserved mobile loop 
cysteine assisted conversion of cysteine to alanine. That sulfane sulfur then reacts with 
ferrous iron and electrons provided most likely from reduced Fdx to form a [2Fe2S]2+ on 
IscU in a process that is still very poorly understood. The scaffold protein then transfers 
the cluster to Grx4 in a reaction accelerated by HscA-HscB pair in an ATP dependent 
manner. Grx4 then transfers the clusters downstream to terminal acceptors like Fdx, 
Rieske etc. 
Frataxin (FXN), a eukaryotic protein, has been shown to act as an allosteric 
activator of the eukaryotic cysteine desulfurase [31]. It activates iron sulfur cluster 
biosynthesis in eukaryotes by accelerating quinonoid decay and sulfur transfer from 
cysteine desulfurase (NFS1) to scaffold protein (ISCU2) (Chapter IV). Absence of this 
activation without FXN such as in neurodegenerative disease Friedreich’s Ataxia (FRDA) 
[123, 124] leads to impairment of iron sulfur cluster biosynthesis, severe iron overload in 
mitochondria and subsequent elevated oxidative stress that cause severe damage to the 
cell leading to cell death [125-127]. It may also cause neurodegenerative disease 
Friedreich’s Ataxia. In stark contrast to eukaryotic system, CyaY (bacterial homolog of 
FXN) has been shown to inhibit iron sulfur cluster assembly on scaffold protein in vitro 
[128]. It was later shown that FXN also inhibits iron sulfur cluster biosynthesis on E. coli 
IscU and that the inhibitory effect of CyaY/FXN is dependent on cysteine desulfurase 
(prokaryotic vs. eukaryotic) [46]. However, the exact mechanism of how CyaY inhibits 
iron sulfur cluster biosynthesis on IscU is still unknown. Deletion of CyaY did not produce 
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any of the phenotypes associated with FXN deletion most likely because under normal 
growth conditions, iron sulfur cluster biosynthesis is not required to be slowed 
down/inhibited [128]. However, it was recently shown that CyaY is required for cellular 
fitness under oxidative stress and limited iron conditions and has an overall positive role 
[122, 129, 130]. Along the same line, a single mutation (I108M) on IscU was shown to 
make the cell dependent on CyaY by somehow slowing down iron sulfur cluster 
biosynthesis creating condition of oxidative stress [131]. 
In this study, we aimed to determine how CyaY inhibits iron sulfur cluster biosynthesis 
on IscU and whether the inhibition translates to a slower rate of cluster delivery to terminal 
targets. Furthermore, we tested if CyaY has any effect on the process of iorn-sulfur cluster 
transfer from holo-IscU to apo-Grx4. We also investigated in detail the effect of I108M 
mutation on E. coli IscU on the rate of cluster assembly on IscU in presence and absence 
of CyaY. Using a combination of stopped flow experiments, a novel persulfide formation 
assay and CD spectroscopy, we determined that CyaY slows down iron sulfur cluster 
formation on IscU by inhibiting sulfur transfer from IscS to IscU and that the inhibitory 
effect is indeed translated to slower rate of cluster delivery to Grx4 which functions as an 
intermediate cluster carrier. Moreover, we did not see any effect of IscUI108M mutation in 
presence or absence of CyaY. 
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Results 
Both CyaY and IscUI108M do not affect quinonoid decay2. It has been shown that FXN 
as well as CyaY accelerate quinonoid decay for eukaryotic cysteine desulfurase resulting 
in facilitated production of persulfide on mobile loop cysteine of NFS1 (Chapter IV). This 
is in accordance with previously published result that both FXN and CyaY act as allosteric 
activators of eukaryotic cysteine desulfurase. To determine whether or not CyaY slows 
down quinonoid decay for prokaryotic cysteine desulfurase IscS, we decided to monitor 
the formation and decay kinetics of quinonoid intermediate using stopped-flow 
spectroscopy. For this, we determined the λmax (wavelength of maximal absorbance) for 
the quinonoid, aldimine and ketimine intermediates by scanning a 100 nm window in the 
range of 300 nm to 700 nm every 2 ms for 2 s (see methods). This gave us λmax of 
quinonoid and aldimine intermediate as 508 nm and 410 nm respectively. Unfortunately, 
we did not see a peak around 340 nm for ketimine intermediate in any of our runs. We 
decided to use 340 nm to monitor the kinetics of ketimine intermediate nevertheless as 
this wavelength has been previously used to monitor ketamine intermediates [75]. As can 
be seen in Fig. 3.1A-D, quinonoid decay kinetics looks very similar for all the complexes 
and the rates of quinonoid decay were found to be very similar when fitted to consecutive 
B equation (Table 3.1) with no effect of CyaY or IscUI108M on quinonoid decay. We also 
followed aldimine and ketimine formation kinetics by monitoring 410 nm and 340 nm  
                                                 
2 The experiments in this section are performed and analyzed by Shachin Patra from Barondeau group at 
Texas A&M University. 
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Figure 3.1. Both CyaY and IscUI108M do not affect the rate of quinonoid formation 
and decay. The formation and decay of quinonoid intermediate were monitored by 
stopped flow at 508 nm wavelength. Reaction contained 50 µM of all the proteins 
(IscS, IscU/IscUI108M, CyaY) and 5 mM cysteine (final concentrations). Reactions 
were carried out in absence (A, C), and presence (B, D) of CyaY for WT IscU and 
IscUI108M respectively. The rates were obtained by fitting the data to the equation 
[y=y0 + A*(m1/(m3-m2))(exp(-m2*x)-exp(-m3*x))], where m2 and m3 values give 
the apparent rate of formation and decay of the quinoid intermediate respectively. 
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Table 3.1. Effect of CyaY and ISCUI108M on kinetic parameters on all the steps in 
iron sulfur cluster biosynthetic pathway. 
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respectively for SU and SUC complex. The kinetics were found to be similar in presence 
and absence of CyaY. 
CyaY inhibits sulfur transfer from IscS to IscU but does not affect persulfide 
formation on IscS3. Next, we wanted to see if CyaY has any effect on persulfide 
formation on IscS and IscU which is the next downstream step after PLP chemistry. We 
incubated IscS and IscU in presence and absence of CyaY with cysteine that contains trace 
amount of radioactive 35S-cysteine. We then quenched the reaction at different time points, 
separated proteins using HPLC (Fig. 3.2A) and quantified the amount of radioactivity via 
scintillation counting. The amount of radioactivity associated was then converted to the 
amount of persulfide on each protein using a standard curve. As can be seen in Fig. 3.2B, 
overall kinetics of persulfide formation on IscS in presence and absence of CyaY looked 
very similar but the extent of reaction completed were different. This corresponds well 
with our previous observation that CyaY does not affect PLP chemistry, which directly 
results in persulfide formation on IscS. Contrary to this, CyaY significantly slowed down 
sulfur transfer from IscS to IscU (Fig. 3.2C). Interestingly, this contrasts with the effect of 
FXN on human system where FXN accelerates sulfur transfer from NFS1 to ISCU2. 
 
 
                                                 
3 The experiments in this section are performed and analyzed by Shachin Patra from Barondeau group at 
Texas A&M University. 
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Figure 3.2. CyaY does not affect the rate of persulfide formation on IscS but slows 
down persulfide formation on IscU. (A) Separation of proteins by HPLC. 50 µM IscS, 
150 µM IscU and 50 µM CyaY were loaded onto Deltapack C4 column after diluting 
with quenching solution in 1:3 ratios to a final volume of 200 µL (see methods). 
Chromatogram shows that IscS and IscU are well separated. Although CyaY co-elutes 
with IscS, that does not affect our analysis. (B), (C) Persulfide formation on IscS and 
IscU in presence and absence of CyaY was monitored by reacting 30 uM of IscS, IscU, 
CyaY and Cysteine (containing 0.204% 35S-cysteine) at 37ºC for different time (in 0 - 
20 min range). The samples were analyzed with HPLC and scintillation cocktail was 
added after quenching with 1:4 mixture of conc. HCl and 6M guanidine hydrochloride 
at given time points. The area under IscS and IscU in scintillation trace were converted 
into amounts of persulfide using a standard curve made from 35S-cysteine standard. The 
data were fitted with exponential rise equation [y=m1+m2*(1-exp (-m3*x))] where m3 
value gives the apparent rate of formation which is plotted in (D). 
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CyaY and IscUI108M do not affect cysteine desulfurase activity4. Cysteine desulfurase 
activity for all four complexes (SU, SUC, SUI108M, SUI108MC) were measured according 
to previously published protocol. Cysteine desulfurase activity was comparable for all four 
complexes (Fig. 3.3A-D). The absence of an inhibitory effect of CyaY is consistent with 
the lack of any effect on quinonoid decay and persulfide formation on IscS. 
CyaY inhibits iron sulfur cluster formation on scaffold protein while IscUI108M has 
no effect. Iron sulfur cluster formation rates on scaffold protein (IscU or IscUI108M) in 
presence and absence of CyaY were determined using CD spectroscopy by monitoring the 
ellipticity change at 330 nm. Consistent with previously published results, CyaY was 
observed to strongly inhibit iron sulfur cluster formation on scaffold protein (Fig. 3.4). 
This inhibition can be explained as a direct consequence of inhibited sulfur transfer to 
scaffold protein. On the other hand, contrary to literature, the rates were comparable for 
SU and SUI108M in absence of CyaY. Moreover, CyaY did not accelerate iron sulfur cluster 
synthesis in the case of IscUI108M as had been suggested in literature.  
CyaY does not affect iron sulfur cluster transfer from IscU to Grx4. Next, we wanted 
to explore if CyaY has any other effect(s) on cluster biosynthesis process in addition to 
inhibition of cluster assembly on scaffold protein IscU. To determine if CyaY has any 
effect on cluster transfer step, we reconstituted IscU (see methods) followed by addition 
of apo-Grx4 to initiate the reaction. The cluster transfer reaction was monitored using CD 
                                                 
4 The experiments in this section are performed and analyzed by Shachin Patra from Barondeau group at 
Texas A&M University. 
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Figure 3.3. Both CyaY and IscUI108M do not affect cysteine desulfurase activity. The 
reactions contained 0.5 µM IscS, 2.5 µM IscU/IscUI108M, 5 µM CyaY, 4 mM D, L-DTT. 
Reactions were carried out in absence (A, C), and presence (B, D) of CyaY for WT IscU 
and IscUI108M respectively. Reactions were initiated by adding cysteine and incubated for 
6 min before quenching with DPD and FeCl3 solution. Solutions were further incubated 
for 20 min. Then the samples were centrifuged and absorbances at 670 nm were measured 
which were converted to concentration of sulfide using a standard curve generated from 
known amount of sulfide. The data points were fitted to Michaelis-Menten equation (y = 
m1*x/(m2 + x)), where m1 and m2 are kcat and KM respectively.). 
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Figure 3.4. CyaY inhibits cluster assembly on IscU/IscUI108M. Reaction consists of 8 
µM IscS, 40 µM IscU (A) or IscUI108M (B), 200 µM Fe2(NH4)2SO4 in the presence and 
absence of 50 µM CyaY and initiated by the addition of 10 mM GSH and 100 µM 
cysteine.  
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spectroscopy by monitoring ellipticity change at 450 nm (where Holo-Grx4 has much 
larger contribution compared to Holo-IscU). The rates were found to be comparable with 
and without CyaY. This shows that CyaY does not affect cluster transfer from holo-IscU 
to apo-Grx4. 
CyaY inhibits one-pot cluster synthesis on Grx4 while IscUI108M has no effect. We 
further tested whether or not the inhibitory effect of CyaY on sulfur transfer step and 
consequently, iron sulfur cluster assembly on scaffold protein results in inhibition of holo-
Grx4 synthesis in a one-pot reaction where Holo-IscU is not pre-formed and cluster 
assembly on Grx4 is monitored by recording ellipticity change at 450 nm. CyaY strongly 
inhibited cluster synthesis on Grx4 (Fig. 3.5). On the other hand, IscUI108M had no effect. 
This is in stark contrast to the effect of opposite mutation on human ISCU2M106I which has 
been shown to accelerate cluster transfer from ISCU2 to GRX5. 
Discussion 
Although it has been well known for a long time that CyaY inhibits iron sulfur cluster 
synthesis on scaffold protein IscU [46, 132, 133], the mechanism of inhibition remained 
unknown. More specifically, it remained to be discovered which upstream step(s) is 
specifically inhibited by CyaY. Using a step-wise detailed analysis of the effects of CyaY 
on each and every upstream step and one downstream step, we sought to pinpoint the 
step(s) affected by CyaY. To accomplish this, we divided the whole pathway into four 
major steps – 1) persulfide formation, 2) sulfur transfer, 3) cluster synthesis and 4) cluster  
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Figure 3.5. CyaY inhibits one pot cluster assembly on Grx4 while IscUI108M 
has no effect. Reactions included 0.5 µM IscS, 20 µM IscU (A) or IscUI108M (B) 
200 µM Fe2(NH4)2SO4 and 40 µM Grx4 in the presence and absence of 40 µM 
CyaY. The reaction was initiated with addition of 100 µM cysteine and 10 mM 
GSH. Cluster assembly on apo-Grx4 was measured by monitoring ellipticity at 
450 nm.  
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transfer (Fig. 3.6). We were aware that FXN activates persulfide formation on NFS1 by 
accelerating quinonoid decay. Therefore, we first tested if CyaY affects quinonoid decay. 
Using stopped-flow spectroscopy, we found that CyaY does not affect quinonoid decay. 
Interestingly, we observed that mobile loop cysteine (C328) of IscS is the proton donor 
that causes quinonoid decay to ketimine. The same result had been obtained for human 
system where mobile loop cysteine of NFS1 was the proton donor (chapter II). This 
strongly suggests that despite the structural and functional differences of prokaryotic and 
eukaryotic type-I cysteine desulfurases, proton donation to quinonoid via mobile loop 
cysteine is common mechanistic step for all type-I cysteine desulfurases. Also, similar 
effect was observed when mobile loop cysteine of SufS of Synechocystis sp. PCC 6803 
(a type-II cysteine desulfurase) was mutated to alanine [75]. This further suggests that 
mobile loop proton donation to quinonoid occurs for all cysteine desulfurases. It will be 
interesting to understand why mobile loop cysteine became the obligate proton donor for 
quinonoid decay instead of PLP-binding lysine residue which has been shown to function 
as proton donor in a number of cases. 
Next, we examined if CyaY inhibits persulfide formation on IscS and IscU. Using 
the persulfide formation assay, we found that CyaY does not affect persulfide formation 
on IscS. This is consistent with our observation that CyaY does not accelerate quinonoid 
decay. It is unlike the effect of FXN on human system where FXN was shown to accelerate 
persulfide formation on NFS1. This suggests that unlike FXN based activation, CyaY does 
not perturb mobile loop trajectory. Further, we found that CyaY did not affect cysteine 
desulfurase activity, consistent with previous literature. As persulfide formation on IscS  
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Figure 3.6 Schematic diagram showing the effect of CyaY and IscUI108M on each 
step. CyaY inhibits only sulfur transfer step and IscUI108M has no effect 
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remained same in presence of CyaY, persulfide cleavage step must also be similar to result 
in similar rate of sulfide production in methylene blue assay. From this, we can further 
deduce that CyaY does not perturb electrophilicity of the mobile loop persulfide which is 
in a stark contrast to FXN. However, in that same persulfide formation assay, we found 
that CyaY strongly inhibits persulfide formation on IscU. This is exactly opposite to the 
effect of FXN which, has been shown to accelerate persulfide formation on ISCU2. The 
question is how does CyaY inhibits persulfide formation on IscU. As we deduced earlier 
that CyaY does not perturb either mobile loop trajectory or electrophilicity, we think CyaY 
may be causing a small conformational change in IscU, which results in misalignment of 
mobile loop trajectory and the cysteine residue on IscU that accepts sulfane sulfur. In 
absence of crystal structure of SUC complex, it is extremely difficult to determine if this 
is the case. It is also possible that CyaY simply sterically prevents mobile loop cysteine 
from reaching to IscU and prevents sulfur transfer, which has been predicted using an in-
silico study [134]. As expected, consistent with previous literature, CyaY was also found 
to strongly inhibit iron sulfur cluster formation on IscU. This shows that inhibition of 
sulfur transfer to scaffold protein directly translates into the inhibition of iron sulfur cluster 
biosynthesis. 
After successfully determining sulfur transfer as the step that is primarily inhibited 
by CyaY resulting in slower iron sulfur cluster formation on IscU, we went further to 
determine - 1) if CyaY has any further role down-stream and 2) if this inhibitory effect 
translates to a slower rate of cluster synthesis on downstream acceptors. We found that 
CyaY does not affect cluster transfer from holo-IscU to apo-Grx4 but inhibits one-pot 
 63 
 
cluster synthesis on Grx4. This shows that the inhibitory effect of CyaY on IscU cluster 
assembly slows down overall cluster biosynthesis process. This leads us to an important 
question - how does this inhibitory effect affect fitness of an organism? We can predict 
that in absence of CyaY, an organism will produce iron sulfur cluster at a much faster rate. 
However, this also means transcriptional regulator IscR will also get iron-sulfur cluster 
faster and will start repressing protein translation to prevent overproduction of iron sulfur 
cluster i.e. iron sulfur cluster production will remain normal in absence of CyaY and there 
would not be any usual phenotypes such as growth defect, unusual activity of iron sulfur 
cluster containing proteins etc. That is exactly what has been reported for CyaY deleted 
strain when grown in normal rich media [122, 128]. However, a number of publications 
also reported that CyaY deletion affects organism’s fitness under specific conditions and 
proposed that CyaY has a positive role in iron sulfur cluster biosynthesis. However, those 
reports did not discuss the inhibitory effect of CyaY in vitro and how this inhibitory effect 
may make CyaY important under those conditions. It has been shown that when YggX 
and ApbC genes were deleted together or separately, the presence of CyaY becomes 
crucial. YggX has been shown to sequester Fe(II) from participating in Fenton chemistry 
while keeping it available for iron dependent cellular processes and thereby preventing 
oxidative damage[135, 136]. ApbC is a member of MinD protein family and takes part in 
iron sulfur cluster metabolism process [137-140]. Understandably, absence of ApbC 
results in iron sulfur cluster metabolism defect and subsequent oxidative stress. When cells 
were grown in presence of H2O2, NO or paraquat, deletion of CyaY inhibited growth. This 
inhibition was exacerbated when YggX was also deleted [129]. Considering these results, 
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CyaY definitely seems to have a positive effect on the fitness of organism under oxidative 
stress conditions. Interestingly, IscR deletion strain which cannot regulate iron sulfur 
production through transcriptional inhibition becomes hypersensitive to oxidative stress 
just like CyaY deletion strain [141]. It seems as if iron sulfur cluster acts as fuel for 
reactive oxygen species. Taken together, overproduction of iron sulfur cluster seems to be 
detrimental to the fitness of an organism in the event of oxidative stress and inhibitory 
effect of CyaY on iron sulfur cluster production can explain the apparent positive effect 
of CyaY. At present, there is no direct evidence that overproduction of iron sulfur cluster 
can exacerbate oxidative stress by acting as fuel for it but if that is the case, it will change 
our understanding significantly. 
 It had been shown by Dancis group that a single point mutation (M → I) on 
scaffold protein in yeast can rescue all FXN deletion phenotypes via bypassing FXN i.e. 
M → I mutation on scaffold protein in eukaryotes can make the organism FXN 
independent [142, 143]. As deletion of CyaY has no effect under normal growth condition, 
E. coli is CyaY independent. This led to study by Roche et al. to determine if the reverse 
mutation I → M would render E. coli CyaY-dependent [131]. They showed that cellular 
iron sulfur cluster level decreased for I → M mutation in E. coli and was even worse in 
absence of CyaY. Recently we determined that ISCU2M106I bypasses FXN by accelerating 
cluster transfer to GRX5 in human system. Here, we did a similar step-wise analysis to 
study the effect of IscUI108M on each step in the presence and absence of CyaY. More 
specifically, we tested if IscUI108M slows down any step and whether CyaY rescues the 
rate. We found that IscUI108M variant behaved just like wild type in all the steps and the 
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effect of CyaY on cluster assembly of scaffold protein was also similar for IscUI108M and 
wt-IscU i.e. inhibitory rather than accelerating. Therefore, we still don’t have a mechanism 
that explains the effect of I → M mutation on scaffold protein of E. coli in vivo. 
Materials and Methods 
Protein purification. IscS, IscU and CyaY were purified as described previously [46]. 
The QuikChange method (Stratagene) was used to introduce point mutation (I108M) into 
plasmid containing wt-IscU [133]. The mutation was confirmed by DNA sequencing 
(Gene Technology Lab, TAMU). IscUI108M was purified using the same protocol as wt-
IscU. Grx4 was purified following literature procedure[144]. Unless otherwise stated, all 
the reactions were carried out in an anaerobic glove box (O2 < 1 ppm). 
Stopped flow kinetics. Proteins (100 µM final concentration of each protein) were taken 
in one of the two syringes of the stopped flow apparatus (KinTek Corporation). The other 
syringe contained 10 mM Cysteine. They were mixed together by pressing both the 
syringes simultaneously. First λmax of each intermediate were determined by monitoring 
the change of absorbance every 2 ms in a 100 nm window. λmax for quinonoid and aldimine 
intermediate were found to be 508 nm and 410 nm respectively, which were later used to 
monitor the kinetics of the intermediate. We could not detect a sharp peak around 340 nm 
for ketimine intermediate. We therefore used 340 nm as this wavelength has been used 
previously [75]. Next, formation of aldimine, quinonoid and ketimine intermediate were 
followed by monitoring absorbance at 410, 508 and 340 nm respectively. For quinonoid 
kinetics, traces of 508 nm with time were fitted with Origin software (OriginLab) to 
Consecutive B equation [y = y0 + (k1*[A]0/( k2-k1))*(exp(-k1*t)-exp(-k2*t))], where k1 
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and k2 are rate constants of the formation and decay of cys-qiononoid intermediate 
respectively. The rates were compared for IscS, IscSC328A, SU, SUC, SUI108M and 
SUI108MC (Fig. 3.1). [R2 values: IscS (0.99), IscSC328A (0.83), SU (0.99), SUC (0.99), 
SUI108M (0.99), SUI108MC (0.99)]. Aldimine and ketimine (410 nm and 340 nm traces 
respectively) could not be fit using Consecutive B equation as kinetics was more complex. 
Separation of proteins for sulfur transfer reaction. All the proteins (IscS, IscU and 
CyaY) were separated using C4 column (WAT011807, Waters) on HPLC (1260 Infinity, 
Agilent Technologies) at pH 2.0 (0.1 % TFA in water, Buffer A) by running a gradient of 
Buffer B (60% CH3CN, 40% Isopropanol, 0.1% TFA) from 30% to 70% within 40 min 
with 1mL/min flow rate (Fig. 3.2A). 
Measurement and quantification of radioactivity on proteins. The amount of 
radioactivity and in turn persulfide on IscS and IscU were determined using a similar 
procedure as described in detail (Chapter IV). Briefly, [35S]-cysteine (PerkinElmer, 10.2 
μM, 1.00796 mCi) was diluted 50 times by 1 mM non-radioactive cysteine resulting in a 
204 nM final concentration of [35S]-cysteine in the stock solution and the ratio of [35S]-
cysteine over cold cysteine became 0.000204. After elution, the protein was passed 
through a mixer where it was combined with scintillation cocktail (BioCount 111182) and 
signal was recorded with β-RAM radio-HPLC detector (Model 5C, LabLogic). Data 
collection and analysis were done with Laura software (LabLogic). Area under the 
scintillation peak (in CPM) was determined for each protein and converted into [35S] 
concentration associated with protein by using a standard curve plotted from known 
amounts [35S]-cysteine (and determining area under the peak corresponding to cysteine). 
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Total amount of persulfide on protein was obtained via dividing it by the [35S]-cysteine 
and non-radioactive cysteine ratio. 
Persulfide formation assay. Protein complexes (SU and SUC) were reacted with 30 μM 
cysteine (contains 0.0204% [35S]-cysteine) at 37°C followed by quenching at different 
time points starting from thirty seconds to one hour. Final protein concentrations were 30 
μM IscS, 30 μM IscU and 75 μM CyaY (for SUC) with 50 µL reaction volume. The 
samples were quenched by mixing 150 µL quenching solution (conc. HCl and 6 M 
Guanidine hydrochloride (in 1:4 ratio, pH<1) to the 50 µL reaction. 150 µL of the resulting 
200 µL was injected into HPLC for analysis. Amount of persulfide associated with IscS 
and IscU was calculated as described above and plotted against time (Fig. 3.2). The data 
points were fitted using Origin software (OriginLab) to exponential rise equation 
[y=m1+m2*(1-exp (-m3*x))] where m3 value gives the apparent rate of formation. [R2 
values; IscS-SSH formation: 0.98 (SU), 0.98 (SUC); IscU-SSH formation: 0.98 (SU), 0.88 
(SUC)]. 
Cysteine desulfurase activity. Cysteine desulfurase activities were measured for each 
complex (SU, SUC, SUI108M and SUI108MC) according to following procedure. In short, a 
heating block was used to bring the temperature to 37°C. The proteins were mixed to a 
final concentration of 0.5 µM IscS, 2.5 µM IscU (or IscUI108M), 5 µM CyaY and 2 mM 
DTT followed by incubation for 15 minutes on heating block already at 37°C, cysteine 
was then added and the reaction was then incubated for additional 6 min before quenching 
the 800 µL reaction mixture with 100 µL of N, N'-diphenyl-p-phenylenediamine (DPD, in 
7.2 M HCl) and 100 µL of FeCl3 (in 1.2 M HCl) with final concentration of DPD and 
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FeCl3 being 30 µM and 20 µM respectively. The samples were centrifuged after 20 min 
incubation at 37ºC and absorbance was measured at 670 nm. The amount of sulfide 
produced was determined for each data point using a standard curve. Rates ([S2-
]/([SD]*min)) were plotted against the amount of cysteine added and fitted with Origin 
software (OriginLab) using Michaelis-Menten Equation to obtain kcat and KM values for 
each complex (Fig. 3.3). [R2 values: SU (0.98), SUC (0.998), SUI108M (0.99), SUI108MC 
(0.99)]. 
CD spectroscopy. CD spectra were recorded on a Chirascan CD spectrometer (Applied 
Photophysics) using a 1 cm path length cuvette. Cuvettes were sealed with a rubber septa 
and electrical tape in a glove box (O2 < 1 ppm). The assays were run in 50 mM HEPES, 
150 mM KCl, and 10mM MgCl2 (pH 7.5) at 22ºC. 
Cluster assembly assay on IscU. The assay constituted 8 µM IscS, 40 μM IscU (or 
IscUI108M), 50 μM CyaY, 200 μM Fe(NH4)2(SO4)2 and was initiated with addition of 10 
mM GSH and 100 µM cysteine using air tight syringes. The cluster assembly rates were 
measured for SU, SUC, SUI108M, SUI108MC by monitoring the ellipticity change at 330 nm 
over time and fitting the initial data points using Kaleidagraph (synergy software) to linear 
equation (y=m1x+m2), where m1 gives the initial rate of cluster synthesis (Fig. 3.4). [R2 
values: SU (0.99), SUC (0.96), SUI108M (0.99), SUI108MC (0.99)]. 
Cluster transfer assay from holo-IscU to apo-Grx4. 20 μM IscU was re-constituted 
using 1 μM IscS, 40 µM CyaY, 400 μM Fe(NH4)2(SO4)2 and 40 μM cysteine with cysteine 
being the limiting reagent to inhibit any further cluster-synthesis. 40 μM Grx4 was then 
injected into the cuvette anaerobically using an air-tight syringe and the cluster transfer to 
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the latter was followed by monitoring the ellipticity change at 450 nm over time and fitting 
the initial data using Kaleidagraph (synergy software) to linear equation (y=m1x+m2), 
where m1 gives the initial rate of cluster transfer from Holo-IscU to apo-Grx4. 450 nm 
was chosen as the wavelength to monitor the transfer due to minimal contribution from 
holo-IscU at that wavelength. The rates were compared for SU, SUC. [R2 values: SU 
(0.93), SUC (0.93)]. 
One-pot cluster synthesis on apo-target. 0.5 µM IscS, 20 μM IscU (or IscUI108M), 40 
µM CyaY, 40 μM Grx4, 200 μM Fe(NH4)2(SO4)2 and initiated by the addition of 10 mM 
GSH and 100 μM cysteine. Cluster formation on Grx4 was then measured for SU, SUC, 
SUI108M, SUI108MC by monitoring the change of ellipticity at 450 nm over time and fitting 
the initial time points using Kaleida graph (synergy software) to linear equation 
(y=m1x+m2), where m1 gives the initial rate of cluster formation on Grx4 (Fig. 3.5). [R2 
values: SU (0.99), SUC (0.94), SUI108M (0.99), SUI108MC (0.62)].  
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CHAPTER IV 
MECHANISM FOR ACTIVATION AND BYPASS OF FRATAXIN IN HUMAN 
IRON SULFUR CLUSTER BIOSYNTHESIS 
Introduction 
Iron sulfur (Fe-S) clusters are ubiquitous protein cofactors that are required for 
critical cellular processes in most organisms [2, 69]. Fe-S clusters exist in a variety of 
stoichiometries, most often as [2Fe-2S]2+/1+ and [4Fe-4S]2+/1+ species, and commonly 
function in substrate activation and as electron transfer conduits. These Fe-S clusters are 
synthesized and distributed to apo-target proteins by conserved biosynthetic pathways The 
structural core of this assembly complex consists of cysteine desulfurase (NFS1), 
eukaryotic-specific LYR protein (ISD11), and acyl carrier protein (ACP) subunits and is 
referred to as the SDA complex [145, 146]. The ISD11 and ACP subunits are required for 
function, stabilize NFS1, and favor different quaternary interactions for NFS1 than its 
prokaryotic homologs [47, 78, 146-148]. Sulfur is then transferred from NFS1 to a 
cysteine residue on the scaffold protein ISCU2 (Fig. 4.1, step 2). ISCU2 combines sulfane 
sulfur with Fe2+ and electrons to produce [2Fe-2S]2+ clusters (Fig. 4.1, step 3) in a poorly 
understood process. To complete catalytic turnover, intact [2Fe-2S] cluster intermediates 
on ISCU2 are transferred to a cluster carrier protein, such as the monothiol glutaredoxin 
GRX5 (Fig. 4.1, step 4), as a part of the cluster distribution network. 
Although eukaryotes clearly also require frataxin (FXN) for the synthesis of Fe-S 
clusters [149, 150], the precise role of FXN remains controversial. The loss of FXN is 
linked to the fatal neurodegenerative disease Friedreich’s ataxia [84], and results in  
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Figure 4.1. Steps involved in cluster biosynthesis pathway. The overall process 
of cluster biosynthesis in humans was divided into four broad steps and used as a 
general guideline to evaluate which step(s) FXN and ISCU2M106I are affecting.  
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decreased activity for Fe-S cluster enzymes, accumulation of iron in the mitochondria, and 
susceptibility to oxidative stress [42]. Identifying the role of FXN has been complicated 
by the existence of isoforms of different lengths. The longer form, FXN56-210, can undergo 
an iron-dependent oligomerization to produce a species reminiscent of ferritin that may 
function in iron storage [151, 152]. The truncated form, FXN1-80, is widely considered to 
be the functional form in vivo; truncated FXN is monomeric even in the presence of iron 
[153], interacts with the NFS1-ISD11-ISCU2 complex [31, 77, 89, 154, 155], and rescues 
cells challenged with FXN depletion [156]. Early studies revealed that FXN1-80 has a 
modest binding affinity for iron (3-55 µM) and led to the proposal that FXN accelerates 
Fe-S cluster synthesis by functioning as a chaperone that donates iron [43, 44, 85, 86, 154, 
157-160] More recently, multiple studies provide evidence that FXN functions as an 
allosteric activator that enhances cysteine desulfurase activity and the subsequent rate of 
Fe-S cluster assembly on the scaffold protein [31, 33, 89, 161]. FXN has been proposed 
to affect the sulfur chemistry by enhancing cysteine binding to the PLP cofactor of the 
cysteine desulfurase [99], and increasing sulfur transfer to the scaffold protein and small 
molecule thiols [31, 161]. Conflicting results indicate that FXN does [33, 99] or does not 
[161] affect persulfide formation on NFS1. Interestingly, a suppressor mutant on 
Saccharomyces cerevisiae Isu1 (homolog of human ISCU2; Isu1M107I also known as 
Isu1Sup) was identified that rescues the depletion of S. cerevisiae Yfh1 (homolog of human 
FXN) [142, 162]. Initial studies have suggested that Isu1M107I increases the accumulation 
of persulfide species on Nfs1 similar to the addition of FXN [33, 99]. Despite these 
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advances, mechanistic details of how FXN functions in Fe-S cluster biosynthesis are still 
lacking. 
Here, new assays were developed to probe how FXN and human ISCU2M106I 
(equivalent to Isu1M107I) affect the kinetics of individual steps in Fe-S cluster biosynthesis. 
We found that the addition of either FXN or substitution of ISCU2 with ISCU2M106I 
increased the overall rate of cluster synthesis and transfer to GRX5. Further, these studies 
provide compelling evidence that FXN accelerates reactions involving the NFS1 mobile 
S-transfer loop that result in an increased rate of [2Fe-2S] cluster assembly on ISCU2. In 
contrast, ISCU2M106I primarily affects the transfer rate of intact [2Fe-2S] clusters from 
ISCU2 to GRX5. Overall, our results provide new mechanistic insight into Fe-S cluster 
biosynthesis and indicate FXN and ISCU2M106I function at distinct stages of this pathway. 
Results 
Both the ISCU2M106I substitution and FXN accelerate the formation of [2Fe-2S] 
clusters on GRX5. Our initial objective was to test if substitution of human ISCU2 with 
the ISCU2M106I variant functions analogously to FXN and stimulates Fe-S cluster 
biosynthesis. A circular dichroism (CD) assay was developed to monitor an entire Fe-S 
cluster assembly and transfer reaction (Fig. 4.1, steps 1-4) to better reproduce the in vivo 
biosynthetic pathway than previously reported assays that only monitor partial reactions. 
This assay takes advantage of the positive ellipticity from [2Fe-2S]-GRX5 and low 
ellipticity from [2Fe-2S]-ISCU2 at 450 nm. The reaction conditions contained the 
recombinantly expressed human NFS1-ISD11 complex that co-purified with Escherichia 
coli ACP (SDAec) [4, 41], with the addition of recombinant human ISCU2 (SDAecU), 
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ISCU2M106I (SDAec UM106I), or ISCU2 and FXN (SDAec UF). Reactions were initiated 
with the addition of L-cysteine and glutathione, which is required for binding the Fe-S 
cluster to GRX5. All complexes exhibited final CD spectra consistent with [2Fe-2S]-
GRX5. Similar overall rates were observed for the SDAec UF and SDAecUM106I complexes 
(Fig. 4.2A and Table 4.1), which were about 3 times greater than the SDAecU complex. 
The results from this in vitro Fe-S cluster biosynthetic assay are consistent with both the 
stimulation of activity by FXN and the bypass of FXN by ISCU2M106I. 
FXN and ISCU2M106I operate at different steps in Fe-S cluster biosynthesis. We tested 
the effect of adding FXN to the SDAecUM106I complex in complete cluster assembly and 
transfer reactions (Fig. 4.1, steps 1-4). The SDAecUM106IF complex had a rate that was 
faster than SDAecU (nearly 7-fold greater) and was about twice the rate of either the 
SDAecUF or SDAecUM106I complex (Fig. 4.2A and Table 4). This additive result in the Fe-
S assembly assay hints that the stimulatory effects of FXN and ISCU2M106I occur at 
different steps in Fe-S cluster biosynthesis. As FXN was previously shown to increase the 
rates of partial reactions, including the Fe-S cluster assembly reaction on ISCU2 and the 
cysteine desulfurase activity of SDAecU [31, 49, 163], we tested whether ISCU2M106I also 
affected those steps of Fe-S cluster biosynthesis. 
The ISCU2M106I variant was tested for its ability to mimic FXN and increase the 
rate of [2Fe-2S] cluster formation on ISCU2 (Fig. 4.1, steps 1-3). We used CD to monitor 
[2Fe-2S] cluster formation on ISCU2 and ISCU2M106I by following changes in ellipticity 
at 330 nm, similar to a previously reported assay [163]. Here, the addition of FXN to the 
SDAecU complex was shown to accelerate Fe-S cluster formation on ISCU2  
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Figure 4.2. FXN and the ISCU2M106I substitution accelerate different steps in Fe-S 
cluster biosynthesis. A) Kinetics of Fe-S cluster synthesis and transfer to GRX5 were 
monitored for different assembly complexes by the change in ellipticity at 450 nm. The 
average change in ellipticity (n = 3; maximum error of 1.8 in ellipticity) is plotted and 
fit with an exponential rise equation. B) Fe-S cluster assembly reactions on ISCU2 were 
monitored for assembly complexes by the change in ellipticity at 330 nm. The average 
change in ellipticity (n = 3; maximum error of 1.8 in ellipticity) is plotted and fit with a 
linear equation. C) Kinetics of cluster transfer from pre-formed holo-ISCU2 to apo-
GRX5 were monitoring by the change in ellipticity at 450 nm. Reactions were initiated 
(time = 0) by the anaerobic injection of GRX5 (with or without FXN). The average 
change in ellipticity (n = 3; maximum error of 0.8 in ellipticity) is plotted and fit with a 
linear equation. D) Chemically reconstituted ISCU2 (or ISCU2M106I) was reacted with 
GRX5 and the [2Fe-2S] cluster transfer was monitored by the increase in ellipticity at 
450 nm. Color scheme: SDAecU (red), SDAecUF (blue), SDAecUM106I (black) and 
SDAecUM106IF (green). 
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Table 4.1. Effect of FXN and ISCU2M106I on kinetic parameters in all the steps 
in iron sulfur cluster biosynthesis pathway 
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(2.8 fold greater) under a comparable set of conditions (Fig. 4.2B, Table 4.1). The 
SDAecUM106I complex exhibited 1.5 times greater cluster synthesis activity compared to 
the native SDAecU complex, but only about half the activity of SDAecUF. Addition of 
FXN to the SDAecUM106I complex further enhanced the activity (1.5 fold greater), 
consistent with FXN stimulation of the native system. 
We also tested the effect of substituting the ISCU2M106I variant for ISCU2 in 
cysteine desulfurase activity assays. SDAec was previously shown to exhibit a low kcat 
(0.60 min-1) for the cysteine desulfurase reaction [49], which was not affected by the 
addition of ISCU2, but showed a stimulation by an order of magnitude upon the addition 
of both ISCU2 and FXN [31, 49]. The SDAecUM106I complex exhibited kinetic parameters 
highly similar to the SDAecU complex with a kcat 10-fold lower than the SDAecUF complex 
(Table 4.1). Moreover, addition of FXN to the SDAecUM106I complex stimulated kcat in a 
manner reminiscent of the wild type system. Overall, the additive effect in complete 
synthesis and transfer assays coupled to the inability of ISCU2M106I to replace FXN in 
partial Fe-S cluster assembly and cysteine turnover reactions are consistent with FXN and 
ISCU2M106I affecting different steps of Fe-S cluster biosynthesis. 
The ISCU2M106I substitution accelerates cluster transfer to GRX5. Since ISCU2 acts 
as a scaffold for [2Fe-2S] cluster synthesis and functions as an intermediate to transfer 
these clusters to target proteins, we evaluated the ability of FXN and ISCU2M106I to affect 
the transfer of the [2Fe-2S] cluster intermediate from ISCU2 to GRX5 (Fig. 4.1, step 4). 
The SDAecU and SDAecUM106I complexes were incubated with L-cysteine and ferrous iron 
in the absence of GRX5 and the development of the characteristic [2Fe-2S]-ISCU2 CD 
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spectrum was observed. After completion of the [2Fe-2S]-ISCU2 formation reaction, apo-
GRX5 (with or without FXN) was added under anaerobic conditions, and the cluster 
transfer reaction from ISCU2 to GRX5 was followed by monitoring the increase in 
ellipticity at 450 nm (Fig. 4.2C). The rates of cluster transfer for the native complex with 
and without FXN were the same within error (Table 4.1), establishing that FXN does not 
have a role in cluster transfer under these conditions. In contrast, Fe-S assembly 
complexes containing the ISCU2M106I substitution almost doubled the rate of cluster 
transfer to GRX5 compared to those with wild-type ISCU2.  
Next, we tested whether the dissociation of [2Fe-2S]-ISCU2 or [2Fe-2S]-
ISCU2M106I from the SDAec complex, which is thought to be necessary to facilitate cluster 
transfer, impacts cluster exchange reactions with GRX5. Fe-S clusters were chemically 
reconstituted on ISCU2 and ISCU2M106I in the absence of the SDAec complex. After 
purification, ISCU2 and ISCU2M106I each bound approximately two iron atoms and two 
sulfide atoms per protein. The [2Fe-2S]-bound proteins were reacted with GRX5 and 
shown to have similar initial kinetics but different overall extents of transfer (Fig. 4.2D). 
The ellipticity change for ISCU2M106I was approximately 4 times greater than that for 
native ISCU2, suggesting that the ISCU2M106I substitution alters the cluster-binding 
equilibrium compared to native ISCU2 and favors the cluster-bound GRX5 species. One 
possible explanation for this result is that the [2Fe-2S] cluster bound to ISCU2M106I is less 
stable leading to enhanced transfer to GRX5. To test this possibility, a DTT extrusion 
assay was used to examine the susceptibility of ISCU2 and ISCU2M106I to loss of their 
[2Fe-2S] clusters. [2Fe-2S] clusters were enzymatically generated on ISCU2 (or 
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ISCU2M106I) and the proteins were combined with DTT. Both samples lost a majority of 
their cluster-dependent CD signal within 30 min. The similar rates of cluster loss (within 
15% of one another; indicates the much greater extent of [2Fe-2S] cluster transfer from 
the ISCU2M106I sample to GRX5 (Fig. 4.2D) involves more than just a change in cluster 
stability. Overall, these studies indicate that the ISCU2M106I substitution, but not FXN, 
affects the Fe-S cluster transfer reaction from ISCU2 to GRX5. 
FXN accelerates persulfide formation on NFS1 and ISCU25. Our next objective was 
to further define how FXN accelerates Fe-S cluster synthesis. To probe the effect of FXN 
on the rates of sulfur accumulation on NFS1 and ISCU2 (Fig. 4.1, steps 1 and 2), a rapid 
acid quench assay was developed that couples HPLC separation with radiolabeled sulfur 
detection. In this assay, various Fe-S assembly complexes are reacted with L-[35S]-
cysteine substrate, quenched with acid after different reaction times, and applied to a 
reverse phase HPLC column for analysis of protein content (absorbance) and persulfide 
label (radioactivity). The ability to rapidly protonate thiolate nucleophiles, which inhibits 
sulfur transfer reactions [164], and analyze proteins for 35S incorporation under quench 
conditions are critical aspects of this assay. Control experiments established conditions to 
separate proteins in the SDAecUF complex that contain cysteine residues (NFS1 and 
ISCU2). The effectiveness of acid in quenching sulfur transfer from NFS1 to ISCU2 was 
established by reactions under normal and quench conditions. Initial studies with excess 
                                                 
5 The experiments in this section are performed and analyzed by Shachin Patra from Barondeau group at 
Texas A&M University. 
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L-[35S]-cysteine substrate resulted in labeling of multiple cysteine residues on NFS1 and 
ISCU2. Some of these labeled cysteine residues, especially on NFS1 (C158, C163, C353, 
and C426), are likely due to side-reactions of the SDAecU complex that occur with excess 
cysteine substrate, long incubation times, and no additional reductant or iron; these 
conditions likely permit sulfur transfer reactions from persulfide species to excess cysteine 
and subsequent scrambling of the radiolabel.  
 The rates of persulfide formation on NFS1 and ISCU2 were determined using 
stoichiometric amount of substrate. The SDAecU and SDAecUF complexes were combined 
with L-[35S]-cysteine, quenched after different reaction times, and the proteins were 
separated under quenching conditions. Plotting the amount of radiolabel as a function of 
time revealed saturation between 0.20-0.25 labels per NFS1 (Figs. 4.3A and 4.3B) and 
ISCU2 (Figs. 4.3C and 4.3D) for the SDAecU and SDAecUF complexes. Interestingly, the 
amount of label on NFS1 did not decrease at longer times as one might expect for 
sequential irreversible reactions using limited substrate (Fig. 4.1, steps 1 and 2). Persulfide 
formation on NFS1 and ISCU2, which were fit simultaneously, matched well with an 
equilibrium sulfur transfer model with a second cysteine turnover (Fig. 4.3E). Models that 
lack the equilibrium step (k-2) or second cysteine turnover (k3) did not adequately fit the 
data. The rates of persulfide formation on NFS1 were constrained to be the same for the 
SDAecU (or SDAecUF) complex with or without a persulfide-bound ISCU2 (k1 = k3). 
Under these conditions, the slow step for both SDAecU and SDAecUF complexes was the 
formation of the persulfide species on NFS1 (Table 4.1 and Fig. 4.3). FXN accelerated 
both the rate of persulfide formation on NFS1 (6.5 fold greater) and sulfur transfer from 
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Figure 4.3. FXN accelerates the persulfide formation kinetics on NFS1 and 
ISCU2. SDAecU and SDAecUF complexes were reacted with a stoichiometric 
amount of L-[35S]-cysteine, quenched with acid, and the proteins were separated 
using conditions similar to Fig. S9. Formation of [35S]-persulfide was quantitated 
and plotted for A) NFS1 (SDAecU), B) NFS1 (SDAecUF), C) ISCU2 (SDAecU), and 
D) ISCU2 (SDAecUF). E) Best-fit kinetic model (k1 = k3) for persulfide 
accumulation on cysteine residues of NFS1 and ISCU2. The data for SDAecU or 
SDAecUF were fit simultaneously with KinTek and the fits were validated using 
FitSpace (Fig. S13). Blue, green, and red dashed lines represent the simulated 
amounts of persulfide on NFS1, ISCU2, or both NFS1 and ISCU2, respectively. 
Black lines indicate the total amount of simulated persulfide on NFS1 or ISCU2.  
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NFS1 to ISCU2 (30 fold greater). This kinetic model suggests the persulfide transfer 
reaction from NFS1 to ISCU2 is reversible with an equilibrium constant near one for both 
complexes. These experiments strongly support the proposed role of FXN as an allosteric 
activator that accelerates sulfur transfer chemistry [31, 33, 161]. 
FXN affects the rate of persulfide cleavage by free cysteine6. Pulse chase experiments 
were designed to evaluate the ability of FXN to labilize persulfide species and facilitate 
sulfur transfer chemistry. The cysteine desulfurase substrate, L-cysteine, was tested for its 
ability to cleave persulfide species associated with the SDAecU and SDAecUF complexes. 
A stoichiometric amount of L-[35S]-cysteine was first incubated with the individual 
complexes. The labeled complexes were then combined with non-radioactive L-cysteine 
for various times, quenched with acid, and analyzed as described above. For the SDAecU 
complex, spiking the sample with non-radioactive cysteine resulted in the loss of most of 
the labeled sulfur on both NFS1 and ISCU2, which occurred at similar rates (Fig. 4.4A 
and 4.4B; Table 4.1). Intriguingly, the addition of FXN resulted in an approximate 5-fold 
increased rate of sulfur loss from NFS1, but almost no loss of label from ISCU2. To 
rationalize these results with the above equilibrium kinetic model (Fig. 4.4E), we suggest 
that cleavage of the [35S]-label occurs primarily from the mobile S-transfer loop of NFS1 
and not from ISCU2 (Fig. 4.4C). After NFS1 persulfide cleavage, slow cysteine turnover 
for the SDAecU complex results in re-equilibration of the label through inter-protein sulfur  
                                                 
6 The experiments in this section are performed and analyzed by Shachin Patra from Barondeau group at 
Texas A&M University.   
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Figure 4.4. FXN accelerates the persulfide decay kinetics from NFS1. 
SDAecU (red) and SDAecUF (blue) complexes were reacted with stoichiometric 
amounts (30 M) L-[35S]-cysteine for 40 min and then chased with 1 mM non-
radioactive L-cysteine. Samples were then quenched with acid at various times 
and the amount of remaining [35S]-label on A) NFS1 and B) ISCU2 were 
determined. The data were fit to an exponential decay or linear (loss of ISCU2 
label from SDAecUF complex) equation. C) Model for the effect of FXN on 
persulfide decay from the SDAecU and SDAecUF complexes. The NFS1 
persulfide is proposed to be the primary species cleaved during the chase 
experiment. In the presence of FXN, the persulfide on NFS1 is rapidly 
regenerated by turnover with non-radioactive L-cysteine. In the absence of FXN, 
slower cysteine desulfurase turnover results in re-equilibration (transfer) of the 
ISCU2 radiolabeled sulfur (atom colored red) to NFS1 and subsequent cleavage.  
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transfer from ISCU2, explaining the similar persulfide depletion rates for NFS1 and 
ISCU2 (Table 4.1 and Fig. 4.4). In contrast, the SDAecUF complex is proposed to 
repopulate the mobile S-transfer loop of NFS1 through rapid enzymatic cysteine turnover 
rather than re-equilibration, reconciling the apparent protection by FXN of the [35S]-label 
on ISCU2. Overall, these radiolabeling studies coupled to previous cysteine desulfurase 
assay results suggest that FXN accelerates PLP-associated chemistry and sulfur transfer 
reactions from NFS1 to thiol-containing molecules (ISCU2, DTT, and L-cysteine). 
FXN accelerates the decay of the PLP quinonoid intermediate for NFS1. To determine 
how FXN accelerates persulfide formation on NFS1, the PLP chemistry associated with 
the cysteine desulfurase reaction was directly probed using stopped-flow kinetics (Fig. 
4.1, step 1). The proposed cysteine desulfurase mechanism includes sequential formation 
of cys-aldimine, cys-quinonoid, and cys-ketimine intermediates (Fig. 4.5A) [74, 75, 165], 
which have distinct absorbance maxima. The SDAecU and SDAecUF complexes were 
combined with L-cysteine and changes in absorbance were monitored. A high substrate 
concentration (10 mM) was used to increase the accumulation of PLP-based intermediates 
in the reaction. The first observed event is a rapid increase in absorbance at 410 nm, which 
was assigned to the cys-aldimine intermediate [75]. The SDAecUF sample developed this 
signal more rapidly (the formation occurred during the dead time of the instrument) 
compared to the SDAecU sample and accumulated approximately 8-fold more of this 
intermediate. Decay of this 410 nm species occurred at similar rates for the two complexes. 
The next intermediate, which absorbed maximally at 508 nm and was assigned to the cys-
quinonoid species [75], developed at similar rates in the presence and absence of FXN  
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Figure 4.5. FXN accelerates the decay of quinonoid intermediate. A) Scheme 
showing steps of PLP chemistry that leads to C-S bond cleavage and persulfide 
formation on the mobile loop cysteine (NFS1-SSH). Stopped-flow kinetics for the 
cis-quinonoid decay of B) SDAecU and SDAecUF complexes, C) SDAecU and 
SDAecUCec (includes E. coli FXN homolog CyaY), D) SDAecU and SDAecUM106I and 
E) SDAecUF and SC381ADAecUF. The traces are an average of three independent 
experiments. The rates for the development and decay of the quinonoid intermediate 
were obtained by nonlinear regression analysis (solid lines). 
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(Fig. 4.5B and Table 4.1). Interestingly, the decay rate of this cys-quinonoid intermediate 
was increased by a factor of four in the presence of FXN. Correspondingly, the formation 
of a species that absorbs at 340 nm, which was assigned to the cys-ketimine intermediate 
[75], was also enhanced by the addition of FXN. We next found that addition of the 
bacterial homolog of FXN (CyaY) to the SDAecU complex also increased the decay rate 
(2.4 fold greater) of the cys-quinonoid intermediate (Fig. 4.5C), consistent with the ability 
of CyaY to activate the human cysteine desulfurase complex [46]. Finally, ISCU2M106I 
was tested for its ability to mimic FXN and affect steps in the PLP chemistry of NFS1. 
Stopped flow kinetics of the SDAecUM106I complex showed slower development and 
slightly faster decay kinetics (1.2 fold greater) for the cys-quinonoid intermediate 
compared to the native SDAecU complex (Fig. 4.5D and Table 4.1). These stopped-flow 
experiments suggest that FXN, and to a smaller extent CyaY, affects the ability of NFS1 
to accelerate the decay of the cys-quinonoid intermediate and generate the cys-ketimine 
species that is attacked by the mobile S-transfer loop during cysteine turnover. 
We then tested whether the mobile S-transfer loop influences the decay kinetics of 
the cys-quinonoid intermediate in addition to its critical role in carbon-sulfur bond 
cleavage of the cys-ketimine intermediate to generate the NFS1 persulfide species. The 
conversion of the quinonoid intermediate to the ketimine species requires protonation at 
the C4’ position (Fig. 4.5A). In bacterial cysteine desulfurases, the mobile S-transfer loop 
cysteine is thought to be the proton donor for this step of the mechanism [74, 75]. We 
therefore generated the NFS1C381A variant to test if the mobile S-transfer loop cysteine of 
NFS1 functions as the general acid for quinonoid decay in the SDAec complex. Stopped 
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flow kinetics for the SC381ADAecUF complex revealed that the quinonoid intermediate does 
not decay to generate the ketimine species (Fig. 4.5E), consistent with a proton donation 
role for C381. Overall, these results indicate FXN affects reactions associated with the 
NFS1 mobile S-transfer loop, which functions as a general acid, nucleophile, and sulfur 
transfer agent in Fe-S cluster biosynthesis.  
Discussion 
A direct link between the FXN gene and the neurodegenerative disease 
Friedreich’s ataxia (FRDA) was established in a seminal 1996 study [84]. Typical FRDA 
patients have lower wild-type FXN expression levels (4-36% of controls) [166-170], 
suggesting a threshold level of FXN is required for normal function. FXN depletion results 
in the loss of activity for Fe-S cluster enzymes, increased iron accumulation in 
mitochondria, and enhanced sensitivity to oxidative stress [42]. Strategies to treat FRDA 
have focused on iron chelators, antioxidants, and mechanisms to increase FXN levels 
[171, 172]. Unfortunately, FRDA remains incurable. An alternate approach to generating 
a FRDA treatment is to first determine the biological role of FXN in Fe-S cluster 
biosynthesis and then replace or bypass that function.  
An initial hypothesis was promoted that FXN functions as a chaperone that 
provides iron for Fe-S cluster assembly. This assignment was based on FXN depletion 
studies, which reveal a disruption of iron homeostasis and accumulation of iron in the 
mitochondria, and the lack of a designated iron chaperone for the Fe-S assembly pathway 
coupled to the presence of an iron-binding patch of carboxylate residues on FXN. 
However, FXN has weak iron binding affinity towards ferrous iron (55 µM), which is the 
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substrate for Fe-S cluster biosynthesis, and the iron-binding carboxylate patch residues are 
only semi-conserved [43, 44, 85, 86, 154, 157-160, 173]. Moreover, a similar iron 
overload phenotype is generated upon depletion of other members of the mitochondrial 
Fe-S assembly system [174], indicating that this phenotype is linked to loss of Fe-S 
clusters and not necessarily the ability to donate iron for this pathway. Furthermore, FRDA 
clinical variants for FXN have been identified on a region distinct from the carboxylate 
patch. These FRDA variants are not iron-binding residues and exhibit diminished ability 
to bind and activate the Fe-S assembly complex. Finally, the presence of ~150 µM labile 
iron pool in mitochondria could function as a feedstock for iron-containing proteins and 
raises the question as to whether a designated iron chaperone is even required for the Fe-
S cluster biosynthetic pathway [175]. Despite these concerns, many investigators still 
champion an iron donor role for FXN.  
More recently, much stronger evidence has been provided that supports a role for 
FXN in facilitating sulfur-based chemistry required for Fe-S cluster biosynthesis [31, 33, 
49, 81, 89, 99, 161, 163, 176, 177]. Here, we have extended these FXN functional studies 
to include stopped-flow interrogation of the eukaryotic cysteine desulfurase reaction and 
functional assays that incorporate both synthesis of the Fe-S cluster intermediate and 
transfer of the cluster to an acceptor protein. We provide a stepwise analysis of the role of 
FXN in (i) the PLP-associated formation of intermediates for the cysteine desulfurase 
NFS1; (ii) the kinetics of sulfur accumulation on NFS1; (iii) the kinetics of interprotein 
sulfur transfer to the scaffold protein ISCU2; (iv) the rate of Fe-S cluster intermediate 
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formation on ISCU2; and (v) the kinetics of [2Fe-2S] cluster transfer from ISCU2 to the 
monothiol glutaredoxin GRX5 (Figs. 4.5A and 4.2).  
FXN accelerates steps associated with the mobile S-transfer loop of NFS1. 
Stopped-flow experiments revealed a clear role for FXN in accelerating the decay of the 
cys-quinonoid intermediate for the SDAecU complex (Fig. 4.5). The transformation of the 
cys-quinonoid intermediate to the cys-ketimine species requires protonation at the C4’ 
position. Substitution of the mobile S-transfer loop cysteine (C381A) of NFS1 
compromised the ability to advance to the ketimine intermediate. This result is consistent 
with NFS1 residue C381 functioning as a general acid for this step in the mechanism, 
consistent with the prokaryotic cysteine desulfurases [74, 75]. Radiolabeling studies 
revealed that FXN also accelerates the rate of persulfide formation on NFS1, which results 
from attack of the deprotonated mobile S-transfer loop cysteine on the cys-ketimine 
intermediate, and the rate of interprotein sulfur delivery from the mobile S-transfer loop 
cysteine of NFS1 to ISCU2 (Fig. 4.3 and Table 4.1). These enhanced rates of sulfur 
transfer also manifested in increased rates for the formation of [2Fe-2S] cluster 
intermediates on ISCU2 and in complete reactions in which [2Fe-2S] clusters were 
synthesized and transferred to GRX5.  
In addition, we determined how human ISCU2M106I, which is analogous to 
Isu1M107I [142, 162], is able to bypass the function of FXN and stimulate Fe-S cluster 
biosynthesis. ISCU2M106I was unable to replace FXN and affect the cysteine desulfurase 
kinetic parameters of the SDAec complex (Table 4.1) and only had a minor stimulatory 
effect on the rate of Fe-S cluster formation on ISCU2. Consistent with this result, a recent 
 90 
 
crystal structure indicates that this ISCU2M106I substitution is unlikely to affect the mobile 
S-transfer loop of NFS1 [178]. Instead, we show that ISCU2M106I, unlike FXN, accelerates 
the rate of intact [2Fe-2S] cluster transfer from ISCU2 to GRX5 (Fig 4.2C). Further 
analysis indicates that the ISCU2M106I substitution does not affect cluster stability on 
ISCU2 but appears to affect the [2Fe-2S] cluster binding equilibrium between ISCU2 and 
GRX5 (Fig. 4.2D). We hypothesize that substitutions on the scaffold protein that are 
capable of bypassing FXN (including the substitution of Isu1 M107 with residues that 
have a higher hydropathy index such as valine or isoleucine) [142] favor hydrophobic 
protein-protein interactions that drive the cluster transfer reaction from ISCU2 to GRX5. 
Stimulation of different steps by FXN and ISCU2M106I is further supported by the additive 
effect that was observed in complete synthesis and transfer assays.  
The eukaryotic SDAecU complex has unusually low activity for a cysteine 
desulfurase enzyme (kcat < 10% of prokaryotic IscS) and requires FXN binding to stimulate 
activity and approach the catalytic turnover of IscS [31, 49]. CyaY, which is the 
prokaryotic homolog of FXN, does not activate IscS and, instead, inhibits in vitro Fe-S 
cluster biosynthesis [90]. Swapping protein components between the prokaryotic and 
eukaryotic systems reveals that these activation/inhibition effects were surprisingly 
independent of the FXN and ISCU2 homologs, but dependent on the cysteine desulfurase 
[46]. A recently determined structure of the SDAec complex revealed an incomplete 
substrate binding site with a solvent exposed PLP cofactor, and an overall architecture in 
which ISD11 molecules mediate interactions between NFS1 subunits [49]. Quaternary 
interactions between NFS1 subunits for the SDAec complex are quite different than its 
 91 
 
prokaryotic homologs IscS, which have contributions from each subunit to the active site 
channel of the other subunit [48, 179]. The Cory SDAec architecture provides a rationale 
for the essential nature of ISD11 in eukaryotes, the low basal levels of cysteine desulfurase 
activity for the SDAec or SDAecU complex, and the stimulation of sulfur-based chemistry 
upon FXN homolog binding to the eukaryotic cysteine desulfurases.  
In our model, the SDAecU is a low activity form of the Fe-S assembly complex 
with an incomplete substrate binding site and a mobile S-transfer loop that occupies a 
primarily non-productive conformation (Fig. 4.6). FXN functions as an allosteric activator 
and upon binding completes the substrate binding site and favors productive 
conformations for the mobile S-transfer loop cysteine. This alteration of the mobile S-
transfer loop trajectory results in an acceleration of proton donation, which is necessary 
for advancing the cys-quinonoid intermediate, and an increased rate of persulfide 
formation on NFS1 and sulfur transfer to ISCU2. A role in binding and excluding non-
productive conformations is further supported by the ability of the FXN homolog CyaY, 
which shares a mere 20% sequence identity with the human form, to impart the same 
effects on the cys-quinonoid decay (Fig. 4.5C) and on the cysteine desulfurase activity 
[46]. Although the FXN-induced stimulation of the mobile S-transfer loop reactions are 
relatively small (Table 4.1; 3 to 30 fold), this may be sufficient to reach the modest in vivo 
activity threshold that supports Fe-S cluster biosynthesis and mitochondrial function. The 
incorporation of ISD11/ACP into the eukaryotic Fe-S cluster biosynthetic pathway is 
thereby a mechanism to integrate FXN as an activity control element or regulator that 
drives sulfur chemistry. Overall, these results provide new insights into FXN function and  
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Figure 4.6. Model for how FXN and FXN bypass variant accelerate Fe-S 
cluster biosynthesis. A) Cysteine binding to NFS1 generates the Cys-quinonoid 
intermediate. B) In the absence of FXN, the NFS1 mobile S-transfer loop exists 
primarily in a non-productive conformation. FXN binding favors the active 
conformation. C) The FXN promoted conformation of the S-transfer loop allows 
its cysteine to function as a general acid and accelerate the decay of the cys-
quinonoid intermediate. D) The deprotonated cysteine of the S-transfer loop 
nucleophilically attacks the cys-ketimine intermediate to generate a persulfide 
intermediate on NFS1 (NFS1-SSH). E) FXN favors the appropriate trajectory to 
deliver sulfur and produce a persulfide species on ISCU2 (ISCU2-SSH). F) A 
second cysteine turnover generates the NFS1-SSH ISCU2-SSH intermediate. G) 
Incorporation of ferrous iron and electrons generates the [2Fe-2S] intermediate 
on ISCU2. H) The [2Fe-2S] cluster is transferred to the apo acceptor GRX5. 
Steps labels in red are accelerated by FXN.  Steps labeled in blue are accelerated 
by the ISCU2M106I bypass variant.  
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suggest strategies to replace (exclude non-productive mobile S-transfer loop 
conformations) or bypass FXN function (facilitate Fe-S cluster transfer from ISCU2) and 
provide potential new mechanisms to treat FRDA. 
Materials and Methods 
Protein purification. Plasmids containing human NFS1 (Δ1-55) and ISD11 (pZM4) were 
generously provided by S. Leimkuhler [100]. The NFS1 and ISD11 plasmids were 
transformed into E. coli strain BL21(DE3) cells and copurified with the bacterial ACP 
(ACPec) as the SDAec complex [49]. Human ISCU2 (Δ1-35) and FXN (Δ1-55) were 
separately expressed and purified as previously described [31]. The spontaneous 
conversion of Δ1-55 FXN to the truncated form was confirmed by SDS-PAGE [31]. The 
QuikChange protocol (Agilent) was used to introduce the M106I point mutation into the 
ISCU2-pET11a plasmid [31] and the C381A point mutation into the NFS1-pET15b 
plasmid [100]. The protein sequence numbering for the M106I variant does not include 
the ISCU2 signal sequence to be consistent with the literature for the bacterial and yeast 
homologs. The MEGAWHOP [180] method was used to substitute human GRX5 for FDX 
in the pHis-GFP-TEV-FDX plasmid [67] and produce pHis-GFP-TEV-GRX5. Sequences 
were confirmed by the Gene Technologies Lab (Texas A&M University). 
The pHis-GFP-TEV-GRX5 plasmid was transformed into Rosetta (DE3) cells 
(VWR). The cells were grown in LB media (VWR) at 37 °C until the OD600 reached 0.5 
and then β-D-1-thiogalactopyranoside (IPTG) was added to a final concentration of 0.5 
mM. The temperature was decreased to 16 °C and the cells were grown for an additional 
~16 h. The harvested cell pellets were resuspended in Buffer A (50 mM Tris and 250 mM 
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2NaCl at pH 7.5) with 5 mM imidazole and lysed by sonication (Branson sonifier 450). 
The soluble fraction was loaded on a Ni-NTA column (5 mL; GE Life Sciences) and the 
his-GFP-TEV-GRX5 fusion was eluted using Buffer A and a linear gradient between 5 
and 500 mM imidazole. The green fractions were combined and dialyzed into Buffer B 
(50 mM Tris, pH 7.5). The sample was then incubated overnight at room temperature with 
TEV protease (1:50 molar ratio of protease to fusion protein). The cleaved material was 
then loaded onto an anion exchange column (27 mL; 16 mm × 13.5 cm, POROS HQ 50) 
and eluted with Buffer B and a linear gradient from 0 to 1 M NaCl. The GRX5 fractions 
were concentrated and loaded onto a 26/60 Sephadex 100 column (GE Life Sciences) 
equilibrated with 50 mM HEPES and 150 mM NaCl at pH 7.5. Monomeric fractions with 
> 96% purity were concentrated, frozen in liquid nitrogen and stored at −80 °C. Unless 
otherwise stated, all protein manipulations and reactions were carried out in an anaerobic 
glove box (MBRAUN; maintained at ~14 °C with O2 < 1 ppm). Protein concentrations 
were estimated using the following extinction coefficients: SDAec using 10.9 mM-1cm-1 at 
420 nm, ISCU2 using 8490 M-1cm-1 at 280 nm, FXN using 26030 M-1cm-1 at 280 nm, and 
GRX5 using 17780 M-1cm-1 at 280 nm [31, 181]. Protein variants were assumed to have 
the same extinction coefficient as the native proteins.  
Complete Fe-S cluster synthesis and transfer reactions. The complete reaction assays 
included 0.5 µM SDAec, 20 µM ISCU2 (or ISCU2M106I), 20 µM (or 0 µM) FXN, 40 µM 
GRX5, and 400 µM Fe(NH4)2(SO4)2 and Buffer C (50 mM HEPES, 150 mM KCl and 10 
mM MgCl2 at pH 7.5). The reactions were initiated by the addition of 100 µM L-cysteine 
and 10 mM GSH. Cluster formation on GRX5 was then measured for SDAecU, SDAecUF, 
 95 
 
SDAecUM106I and SDAecUM106IF by monitoring the ellipticity change at 450 nm using a 
Chirascan circular dichroism (CD) spectrometer (Applied Photophysics). Cuvettes (1 cm 
path length) were sealed with a rubber septa and electrical tape in a glove box. The kinetic 
data were fit to an exponential rise equation ([y=y0+A0*(1 - exp(-k*t))] where the k is the 
apparent rate of cluster formation on GRX5) using Kaleidagraph (Synergy Software, 
Reading, PA).  
Fe-S cluster assembly reactions on ISCU2. Fe-S assembly reactions on ISCU2 
contained 10 µM SDAec, 30 µM ISCU2 (or ISCU2M106I), 30 µM FXN (when added), 400 
µM Fe(NH4)2(SO4)2 and Buffer C. The reactions were initiated with 1 mM L-cysteine. The 
formation of [2Fe-2S] clusters was monitored by the change in ellipticity at 330 nm [163]. 
The initial increase in ellipticity was plotted with time and fit to a linear equation (R2 
values ≥ 0.97) using Kaleidagraph.  
Cysteine desulfurase activity measurements. Cysteine desulfurase activities were 
measured for each complex using a slightly modified methylene blue assay [31, 101]. 
Protein complexes were generated with final concentrations of 0.5 µM SDAec, 1.5 µM 
ISCU2 (or ISCU2M106I), and 1.5 µM FXN (when included). The complexes were 
combined with 4 mM D,L-DTT and incubated for 15 min anaerobically on a heating block 
at 37 °C. Different concentrations of L-cysteine were added, incubated for 6 min, and 
quenched with 20 mM N,N'-diphenyl-p-phenylenediamine (DPD) (in 7.2 M HCl) and 30 
mM FeCl3 (in 1.2 M HCl). The samples were centrifuged after 20 min and the absorbance 
was measured at 670 nm. The amount of sulfide produced was determined for each data 
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point using a standard curve. Rates ([S2-]/([NFS1]*min)) were plotted against the amount 
of L-cysteine added and fit to the Michaelis-Menten equation using Kaleidagraph. 
[2Fe-2S] cluster transfer reactions from enzymatic and chemically reconstituted 
ISCU2 to GRX5. Clusters were enzymatically generated on ISCU2 (or ISCU2M106I) using 
0.5 µM SDAec, 20 µM ISCU2 (or ISCU2M106I), and 400 µM Fe(NH4)2(SO4)2 and Buffer 
C. The reactions were initiated with of 100 µM L-cysteine and 10 mM GSH. After 160 
min, the enzymatic formation of [2Fe-2S] clusters appeared to be complete based on the 
lack of changes in ellipticity at 450 nm. A solution containing 40 µM GRX5 (with or 
without 20 µM FXN) was then injected with an air-tight syringe into the sealed cuvette to 
initiate the transfer reactions. The change in ellipticity was plotted with time and fit to a 
linear equation with Kaleidagraph (R2 values ≥ 0.97). 
[2Fe-2S] clusters were chemically generated on ISCU2 (or ISCU2M106I) by 
reacting 30 µM of apo protein with 600 µM ferric ammonium citrate, 600 µM Na2S and 
10 mM D, L-DTT for an hour. DTT and the excess iron and sulfide were then removed 
with a desalting column (5 mL, GE Healthcare) equilibrated in Buffer C. Iron was 
quantitated with the ferrozine assay (extinction coefficient of 28,000 M−1cm−1 at 562 nm) 
[102] and sulfide was quantitated using a methylene blue assay with an additional pre-
treatment of the protein with NaOH and zinc acetate to release bound sulfide [182]. The 
protein concentration was determined using the Bradford assay. Chemically reconstituted 
ISCU2 had 2.1 ± 0.3 iron and 2.0 ± 0.6 sulfide atoms per protein, whereas ISCU2M106I had 
1.9 ± 0.5 iron and 2.2 ± 0.1 sulfide atoms per protein. Cluster transfer reactions were 
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initiated by combining [2Fe-2S]-ISCU2 or [2Fe-2S]-ISCU2M106I with 60 µM GRX5 and 
10 mM GSH. Transfer reactions were monitored by the change in ellipticity at 450 nm.  
[2Fe-2S] cluster extrusion assay. [2Fe-2S] clusters were assembled on 30 µM ISCU2 (or 
ISCU2M106I) in the presence of 10 µM SDAec, 100 µM L-cysteine, 400 µM Fe(NH4)2(SO4)2 
and 10 mM GSH. 4 mM D, L-DTT was added to the samples to initiate the cluster 
extrusion reaction, which was followed by the loss of ellipticity at 330 nm. The extrusion 
rates were determined by fits to a linear equation. 
Protein separation and 35S quantification for sulfur transfer reactions. L-[35S]-
cysteine (PerkinElmer, 10.2 µM, 1.00796 mCi) was diluted 50 times by non-radioactive 
L-cysteine to generate a 1 mM stock solution (final concentration of L-[35S]-cysteine was 
204 nM). Proteins from Fe-S assembly complexes (SDAec and ISCU2) were applied to a 
reverse phase C4 column (Waters) attached to a HPLC (1260 Infinity, Agilent 
Technologies) and separated using a gradient from either 0 to 100% or from 30% to 70% 
Buffer D (0.1 % TFA in water, pH 2.0) with the remainder of the composition made up of 
Buffer E (60% CH3CN, 40% isopropanol, 0.1% TFA). Both the absorbance (diode array 
detector) and, after mixing with scintillation cocktail (BioCount 111182), the [35S] signal 
(Model 5C β-RAM radio-HPLC detector, LabLogic) were recorded for the eluted proteins. 
The retention time of NFS1 (ISD11 and ACPec do not contain cysteine residues required 
for persulfide formation) was determined by reacting a 25 µL aliquot of the SDAec 
complex (37.5 µM) with 25 µL of L-[35S]-cysteine (final concentration of 500 µM) for 30 
min. The reaction was stopped by addition of 50 µL quenching solution and the proteins 
were separated under quench conditions. The quenching solution was made by mixing 1 
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volume of concentrated HCl with 4 volumes of 6 M guanidine hydrochloride (pH < 1). 
The retention time for ISCU2 was determined using absorbance or reaction of the SDAecU 
complex with L-[35S]-cysteine and comparison to the SDAec complex. Note that FXN, like 
ISD11 and ACPec, lacks cysteine residues needed to form a persulfide intermediate. To 
demonstrate that the quench solution inhibits sulfur transfer, labeled NFS1 was first 
generated by reacting the SDAec complex (30 µM) with L-[35S]-cysteine (400 µM final 
concentration, 45 µl total reaction volume) for 30 min. The labeled NFS1 was either (i) 
incubated with ISCU2 (80 µM, 5 µL) for 30 min, followed by the addition of 50 µL 
quenching solution; or (ii) first combined with 50 µL quenching solution and then 
incubated with ISCU2 (80 µM, 5 µL) for 30 min. Samples were analyzed by a reverse 
phase chromatography under quench conditions. NFS1Data collection and analysis were 
performed with Laura software (LabLogic). To quantitate the amount of persulfide 
associated with the peak, the area under the scintillation curve (in CPM) was converted 
into a [35S] concentration using a standard curve generated from known amounts of L-
[35S]-cysteine and then multiplied by the dilution factor (unlabeled / labeled L-cysteine = 
4901.96). 
Assays for monitoring persulfide formation and decay. For the persulfide formation 
and decay assays, 30 M SDAec and 30 M ISCU2 were combined to generate the 
SDAecU complex, which was converted to the SDAecUF complex by the addition of 75 
M FXN. The SDAecU and SDAecUF complexes were reacted with either 30, 200, or 600 
M cysteine (0.0204% [35S]-cysteine), incubated at 37°C for different lengths of time (30 
sec to 1 h), and diluted 4-fold into the quenching solution described above. The amount of 
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persulfide associated with NFS1 and ISCU2 was calculated as described above, plotted 
against time, and fit to a reaction scheme (see below) using KinTek software (KinTex 
Corporation, Austin, TX). To determine which cysteine residues were labeled with 
persulfide species, the SDAecU complex was combined with 300 µM L-cysteine, 
incubated at 37 °C for 30 min, and quenched with concentrated HCl. The sample was 
digested with pepsin (100:1 sample:pepsin based on concentration in mg/mL) at 22 °C for 
30 min and subjected to LC/MS/MS analysis (Center for Mass Spectrometry (CMS) at 
Texas A&M University). 
Pulse chase experiments were conducted by first reacting the SDAecU and 
SDAecUF complexes (30 M SDAec, 30 M ISCU2, with or without 75 M FXN) with 
30 M [35S]-cysteine for 40 min (the amount of label maximized after 10-20 min) to 
generate radiolabeled NFS1 and ISCU2. Next, we added a final concentration of 1 mM 
non-radioactive L-cysteine to the samples and then diluted 4-fold into the quenching 
solution at various times. The amount of residual persulfide labels on NFS1 and ISCU2 
were determined and fit to an exponential decay equation [y=y0+A0*exp (-k*x)] using 
Kaleidagraph, where the k value gives the apparent rate of persulfide loss.  
Validation of data fitting for persulfide formation kinetics. The data were fitted to a 
simulated mechanism according to the reaction scheme (Fig. 4.3E) using KinTek software. 
The estimation of error was determined by FitSpace confidence contour analysis. FitSpace 
determines the goodness of the fit by measuring the dependence of the sum of square 
errors (SSE) on each pair of parameters while all other parameters were varied. The 
confidence interval of all the fitted parameters were constrained by χ2 threshold values of 
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0.99 and 0.997 for the SDAecU and SDAecUF data, respectively. These thresholds indicate 
that varying the parameter within the confidence interval would not increase the χ2 value 
more than 1% (SDAecU) and 0.3% (SDAecUF) from the minimum χ2 (χ2min) value, which 
represents the best fit. Confidence contour plots are provided that indicate well-defined 
regions determined by χ2 threshold values (red colored patches). 
Stopped flow kinetics for cysteine desulfurase reaction. 100 µM SDAecU (100 µM 
SDAec + 100 µM ISCU2) or 100 µM SDAecUF (100 µM SDAec + 100 µM ISCU2 + 100 
µM FXN) in assay buffer (50 mM HEPES, 250 mM NaCl, pH 7.5) was placed in one of 
the syringes of the stopped flow apparatus (KinTek Corporation). The other syringe 
contained 10 mM L-cysteine. The samples were mixed by simultaneously pressing both 
syringes. Formation of the aldimine, quinonoid, and ketimine intermediates were followed 
by monitoring changes in absorbance at 410, 508 and 340 nm, respectively. For the 
aldimine and quinonoid kinetics, traces monitored at 410 nm and 508 nm with time were 
fitted with Origin software (OriginLab) to a consecutive B equation [y = y0 + (k1*[A]0/(k2-
k1))*(exp(-k1*t)-exp(-k2*t))], where k1 and k2 are rate constants of the formation and decay 
of intermediates respectively. The ketimine kinetics could not be adequately fit using a 
consecutive B equation. 
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 CHAPTER V 
REAL TIME KINETIC PROBES SUPPORT MONOTHIOL GLUTAREDOXINS AS 
INTERMEDIATE CARRIERS IN FE-S CLUSTER BIOSYNTHETIC PATHWAYS7 
Introduction 
Iron-sulfur clusters (Fe-S) are found throughout all of the kingdoms of life, where they 
serve a wide variety of critical functions [183]. Fe-S clusters are involved in electron 
transport[13, 184-186], catalysis of biological reactions [187-189], and regulation of 
cellular responses to oxidative stress [55, 190]. It is not surprising that defects in the 
biosynthesis and transfer of Fe-S clusters are associated with numerous human diseases 
[71, 191, 192]. Despite the importance of these cofactors, many mysteries remain 
regarding their biosynthesis and insertion into their target proteins. 
 In bacterial and eukaryotic mitochondria, the ISC biosynthetic machinery is 
responsible for cluster biosynthesis [21]. The ISC pathway utilizes a core complex 
consisting of a cysteine desulfurase (IscS) and a scaffold protein (IscU) [21]. IscS 
catalyzes the conversion of cysteine to alanine and a persulfide [32]. IscU serves as the 
site for cluster assembly. The persulfide that is formed on IscS can be transferred to IscU, 
where it is combined with ferrous iron and two electrons to form a [2Fe-2S] cluster [33, 
34]. 
                                                 
7 Reprinted with permission from “Real-Time Kinetic Probes Support Monothiol Glutaredoxins As 
Intermediate Carriers in Fe−S Cluster Biosynthetic Pathways” by James Vranish, Deepika Das, David P. 
Barondeau, 2016. ACS Chemical Biology, 11, 3114-3121. Copyright 2016 American Chemical Society. 
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 The cluster that is formed on IscU must then be transferred to a variety of apo 
target proteins in the cell. Several proteins have been implicated in the process of 
transferring clusters, including the chaperone/co-chaperone pair of HscA/HscB [109], 
IscA [59] and the monothiol glutaredoxins (Grxs). The role of the glutaredoxins has been 
quite mysterious. Grxs come in two varieties, the monothiol and dithiol glutaredoxins, 
with their respective names indicating the number of cysteine residues present in the active 
site of these enzymes. The Grxs are so named due to their ability to catalyze disulfide 
reduction reactions on molecules such as ribonucleotide reductase in a process that utilizes 
reduced glutathione (GSH) [109]. While similar to thioredoxins, they are uniquely able to 
reduce S-glutathionylated proteins [109, 171]. Interestingly, both classes of Grxs also 
possess the ability to bind an Fe-S cluster [109, 171, 178-180]. Curiously, this binding 
requires two monomers of Grx that both provide a single cysteine ligand to opposite iron 
atoms of the cluster with the other two ligands coming from two molecules of non-
covalently bound GSH. Even more intriguing is the observation that the ligating cysteine 
is the residue that is required for Grxs thiol reduction function [109]. Additionally, there 
is evidence from crystal structures that the form of the cluster that is bound to monothiol 
Grxs is a [2Fe-2S] cluster. However, other studies have demonstrated the ability of this 
class of Grxs to bind both linear [3Fe-4S] and traditional [4Fe-4S] clusters [41]. The 
physiological relevance of these cluster forms remains a matter of debate, the monothiol 
Grxs can also bind clusters in heterodimeric complexes with BolA/Fra2, forming 
complexes with perturbed cluster properties and specific regulatory functions [52, 53, 55, 
109, 171]. 
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 In Fe-S cluster biosynthesis, glutaredoxins have been proposed to function as 
intermediate cluster carriers for transfer processes or as cluster storage proteins based on 
in vivo and in vitro studies [178, 179]. Holo-monothiol and dithiol glutaredoxins have 
been shown to transfer their clusters to ferredoxin (Fdx), but in vivo data more strongly 
links the monothiol Grxs to Fe-S cluster biosynthesis [109, 171, 178]. Additionally, the 
monothiol glutaredoxins have been shown to be able to transfer clusters to IscA and to 
aconitase [41, 60]. Clusters bound to monothiol glutaredoxins are generally regarded as 
more labile than clusters bound to dithiol Grxs [109]. Additionally, the monothiol 
glutaredoxins have also been shown to accept a cluster from holo-IscU, in a chaperone 
enhanced fashion [109]. In the presence of chaperones, the measured rates of transfer from 
IscU to monothiol glutaredoxin and then glutaredoxin to ferredoxin was determined to 
occur faster than the transfer from IscU to ferredoxin alone, providing the first kinetic 
evidence for the role of glutaredoxin as an intermediate cluster carrier [109]. However, it 
is important to note that several of these transfer steps include DTT, which has been shown 
to artificially enhance the rates of cluster transfer reactions. Furthermore, these rates were 
measured without any determination of Km values and didn’t allow for competition 
between glutaredoxin and ferredoxin for a common cluster source, thus calling into 
question the relevance of these findings in a biological setting that includes all three 
proteins at much lower protein concentrations. Additionally, these studies utilized a [2Fe-
2S]-IscU dimer species as the cluster source, despite the fact that it has never been 
established to be a kinetically competent intermediate of the cluster biosynthetic pathway. 
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Finally, the ability of monothiol glutaredoxins to act as intermediate carriers has not been 
kinetically investigated for other terminal target proteins other than Fdx and aconitase. 
  We demonstrated the ability of fluorescent Fe-S cluster binding proteins to report 
of their cluster content in mixtures containing other chromophores [67]. Here we extend 
the utility of this assay to investigate enzymatic cluster formation on E. coli IscU and 
monothiol Grx4. We directly investigate the transfer of clusters from IscS/IscU to Grx4 in 
the presence of a possible downstream target protein and thereby determine the ability of 
Grx4 to function as an intermediate cluster carrier. This study shows the power of this 
technique to detect pathway intermediates and directly investigate the complex network 
of cluster transfer reactions. 
Results 
Grx4 and DTT accelerate Fe−S Cluster transfer reactions to Fdx. We initially 
designed in vitro experiments monitored by CD spectroscopy, which is currently the 
preferred methodology for tracking Fe−S cluster transfer, to evaluate whether the E. coli 
monothiol glutaredoxin, Grx4 (also known as GrxD), can function as an intermediate 
[2Fe−2S] cluster carrier species in biosynthetic pathways. Apo-ferredoxin (apo-Fdx), 
which is a terminal [2Fe−2S] cluster binding protein, was chosen as an initial target. Here, 
a terminal cluster binding protein is defined as one that utilizes its Fe−S cluster for 
function, such as electron transfer, and is not an intermediate in the cluster distribution 
pathway. [2Fe−2S] clusters bound to proteins typically produce significant ellipticity 
features in the visible region of the spectrum, which are probably due to S → Fe charge 
transfer transitions. A negative ellipticity feature at 515 nm was selected to monitor the  
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Figure 5.1. CD spectra of [2Fe-2S]-IscU, [2Fe-2S]-Grx4 and [2Fe-2S]-Fdx are 
distinctive. CD spectra of 25 μM [2Fe-2S]-IscU (black), 30 μM [2Fe-2S]-Grx4 (green), 
and 40 μM [2Fe-2S]-Fdx (cyan). [2Fe-2S]-IscU was generated by enzymatic 
reconstitution (0.5 μM IscS, 400 μM Fe2+, and 1 mM Lcysteine) and was 80% 
occupied with cluster. [2Fe-2S]- Fdx and [2Fe-2S]-Grx4 were isolated as holo-proteins 
from E. coli and were 90% occupied with cluster. 
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kinetics of [2Fe−2S] cluster binding to Fdx, as this feature is much larger for cluster-bound 
Fdx than for either IscU or Grx4, whereas a positive feature at 330 nm was used to monitor 
[2Fe−2S] cluster binding to IscU (Fig. 5.1). Clusters were synthesized anaerobically in 
situ from Fe2+, L-cysteine, and GSH by the IscS−IscU complex. Control reactions that 
lacked Grx4 and Fdx fully developed a [2Fe−2S]−IscU signal in about 30 min (Fig. 5.2A). 
The addition of the apo-acceptor Fdx resulted in the slow development of the 515 nm CD 
signal from [2Fe−2S]−Fdx that was not complete even after 6 h (Fig. 5.2B, D).Identical 
reactions that also included Grx4 developed this 515 nm signal at a ∼2.4-fold faster rate 
(Fig. 5.2C, D). Initial rate data were fit to linear equations) to obtain crude estimates of 
the second order rate constants for the transfer of cluster to Fdx from IscU (Fig. 5.3, k3 = 
194(3) M−1 min−1) and Grx4 (Fig. 5.3, k2 = 920(2) M−1 min−1). Next, the ability of the non-
physiological reagent DTT to substitute for or enhance Grx4 function was tested. A Grx4-
containing cluster assembly reaction was spiked with DTT after 50 min, which was 
sufficient time to generate [2Fe−2S]−IscU (Fig. 5.2A) and allow testing of the role of DTT 
in subsequent cluster transfer reactions. The resulting development of the 515 nm signal 
was greatly accelerated compared to the sample without DTT (Fig. 5.2D). Note that 
[2Fe−2S] clusters bound to small molecule thiolates such as GSH and DTT do not 
contribute to this region of the CD spectrum. These results demonstrate that both Grx4 
and DTT accelerate the rate of [2Fe−2S] cluster accumulation on Fdx and illustrate the 
need to exclude DTT in experiments aimed at interrogating the role of Grx4 in cluster 
transfer. Difficulties in resolving the individual component CD spectra at intermediate 
time points and, more importantly, limited assay sensitivity led us to apply newly 
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Figure 5.2. Both Grx4 and DTT accelerate cluster transfer reactions to apo-Fdx. 
Complete reactions contained 0.5 μM IscS, 10 μM IscU, 20 μM Grx4, 40 μM apo-Fdx, 
400 μM Fe2+, 100 μM L-cysteine, and 10 mM GSH. For reactions lacking both Grx4 
and Fdx, [2Fe−2S] cluster formation on IscU was monitored by the change in CD 
ellipticity at 330 nm (A). CD spectra are shown for Fdx-containing reactions that lack 
(B) or contain (C) Grx4 after 0 (black), 60 (red), 120 (blue), 180 (green), 240 (cyan), 
300 (orange), and 360 (yellow) min. An additional spectrum (brown) was recorded after 
overnight incubation without Grx4 (panel B) that showed fully reconstituted [2Fe−2S]− 
Fdx. (D) The change in ellipticity at 515 nm is shown in black and blue for panels B and 
C, respectively. A separate complete reaction identical to panel C was spiked after 50 
min with 5 mM DTT (red). 
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Figure 5.3. Fe−S cluster synthesis and transfer reactions. Overall scheme with 
different steps in the process of cluster biosynthesis are depicted. 
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developed fluorescent reporter method- biosynthesis and transfer reactions. Advantages 
of a fluorophore reporter to track Fe−S cluster content include the ability to use lower and 
broader concentration ranges and the capability to selectively monitor cluster-binding 
events by using labeled Fe−S proteins in biosynthetic assays.  
Cluster transfer is the rate-limiting step in [2Fe− 2S]−Grx4 formation. Grx4 was 
labeled with a sulforhodamine B reporter (Grx4Rho) to probe its role in Fe−S cluster 
biosynthetic networks. First, control reactions were performed to ensure that fluorescence 
quenching of Grx4Rho was due to [2Fe−2S] cluster binding. Grx4Rho exhibited little change 
in fluorescence intensity upon the addition of biosynthetic reagents (or reaction side-
products) L-cysteine, Fe2+, GSH, or sulfide (data not shown), similar to results for control 
reactions using FdxRho. Additional control experiments revealed Grx4Rho could be used to 
monitor Fe−S biosynthetic reactions. Separate CD and fluorescence assays were used to 
monitor the in situ development of the [2Fe−2S]−Grx4 species (Fig. 5.3, Reactions A and 
B). These reactions lack any terminal acceptor such as Fdx or HcaC. For the CD assay, a 
positive feature at 455 nm was used to monitor cluster transfer, as this wavelength is 
diagnostic of [2Fe−2S]−Grx4 and has little intensity for [2Fe−2S]−IscU (Fig. 5.1). The 
rate of cluster accumulation on Grx4 was also measured using the fluorescence intensity 
for Grx4Rho, which exhibits [2Fe−2S] cluster dependent quenching. The fluorescence 
intensity was corrected for the inner filter effect and for loss of signal due to 
photobleaching or adhesion to the plate. Biosynthetic assays using the IscS−IscU complex 
to generate clusters revealed similar pseudo-first-order generated by taking the difference 
between the sample at the beginning and end of the fluorescenc experiment was highly 
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similar to the [2Fe−2S]−Grx4 control (Fig. 5.4). Size exclusion chromatography verified 
multimerization, likely dimerization, of Grx4 during the reaction with the generation of 
very little, if any, aggregated material. Control reactions that include DTT exhibited 
decreased amounts of [2Fe−2S] cluster binding based on the lack of Grx4Rho quenching. 
Control reactions without IscU showed a low level of transient fluorescence quenching 
that occurred on a slower time scale than reactions with IscU. These results suggest the 
clusters formed on Grx4Rho in full biosynthetic assays were generated through an IscU-
dependent enzymatic process rather than a chemical Fe−S reconstitution process (favored 
by non-enzymatic sulfide generation). Moreover, a similar extent of quenching at different 
ratios of Grx4Rho to Grx4 indicated minimal contribution of homo-FRET to the overall 
quenching. These control studies reveal the fluorescence of Grx4Rho is sensitive to the 
binding of IscS:IscU derived Fe−S clusters, and off pathway Fe−S minerals or protein 
aggregates contribute little to the changes in the fluorescence intensity. We further 
explored the mechanism of [2Fe−2S] cluster transfer to Grx4 by determining the 
concentration dependence of GSH and apo- Grx4Rho. A lag phase for Grx4Rho quenching 
was observed at lower GSH concentrations that is shorter or absent at 10 mM GSH (Fig. 
5.5A). The initial linear rates of quenching (following any lag phase) were converted to 
cluster transfer rates. Interestingly, the resulting cluster transfer rates varied linearly with 
concentration of GSH, implicating a single GSH molecule in rate-limiting cluster transfer 
to Grx4 (Fig. 5.3, Reaction B). This rate dependence is consistent with the GSH ligation 
requirement for [2Fe−2S] cluster binding to Grx4Rho. The simplest explanation for the lag 
phase is that GSH also participates in cluster synthesis (Fig. 5.3, Reaction A), possibly  
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Figure 5.4. IscS–IscU mediated [2Fe–2S] cluster formation on Grx4. (A) The rate 
of cluster assembly on Grx4Rho was monitored using CD (blue) and fluorescence (red) 
spectroscopy. Fluorescence was measured using 550 nm excitation and 600 nm 
emission wavelengths. (FReaction/Fref)′ is the fluorescence of the reaction compared to a 
reference well (see Methods). CD ellipticity was measured at 455 nm. Reactions 
contained 10 mM GSH, 100 μM Fe2+, 2 μM IscS, 10 μM IscU, 20 μM fluorescently 
labeled (red) or unlabeled (blue) Grx4, and 100 μM L-cysteine. (B) Difference CD 
spectrum obtained for the reaction containing Grx4Rho (red in panel A) by subtracting 
the 0 min from the 265 min spectra. 
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Figure 5.5. Rate of [2Fe–2S] cluster formation on Grx4 increases with higher GSH 
and Grx4Rho concentrations. Fluorescence quenching was monitored for Grx4Rho in 
reactions containing 5 μM IscU, 100 μM Fe2+, and 100 μM L-cysteine. (A) Reactions 
contain 0.5 μM IscS, 2 μM Grx4Rho, and either 1 mM (black), 3 mM (red), or 10 mM 
(cyan) GSH. (B) Reactions also included 100 nM IscS, 10 mM GSH, and either 1 μM 
(orange), 2 μM (blue), 6 μM (green), 15 μM (black), 30 μM (yellow), or 50 μM (cyan) 
Grx4Rho. 
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as an electron source, under these conditions. The cluster transfer rate also depends on the 
apo-Grx4Rho concentration. The fluorescence assay measures the quenching rate or, 
stated another way, the time-dependent fraction of [2Fe−2S] cluster bound to Grx4Rho (Fig. 
5.5B). The overlaid quenching rates indicate the cluster transfer rate increases with 
increasing acceptor levels. Interestingly, [2Fe−2S]−Grx4 appears unstable at 
concentrations of 2 μM or less, which might reflect the physiological dimerization/cluster 
binding constant. Again, the initial linear rates of quenching were converted to cluster 
transfer rates. A plot of cluster transfer rate as a function of apo- Grx4Rho concentration 
best fit to the Michaelis−Menten equation. Even though the substrate concentration was 
insufficient to reach saturation, we estimate a Km of 50 ± 10 μM and Vmax of 0.19 ± 0.03 
μM cluster/min. On the basis of these results, we conclude that cluster transfer from IscU 
to Grx4 was at least partially rate limiting under these conditions and that GSH likely plays 
a functional role in this cluster transfer process. 
Grx4Rho directly transfers clusters to apo-Fdx and apo-HcaC. We next investigated 
Grx4-dependent cluster exchange reactions by measuring transfer rates from [2Fe−2S]− 
Grx4Rho to Fdx and HcaC. [2Fe−2S]− Grx4Rho was first produced by an overnight cluster 
synthesis reaction catalyzed by the IscS−IscU complex. The quenched [2Fe−2S]− Grx4Rho 
reaction mixture was then diluted into wells containing varying concentrations of GSH 
and apo-Fdx or apo-HcaC (Fig. 5.6). The fluorescence quenching did not recover at a 
significant rate for reactions lacking an apo-acceptor protein (Fig. 5.6A and B, black line), 
indicating that [2Fe−2S]− Grx4Rho is stable upon dilution. The addition of either apo-Fdx 
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Figure 5.6. Direct cluster transfer from Grx4 to apo-acceptors. 2.5 μM [2Fe–2S] -
(Grx4Rho)2 was diluted into reactions containing 10 mM GSH and (A) apo-Fdx or (B) 
apo-HcaC. Acceptor protein concentrations were 0 μM (black), 5 μM (green), 10 μM 
(orange), and 20 μM (cyan). Similar cluster transfer reactions were performed using 0.7 
mM (black), 2 mM (green), 5 mM (orange), and 10 mM (cyan) GSH and either (C) apo-
Fdx (5 μM) or (D) apo-HcaC (5 μM). 
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or apo-HcaC to quenched [2Fe−2S]− Grx4Rho resulted in an increase in fluorescence (Fig. 
5.6A and B), consistent with cluster transfer to acceptor proteins and recovery of the 
quenched fluorescence. The fluorescence intensity approached that of apo- Grx4Rho for 
reactions with high apo-Fdx concentrations but leveled off at lower values for apo-HcaC. 
The rate of increase in fluorescence was strongly dependent on the concentration of apo-
acceptor protein. Moreover, the fluorescence of [2Fe−2S]− Grx4Rho failed to fully recover 
in some reactions, suggesting a reversible equilibrium between Fdx/HcaC and Grx4 for 
binding clusters.To test this hypothesis, the four curves from reactions containing 10 mM 
GSH were fit to models (Fig. 5.3, reaction C) for irreversible and reversible cluster transfer 
from [2Fe−2S]−Grx4 to Fdx. The reversible model (Grx4−Fdx-2) better fit the cluster 
transfer data (Table 5.1) than the irreversible model (Grx4−Fdx-1). A cluster degradation 
step (Fig. 5.3, kdegrade) was also included in the fits (Table 5.1). The very slow rates for 
kdegrade further support the conclusion that [2Fe−2S]− Grx4Rho is stable upon dilution. The 
second order rate constant for [2Fe−2S] cluster transfer from Grx4 to Fdx (k2 in Fig. 5.3 
and Table 5.1) is 2-fold larger than the rate constant for the equivalent reaction with HcaC 
(model Grx4− HcaC-1 in Table 5.1). Interestingly, the rate constant for the reverse 
reaction (k−2) revealed the back reaction is 10-fold greater for cluster transfer from 
[2Fe−2S] − HcaC to apo-Grx4 compared to the analogous reverse reaction from 
[2Fe−2S]−Fdx. Analysis of cluster transfer at different GSH concentrations revealed that 
the rate and extent of cluster transfer from [2Fe−2S] −Grx4 to acceptor proteins increases 
at the lowest GSH concentrations (Fig. 5.6C and D), suggesting a GSH independent or 
direct [2Fe−2S] cluster transfer mechanism from Grx4 to Fdx/HcaC. Collectively, these 
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Table 5.1 Global fit kinetic parameters for cluster transfer reactions 
Cluster transfer from [2Fe-2S]-Grx4Rho to apo-acceptors 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Biosynthetic reactions on apo-acceptors monitored by Grx4Rho (Figures 5.6 and 5.7) 
 
avalues for k2 were restrained below 5000 M-1min-1. bParameters were restrained near 
values derived from cluster transfer experiments from [2Fe-2S]- Grx4Rho to HcaC. 
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results indicate that transfer reactions from [2Fe−2S] −Grx4 are reversible with large 
differences in apparent equilibrium constants (Table 5.1), Ktransfer (k2/k−2), which results 
in a cluster stability ranking of Fdx > Grx4 > HcaC. 
Grx4 functions as an intermediate [2Fe−2S] cluster carrier. Here, an IscS:IscU 
biosynthetic reaction was used to simultaneously generate [2Fe−2S] clusters and transfer 
these clusters to acceptor proteins (Fig. 5.3, Reactions A−D). In these reactions, Fdx or 
HcaC were allowed to directly compete with Grx4Rho for clusters generated by the 
IscS:IscU complex. Cluster binding to Grx4Rho results in quenching of the fluorescence, 
whereas cluster binding to unlabeled Fdx or HcaC is not expected to affect the 
fluorescence intensity of Grx4Rho (assuming the fraction of [2Fe−2S]−Grx4Rho does not 
change). The rhodamine fluorescence was converted to [2Fe−2S]−(Grx4Rho)2 
concentration and plotted as a function of time (Fig. 5.7). When apo-Fdx was added into 
a reaction mixture with Grx4Rho, the time dependence of the fluorescence quenching was 
greatly perturbed. At higher concentrations of apo-Fdx, an initial formation of [2Fe−2S]− 
Grx4Rho was observed, followed by a steady state leveling as clusters are both accepted by 
Grx4 and donated to apo-Fdx. At later time points, the supply of apo-Fdx was depleted 
and quenching of Grx4Rho proceeded to completion. In the case of HcaC, rapid formation 
of [2Fe−2S]− Grx4Rho was observed followed by leveling off at different values that were 
dependent on the concentration of apo-HcaC (Fig. 5.8). This behavior further supports the 
observation that Grx4 and HcaC exhibit equilibrium cluster binding. Notably, the majority 
of reactions containing either Fdx or HcaC exhibit unperturbed initial kinetics of [2Fe−2S]  
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Figure 5.7. Cluster transfer to Grx4Rho in the presence of apo-Fdx. Cluster transfer 
reactions contained 10 mM GSH, 100 μM Fe2+, 0.1 μM IscS, 5 μM IscU, 100 L-
cysteine, and either 0 μM (black), 5 μM (red), 10 μM (blue), or 20 μM (cyan) apo-Fdx. 
The Grx4Rho concentrations were (A) 5 μM, (B) 10 μM, (C) 15 μM, and (D) 20 μM. 
The best fit from the global kinetic modeling (Table 5.1) is shown as green lines. 
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Figure 5.8. Cluster transfer to Grx4Rho in the presence of apo-HcaC. Cluster 
transfer reactions contained 10 mM GSH, 100 μM Fe2+, 0.1 μM IscS, 5 μM IscU, 100 
μM L-cysteine and either 0 μM (black), 5 μM (red), 10 μM (blue), or 20 μM (cyan) 
apo-HcaC. The Grx4Rho concentrations were (A) 5 μM, (B) 10 μM, (C) 15 μM, and 
(D) 20 μM. Green lines show the best fit to the kinetic modeling (Table 5.1). 
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-Grx4Rho formation upon addition of the apo-acceptor, suggesting that Grx4Rho is an early 
cluster transfer intermediate and hence successfully outcompetes terminal apo-targets for 
IscU-bound cluster. We used global fit kinetic analysis of the cluster transfer reactions to 
Grx4Rho in the presence of acceptor protein to define the cluster biosynthesis pathway. 
Multiple kinetic models were evaluated, and the kinetic parameters are provided in Table 
5.1. The observation that the rate-limiting step of the reactions was cluster transfer rather 
than cluster synthesis allowed the reactions to be modeled (in some cases) with a fixed 
concentration of [2Fe−2S]−IscU. Additionally, fluorescence quenching data and results 
from other groups [50, 83] suggest that cluster transfer from IscU to either Grx4 or Fdx is 
irreversible, so all transfer steps from [2Fe−2S]−IscU were modeled as irreversible 
processes with only a forward rate constant (Fig. 5.3, steps k1 for Reaction B and k3 for 
Reaction D). Including Michaelis complexes for transfer reactions from [2Fe−2S] −IscU 
did not substantially improve the fit and failed to converge for Vmax and Km (data not 
shown). An initial model for cluster transfer to Fdx that contained only the linear transfer 
pathway from IscU to Grx4 to Fdx (Model IscU−Fdx-1; Fig. 5.3, k1 and k2) was improved 
by incorporating the ability of IscU to donate a cluster directly (Fig. 5.3, k3) to the terminal 
target protein (Model IscU−Fdx-2). Limiting the amount of cluster in the model by 
including a cluster biosynthesis reaction (Fig. 5.3, ksynth) further improved the fit (model 
IscU−Fdx-3). Inclusion of reversible cluster transfer reactions (Fig. 5.3, k−2) from Grx4 to 
Fdx with or without cluster synthesis (ksynth) and/or direct IscU−Fdx transfer (k3) slightly 
improved fits (models IscU−Fdx-4 to IscU−Fdx-7) compared to the equivalent irreversible 
model and produced. Ktransfer values that ranged from 3.2 to 5.2. These values are in good 
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agreement with the results from the holo-Grx4 transfer experiments, supporting the 
reversibility of this reaction. In all cases, the addition of direct transfer (k3) and cluster 
biosynthesis (ksynth) steps into the model had only minor effects on the k1 and k2 kinetic 
parameters. The observation that k3 is substantially less than k1 or k2 implies that cluster 
transfer to Fdx proceeds through a [2Fe−2S] −Grx4 intermediate. We used a similar global 
fit kinetic analysis for the cluster transfer reactions to Grx4Rho in the presence of apo-
HcaC. The inclusion of a reversible transfer from [2Fe−2S] −Grx4 to HcaC produced a 
model (IscU−HcaC-1) that closely approaches the observed data (Fig. 5.8 and Table 5.1). 
In this fit, k2 and k−2 were constrained to values obtained from the [2Fe−2S] −Grx4 to 
HcaC transfer experiment since it was more sensitive to those rate constants and attempts 
to relieve the constraints resulted in unstable values. Including a pathway from [2Fe−2S] 
−IscU directly to HcaC produced k3 values that converged on zero and did not improve 
the fit. A scan of curve fit error vs k3 shows that k3 is likely <100 M−1 min−1, which is an 
order of magnitude lower than k1 or k2. Thus, cluster transfer to HcaC also appears to 
proceed through a [2Fe−2S] −Grx4 intermediate. These results support the hypothesis that 
monothiol glutaredoxins are intermediate cluster carriers that transport clusters from IscU 
to multiple target proteins. 
Discussion 
Fe−S cluster biosynthesis is an elaborate process in which multiple protein complexes are 
assembled and disassembled to form Fe−S clusters. These synthesized Fe−S clusters are 
distributed by a branched network of intermediate cluster carrier and apo-target proteins. 
In addition, the Fe−S assembly pathway also appears to include cluster storage and 
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conversion proteins, chaperones that accelerate at least some cluster transfer reactions, and 
the participation of non-protein [2Fe− 2S]−GSH intermediates. A major challenge in 
investigating these Fe−S cluster biosynthetic networks and assigning roles to the different 
proteins is the lack of spectroscopic probes to monitor kinetics of cluster synthesis and 
transfer reactions. Here, we apply newly developed fluorescent reporter methodology to 
track cluster synthesis and transfer. The fluorescence of Grx4Rho, FdxRho, and HcaCRho 
have all previously been shown to be sensitive to Fe−S cluster binding. We further show 
that in biosynthetic assays Grx4Rho exhibits nearly identical time courses for fluorescence 
quenching and changes in CD spectroscopy due to [2Fe−2S] cluster formation. Additional 
experiments show that quenching of Grx4Rho is dependent on IscU and not due to DTT-
dependent aggregation or homo-FRET. These fluorescent reporters are uniquely suited to 
deconvolute the complex kinetic processes of Fe−S assembly pathways by coupling real-
time detection of the cluster content of a single protein in a reaction mixture of cluster 
binding proteins with high throughput plate reader assays and global fit analysis. This 
fluorescent reporter methodology was first applied to examine the mechanism of cluster 
transfer from IscU to Grx4Rho. Importantly, these studies use the IscS−IscU assembly 
complex as the cluster source rather than an uncomplexed [2Fe−2S] −IscU dimeric 
species, which has not been established as a kinetically competent intermediate in the 
biosynthetic pathway. The rate of cluster formation was dependent on the concentration 
of apo- Grx4Rho and GSH, which is a cluster ligand for [2Fe−2S] −Grx4, implying that 
cluster transfer is at least partially rate-limiting in these combined cluster 
biosynthesis/transfer reactions. Interestingly, extrapolation of the Grx4 curve to the higher 
 123 
 
concentrations that have been used previously in the literature [50] (45 μM cluster = 90 
μM Grx4) results in a formation rate of 0.12 μM clusters/min, which corresponds to a 
second order rate constant of 1.1 × 103 M−1 min−1. This is in good agreement with the rate 
of cluster formation we observed on Fdx in the presence of Grx4 derived from CD 
spectroscopy of 920 M−1 min−1 (note: the rate-limiting step should be cluster transfer from 
IscU to Grx4 at these concentrations) and the rate of 1.3− 1.7 × 103 M−1 min−1derived from 
kinetic modeling. Notably, this rate is much higher than values previously determined 
using purified [2Fe−2S] −IscU dimer as the cluster source inthe absence of chaperones 
(30 M−1 min−1) and is more similar to rates measured with chaperones (2 × 104 M−1 min−1). 
This may indicate that the [2Fe−2S] −IscU dimer is not a relevant transfer species and that 
chaperones function in promoting or regenerating the active transfer species that is formed 
during complete biosynthetic reactions. Alternatively, this may reflect differences in 
homologous proteins from different species, reaction conditions, or saturation of assays. 
More studies will be needed to fully address this discrepancy. The ability of Grx4 to 
mediate cluster transfer from IscU to apo-target proteins was then investigated. First, 
preformed and fluorescently quenched [2Fe−2S] −GrxRho was incubated with apo-
acceptor proteins Fdx and HcaC. The fluorescence signal increased rapidly, indicating that 
Grx4 is capable of transferring clusters to these target proteins. The rate of the transfer 
reaction increased with a higher concentration of acceptor protein and decreased with 
increasing GSH concentrations. This implies that the cluster transfer reaction from Grx4 
involves ligand exchange with a residue from the apo-acceptor rather than proceeding 
through a GSH-cluster intermediate. Second, combined IscS:IscU mediated cluster 
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biosynthesis and transfer reactions were carried out with Grx4Rho and apo-acceptor Fdx or 
HcaC. For the Fdx reactions, Grx4Rho exhibited clear intermediate-like behavior. Fitting 
of the kinetic traces showed that even when competing pathways for cluster transfer from 
IscU directly to Fdx/HcaC were included in the model, these rate constants were 
significantly lower than transfer through Grx4. This is in contrast to previous results that 
suggest that Grxs only act as intermediate carriers in the presence of chaperones. We also 
show that DTT is highly efficient at accelerating the cluster transfer reaction between IscU 
and Fdx (even in the presence of Grx4), suggesting previous studies that include DTT 
need to be reevaluated. 
Moreover, cluster transfer reactions from Grx4 to Fdx or HcaC were found to be 
dynamic and reversible. The equilibrium slightly favored the products ([2Fe−2S]−Fdx, 
apo-Grx4, and GSH; Ktransfer ∼ 3−5) for Fdx and the reactants ([2Fe−2S]−Grx4 and apo-
HcaC; Ktransfer ∼ 0.15) for HcaC. The apparent cluster stability (Fdx > Grx4 > HcaC) can 
be rationalized by the better coordination ability of cysteine compared to histidine. In 
summary, these results demonstrate the benefit of using fluorescent probes to interrogate 
enzymatic Fe−S cluster assembly. These probes allowed direct monitoring of the 
development and decay of [2Fe−2S]−Grx4 intermediates in biosynthetic reactions. These 
studies suggest that cluster transfer from Grx4 to terminal target proteins proceeds via 
direct ligand exchange, rather than a GSH mediated process. The rates of cluster transfer 
to Grx4 using the IscS−IscU complex suggest that the role of the chaperone protein in 
cluster transfer may need to be reevaluated. Furthermore, kinetic modeling strongly 
supports Grx4 as an intermediate carrier that accepts Fe−S clusters from IscU and transfers 
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them to multiple acceptor proteins. The Grx4-dependent transfer reactions were highly 
reversible, and the back reaction was even favored under some conditions, suggesting that 
cluster transfer networks are much more dynamic than previously thought. Future studies 
that determine the fraction of Grxs bound with clusters under varied growth conditions 
and exposure to oxidative stress may shed light on the functional dynamics of Grxs in 
vivo. Overall, the sensitivity of the fluorescent reporterand ability to monitor a labeled 
protein in the presence of unlabeled Fe−S proteins have the potential to be transformative 
for investigating the enzymology of Fe−S cluster biosynthetic networks. 
Materials and Methods 
Preparation of proteins and fluorescent labeling. Escherichia coli proteins were used 
for all studies. IscS, IscU, and Fdx were purified as previously described. The genes for 
Grx4 and HcaC were cloned into the Fdx expression vector that encoded N-terminal His-
tag, GFP, and TEV protease cleavage sequences. Mature Grx4 and HcaC were generated 
using the proteolysis and purification procedure described for Fdx.2 Grx4Rho was purified 
and fluorescently labeled with efficiencies of 0.76(4)-0.89(2). Apo-proteins were prepared 
by treatment with DTT and TCA, followed by washing with water and dissolving in 50 
mM HEPES, 150 mM KCl pH 7.2 buffer.2 Ferrous ammonium sulfate was used as the 
Fe2+ source for all experiments. 
Fe-S cluster transfer reactions monitored by CD spectroscopy. Samples were prepared 
in an anaerobic glovebox and sealed in a 1 cm pathlength cuvette with a rubber septum 
and electrical tape. Reactions were performed in 50 mM HEPES, 150 mM KCl, and 10 
mM MgCl2 at pH 7.5 and recorded at 25 °C on a CD spectrometer (Applied Photophysics 
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Chirascan). Formation of [2Fe-2S]-Fdx was monitored by the change in ellipticity at 515 
nm, the CD ellipticity was measured starting at 90 min after the reaction was initiated (to 
minimize contributions from cluster synthesis on IscU and Grx4) and fit to a linear 
equation using Kaleidagraph (Synergy Software) to determine the cluster transfer rates 
from Grx4 to Fdx. The Grx4 ellipticity at 515 nm was converted to concentration by a 
determined extinction coefficient of 7580 M−1 min−1, which is consistent with previous 
measurements. 
Fe-S cluster reactions using Grx4Rho. Kinetic assays with Grx4Rho were performed in 50 
mM Tris with 150 mM KCl at pH 7.2 (Buffer A). Rhodamine fluorescence was measured 
using an excitation wavelength of 550 nm and emission wavelength of 600 nm using a 
fluorescent plate reader located inside an anaerobic glovebox (mBraun, O2 < 1 ppm). 
Fluorescence data were corrected for the inner-filter effect and plotted as a ratio relative 
to a reference well that did not contain IscS or cysteine. Fluorescence data were reported 
as (FReaction/FRef)’, which is the ratio of the corrected fluorescence intensities of the reaction 
well relative to a reference well. The oligomeric state of Grx4Rho was analyzed after 
completion of the reaction (the fluorescence had plateaued). The sample was loaded onto 
a Superdex 200 column (10 x 300 mm) equilibrated with Buffer A and 1 mL fractions 
were collected. The concentration dependence of Grx4Rho was determined (Fig. 5.4B) for 
cluster transfer reactions from IscU to Grx4. The fluorescence quenching data between 30 
min and 75 min (to avoid the lag phase present in some samples) was fit to a linear 
equation. The slope was converted to a rate of cluster transfer by assuming the minimum 
observed fluorescence (for all concentrations of Grx4Rho) corresponded to 100% cluster 
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transfer and then scaling the fluorescence percentage based on the added concentration of 
apo-fluorescent protein. For direct cluster transfer experiments from Grx4Rho to Fdx and 
HcaC, [2Fe-2S] clusters were generated on Grx4Rho (Fig. 5.5) using an overnight reaction 
that included 100 μM Fe2+, 100 nM IscS, 5 μM IscU, 40 μM Grx4Rho, 10 mM GSH, and 
100 μM L-cysteine. Reaction progress was monitored by fluorescence quenching as 
described above. [2Fe-2S]- Grx4Rho samples were then diluted into mixtures containing 
varying concentrations of GSH and apo-Fdx or apo-HcaC. 
Kinetic modeling. Copasi kinetic modeling software was used to fit the data (Table 5.1) 
using evolutionary programming with a population size of >100 and >300 generations. 
Fluorescence data were converted into [[2Fe-2S] -( Grx4Rho)2] concentrations by assuming 
that the minimum fluorescence for the data set corresponded to 100% cluster transfer. The 
fluorescence ratio was corrected by equation [1] to give [[2Fe-2S] -( Grx4Rho)2]. Kinetic 
data were modeled assuming a constant concentration of [2Fe-2S] -(IscU)2 except when 
otherwise stated. Cluster transfer to glutaredoxin was modeled as being first order in 
glutaredoxin concentration since second order models failed to adequately fit the data 
(data not shown). The boundary limits of the variables were adjusted as needed to give 
optimal fits, but in general were kept at least an order of magnitude away from the 
observed final rate constants. Parameter scans were also carried out using Copasi, where 
one variable was systematically varied and the others were optimized using evolutionary 
programming. The sum of squares was obtained as a function of the rate constant that was 
varied. 
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CHAPTER VI 
CHAPERONE-MEDIATED ACCELERATION OF CLUSTER DELIVERY TO APO-
ACCEPTORS IS GLUTAREDOXIN-DEPENDENT 
Introduction 
Iron sulfur cluster biogenesis is one of the most ubiquitous pathways found in all 
life forms from eukaryotes to prokaryotes because of iron-sulfur clusters functioning as 
essential protein cofactors in many critical life processes namely oxidative respiration, 
DNA replication and repair, and photosynthesis [2]. There are four pathways in cells that 
are used for assembling and delivering iron-sulfur clusters known as SUF, NIF, ISC and 
CIA pathways. NIF and SUF pathways are specialized pathways. The NIF (Nitrogen 
Fixation Pathway) is required for cluster biosynthesis on nitrogenase [7] whereas SUF 
(Sulfur mobilization pathway) often operates in prokaryotes under oxidative stress 
conditions [8]. The CIA (cytosolic Iron sulfur protein assembly pathway) functions in 
eukaryotic cytosol and nucleus for iron-sulfur cluster maturation [9]. The ISC pathway is 
commonly the house-keeping pathway under normal growth conditions for prokaryotes 
and is the exclusive pathway in eukaryotic mitochondria [190]. Hence, several studies are 
ongoing to achieve a deeper mechanistic understanding of the pathway.  
Cluster biogenesis consists of two major events, cluster assembly on the scaffold 
protein followed by transfer of the assembled cluster to different targets. The assembly 
process involves the formation of persulfide on cysteine desulfurase [32], transfer of the 
persulfide to scaffold protein, IscU, and assembly of the cluster on IscU in the presence 
of iron and electrons [23]. The next event is cluster transfer from the scaffold protein to 
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different protein targets. The transfer process needs to be well-orchestered as it involves 
the allocation of clusters synthesized on the scaffold protein to a wide array of different 
cluster targets including [2Fe-2S], [4Fe-4S] and [3Fe-4S]. Monothiol glutaredoxins have 
been shown to bind different forms of clusters, including [2Fe-2S], [4Fe-4S], [3Fe-4S] 
etc. [41] and function as an intermediate cluster carrier that transfers clusters to apo-
acceptors such as ferredoxin and HcaC [109]. Glutaredoxin can also transfer cluster to 
IscA [57] which has been shown to be involved in maturation of [4Fe-4S] proteins [59]. 
Cluster transfer from holo-IscU to apo-Grx4 has been shown to be accelerated by the 
chaperones HscA and HscB in an ATP-dependent manner [50]. However, it is still 
unknown if chaperones or any other proteins are involved in the cluster transfer from 
glutaredoxin to downstream targets like apo-Fdx. The possibility is fueled by the 
observations that HscA interacts with apo-Fdx, glutaredoxin and apo-BioB [65, 66]. 
Further, several studies in the literature demonstrate that direct cluster transfer from holo-
IscU to apo-Fdx is accelerated in the presence of chaperones [39, 83], however these 
experiments were performed in the presence of DTT which may mimic Grx4 and mediate 
thiol-dependent cluster redistribution on proteins [67].  
We have previously shown that glutaredoxin serves as an intermediate in the 
cluster transfer from IscU to apo-acceptors [109]. Here, our objectives were to further 
study the generality of glutaredoxin mediated cluster transfer to apo-acceptors. Towards 
that goal, we investigated (1) interaction of holo-IscU with apo-acceptors in absence of 
Grx4, (2) whether chaperone mediated direct cluster transfer from holo-IscU to apo-Fdx 
in the DTT-independent reaction serves as an alternative pathway that bypasses 
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glutaredoxin and (3) the effect of chaperones on cluster transfer downstream to that of 
glutaredoxin.  
Our results indicate that the acceleration of transfer from holo-IscU to apo-Fdx 
was detected only when DTT, chaperones and MgATP were present together. In the 
absence of chaperones, the transfer occurs but is much slower [109]. Our results support 
DTT as a functional mimic of glutaredoxin. In addition, cluster assembly rates on apo-
Fdx were accelerated in the presence of chaperones and glutaredoxin in a one-pot cluster 
delivery assay consistent with our hypothesis. However, the rate of cluster transfer from 
holo-Grx4 to apo-Fdx was not affected by chaperones. We also provide evidence for 
interaction between holo-IscU and apo-acceptors and propose the formation of an 
encounter complex that does not appear to mediate cluster transfer. The physiological 
significance of these non-transferring complexes is unclear. 
Results 
Holo-Iscu interacts with terminal apo-acceptors without cluster transfer. 
Glutaredoxin has been shown to act as intermediate cluster carrier in the ISC pathway 
[109]. We wanted to further study the generality of glutaredoxin as an intermediate cluster 
carrier by fluorophore labeling IscU (Rho-IscU) and monitoring the fluorescence 
quenching and recovery during cluster assembly in the presence and absence of different 
apo-acceptors such as Grx4, apo-Fdx and HcaC. The presence of an Fe-S cluster quenches 
fluorescence. Previously we had shown minimal cluster transfer from holo-IscU to apo-
Fdx monitored by CD spectroscopy [109]. We therefore expected similar quenching 
patterns of Rho-IscU in presence and absence of terminal apo-acceptors (apo-Fdx and apo- 
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Figure 6.1. Cluster assembly on Rho IscU in the presence or absence of apo-
acceptors.  Reactions contained 10 mM GSH, 30 µM Fe2+, 0.5 µM IscS, 5 µM 
IscURho, 30 µM cysteine (blue).  Other reactions also contained apo-target 
proteins:  40 µM Grx4 (black), 20 µM Fdx (red), or 20 µM HcaC (green). 
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HcAc) consistent with a lack of cluster transfer. However, we observed two distinct 
differences in the presence of terminal apo-acceptors. First, the initial rate of quenching 
in the presence of terminal apo-acceptors (Fig. 6.1, red and green) appeared to be faster 
than IscU by itself (Fig. 6.1, blue) or in the presence of Grx4 (Fig. 6.1, black). Moreover, 
the extent of quenching in presence of apo-acceptors like Fdx and HcaC is much higher 
as compared to IscU by itself where they were expected to be comparable. Second, the 
recovery of fluorescence quenching in the presence of terminal acceptors appeared much 
slower as compared to IscU by itself. We hypothesized that during cluster transfer from 
holo-IscU, an intermediate complex between holo-IscU and apo-acceptor is formed (Fig. 
6.2, step b). The faster rate of quenching in the presence of apo-acceptors can be explained 
by comparing the relative rates of the steps involved in the above process (Fig. 6.2, steps 
b and c). Since the cluster transfer (step c, Fig. 6.2) is very slow in the absence of 
glutaredoxin, there is an accumulation of the intermediate complex leading to apparent 
faster rates of quenching. For Grx4, the hetero-complex is very short-lived leading to rapid 
cluster transfer from holo-IscU to apo-Grx4 resulting in faster recovery of Rho-IscU 
fluorescence. However, for apo-Fdx and HcaC, the process of cluster transfer is much 
slower [109]. This would account for the faster fluorescence quenching of Rho-IscU in 
presence of apo-Fdx and HcaC. The apparent slower rate of fluorescence recovery in 
presence of apo-acceptors as compared to IscU only can be explained by hypothesizing 
that encounter-complex between holo-IscU and apo-Fdx is more-stable as compared to 
holo-IscU alone and hence a slower rate of cluster-loss. 
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Figure 6.2.  Events during cluster assembly on Rho-IscU in the presence of apo-
acceptors. Step a is the cluster assembly on IscU. Step b is the formation of an 
intermediate complex and step c involves the cluster transfer to the apo-acceptor. 
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Figure 6.3. CD spectra for holo-IscU (green), holo-Fdx (red) and encounter 
complex between holo-IscU and apo-Fdx (blue). The CD spectra formed on 
addition to holo-IscU is distinct from holo-Fdx and holo-IscU. Green spectra is the 
final spectra after the cluster assembly reaction on 30 µM IscU in the presence of 
0.5 µM IscS, iron and Cysteine. Blue spectrum is generated on addition of of 40 
µM apo-Fdx to the above reaction. The red spectra is CD spectra for 40 µM Holo-
Fdx as isolated from E.coli for comparison purposes.  
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Apo-Fdx interacts with holo-IscU to form complex with CD signature distinct from 
holo-IscU or holo-Fdx. We decided to further characterize the interaction between holo-
IscU and apo-Fdx using CD spectroscopy. Cluster assembly reaction was performed on 
IscU followed by addition of apo-Fdx to the holo-IscU generated in situ. Immediate 
formation of a new species with CD spectrum distinct from either holo-IscU or holo-Fdx 
(Fig. 6.3) was observed. The CD spectrum remains unchanged even after 2h (Fig. 6.4). A 
complete cluster transfer to Fdx is observed only after an overnight incubation (Fig. 6.3).  
Rho-labeled Fdx undergoes fluorescence quenching in the presence of holo-IscU. The 
interaction of Holo-IscU and apo-Fdx was also monitored using Fdx labeled with a 
fluorophore. When Rho-Fdx was added to holo-IscU, the fluorescence of Rho-Fdx was 
immediately quenched even though no cluster transfer was observed during the timescale 
while monitoring the same reaction via CD spectroscopy (Fig. 5.1, Chapter V). This 
observation would also be consistent with the formation of intermediate complex between 
holo-IscU and apo-Fdx. The fluorescence quenching could be attributed to a possible 
complex formation between apo-Fdx and holo-IscU. 
Cluster transfer from IscU to apo-Fdx is accelerated by chaperones and ATP only in 
the presence of DTT. Chaperones accelerate direct cluster transfer from holo-IscU to apo 
Fdx [26]. We tested the DTT dependence of this pathway. We also wanted to test the effect 
of chaperones on the proposed intermediate complex formed between holo-IscU and apo 
Fdx. Surprisingly, it was observed that cluster transfer from holo-IscU to apo-Fdx was 
accelerated only in the presence of chaperones, ATP and DTT (Fig. 6.5). The accelerated 
 
 136 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4 CD spectra of Fe-S cluster transfer reactions at an intermediate time 
point. CD spectra before apo-Fdx addition (black) to a completed reaction of cluster 
assembly on 30 µM IscU, after 120 min of the addition (blue). The red is spectrum 
for holo-Fdx as isolated from E.coli for comparison purposes. 
 137 
 
cluster transfer was not observed with: i) Chaperones and ATP (Fig. 6.5) ii) Chaperones 
and DTT and iii) ATP and DTT (data not shown). When apo-Fdx was added to holo-IscU, 
intermediate complex with a distinct CD signature was formed without any cluster transfer 
(Fig. 6.3). No further change was observed on addition of chaperones and MgATP to the 
reaction. Immediate cluster transfer to Fdx occurs when DTT is added to the reaction as 
evident from the shift in the peak to 355 nm from 330 nm, the latter being characteristic 
of holo-IscU (Fig. 6.5). The observation that the cluster transfer from holo-IscU to apo-
Fdx did not occur in presence of DTT when chaperones were absent indicated that DTT 
does not initiate solution chemistry in this reaction. It was hence hypothesized that DTT 
here is likely a mimic of a physiological molecule. 
Cluster transfer from IscU to apo-Fdx undergoes chaperone-dependent acceleration 
in the presence of Grx4. Grx4 functions as an Fe-S cluster carrier in transfer reactions 
from IscU to terminal apo-acceptors like Fdx and HcaC [109]. Johnson and co-workers 
demonstrated that the cluster transfer from holo-IscU to Grx4 is accelerated in the 
presence of chaperones [50]. So, we hypothesized that Grx4 is the physiological molecule 
mimicked by DTT and tested whether chaperones accelerate the rate of cluster transfer 
from IscU to apo-Fdx in the presence of Grx4. Hence, we set up a complete assembly and 
transfer reaction containing IscU, IscS, Grx4, apo-Fdx and chaperones. The reaction was 
initiated by the addition of GSH and MgATP. Fe-S cluster formation reactions on Fdx 
were monitored by the loss of ellipticity at 350 nm. The cluster assembly on Fdx was 
significantly faster in the presence of chaperones (Fig. 6.6). 
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Figure 6.5. DTT is required for chaperone dependent cluster transfer from holo-
IscU to apo-Fdx. Reaction contains 30 µM Iscu, 1µM IscS, 400 µMFe2+, 100 µM 
cysteine and 10 mM GSH. Red spectrum is recorded after cluster assembly on IscU is 
complete as monitored by the saturation of ellipticty at 330 nm. 40µM apo-Fdx was 
added to the above reaction and the spectra was recorded (red) immidiatey. No further 
change in the spectra was recorded for next 30 minutes. 20 µM HscA & HscB and 3 
mM MgATP were then added to the above reaction (green) with no change in spectra 
till 15 min. 2 mM DTT addition was then added followed by recording the spectra 
(blue). 
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Figure 6.6. One-pot cluster assembly on apo-Fdx is accelerated by chaperones. 
Assay contained 20 μM IscU, 0.5 μM IscS, 40 μM Grx4, 400 μM Fe(NH4)2(SO4)2 , 40 
μM HscA , 40 μM HscB, 50 μM apo-Fdx and 100 μM cysteine and the reaction is 
initiated by the addition of 10 mM GSH and 3mM MgATP.  
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Chaperones do not affect the rate of cluster transfer from holo-Grx4 to apo-Fdx. We 
found that the rate of Fe-S cluster assembly and transfer to Fdx in the presence of 
glutaredoxin was accelerated by chaperones. The acceleration could be attributed to two 
possible effects. The first possibility is that the faster cluster assembly on Grx4 in the 
presence of chaperones led to an increased concentration of holo-Grx4 and faster cluster 
transfer to apo-Fdx. The second possibility is that the chaperones accelerate cluster 
transfer from holo-Grx4 to apo-Fdx. A combination of these effects is also conceivable. 
To distinguish between these possibilities, the effect of chaperones on cluster transfer from 
holo-Grx4 to apo-Fdx was studied.  First, holo-Grx4 was isolated from E. coli was used. 
Second, the cluster transfer from holo-Grx4 to Fdx was monitored by recording the change 
in ellipticity at 315 nm due to minimal contribution of holo-Fdx at that wavelength (Fig. 
6.7). The rate of cluster transfer from Holo-Grx4 to apo-Fdx was observed to remain 
unchanged in the presence of chaperones. Hence, we concluded that the accelerated rate 
of the complete cluster assembly and transfer reaction on Fdx is due to chaperone-assisted 
faster cluster assembly on Grx4 and not due to faster transfer from holo-Grx4 to apo-Fdx. 
Discussion 
Cluster transfer is the slow step in Fe-S cluster biogenesis and mechanistic details 
of this process are poorly understood. We have demonstrated that Grx4 functions as an 
intermediate cluster carrier in cluster transfer reactions from IscU to Fdx. However, those 
experiments were done in absence of chaperones. The next question is whether Grx4 is 
also an obligate intermediate in the cluster transfer from IscU to apo-acceptors like 
ferredoxin in the presence of chaperones or do chaperones open up an alternate direct 
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Figure 6.7. Chaperones do not affect the rate of cluster transfer from holo-Grx4 
to apo-Fdx. The reaction contained 20 µM holo-Grx4 and 10 mM GSH and was 
initiated by addition of 30 µM Apo-Fdx.The change in ellipticity at 315 nm for cluster 
transfer from holo-Grx4 to apo-Fdx in the presence and absence of chaperones remains 
unchanged. 
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pathway from IscU to apo-Fdx. A chaperone-mediated direct pathway is supported by 
acceleration of cluster transfer from holo-IscU to apo-Fdx in the absence of glutaredoxin 
[26]. Here, we found that the acceleration in reactions in the absence of Grx4. We suggest 
that DTT mimics Grx4’s function as an intermediate cluster carrier, as they can bind 
clusters with two coordinating thiols. We also demonstrated that cluster assembly and 
transfer reaction on apo-Fdx is accelerated in the presence of chaperones and glutaredoxin. 
This is the first time that the effect of chaperones has been tested in a one-pot biosynthetic 
reaction to ferredoxin. This is significant as there is a lack of consensus as to the identity 
of physiologically relevant cluster-bound scaffold protein. Three possible candidates are 
[2Fe-2S]-bound IscU dimer, monomeric [2Fe-2S]-IscU and the cluster bound IscU-IscS 
complex. By letting the reaction proceed with all the proteins present, we are likely to 
circumvent possible formation of off-path intermediates and monitor the correct 
physiological course of the reaction. Now, the observed acceleration of cluster assembly 
on apo-Fdx in presence of chaperones and glutaredoxin could be due to faster cluster 
assembly to Grx4 or a faster cluster transfer from holo-Grx4 to apo-Fdx or both. 
The model of chaperone-mediated acceleration is that HscB, the co-chaperone 
recruits holo-IscU to the chaperone HscA. HscA binds IscU via LPPVK recognition motif 
[38] in a nucleotide-dependent manner. ATP-bound HscA binds IscU with a lower 
affinity. ATP hydrolysis to ADP results in conformational change on HscA leading to a 
stronger binding of IscU which facilitates the cluster transfer from holo-IscU to acceptors. 
However, HscA belongs to Hsp70 class of chaperones that are known to be involved in 
protein folding [37]. Hence, it is possible that chaperones accelerate cluster transfer to 
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apo-acceptors not only by facilitating the release of cluster from IscU via a conformational 
change but also by interacting with apo-acceptors and pre-organizing the unfolded apo-
acceptors. Studies showing an interaction of HscA with apo-Grx4, apo-Fdx and apo-BioB 
lent support to this possibility but a functional relevance of these observations has not been 
explored yet. Hence, we compared the rates of cluster transfer from holo-Grx4 to apo-Fdx 
in presence and absence of chaperones and found the rates comparable. Therefore, we still 
do not have a functional explanation for the interaction of HscA and apo-acceptors. We 
also evaluated whether holo-IscU and apo-acceptors like ferredoxin interact in the absence 
of glutaredoxin. Our observations are consistent with formation of non-transferring 
complex formation between holo-IscU and apo-Fdx. Further studies are required to 
confirm if the observation is an artefact or has functional significance in the process of 
cluster transfer like pre-folding the apo-protein thereby facilitating cluster delivery to the 
targets. 
Materials and Methods 
Preparation of proteins and fluorescent labeling. Escherichia coli proteins were used 
for all studies. IscS, IscU, IscU-intein fusion and Fdx were purified as previously 
described [46, 67]. IscU was labeled with rhodamine fluorophore following the 
established protocol [67].  
Fe-S cluster reactions using IscU-Rho. Kinetic assays with IscU-Rho were performed 
in 50 mM Tris with 150 mM KCl at pH 7.2 (Buffer A). Rhodamine fluorescence was 
measured using an excitation wavelength of 550 nm and emission wavelength of 600 nm 
using a fluorescent plate reader located inside an anaerobic glovebox (mBraun, O2 < 1 
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ppm). Fluorescence data were corrected for the inner-filter effect and plotted as a ratio 
relative to a reference well that did not contain IscS or cysteine. Fluorescence data were 
reported as (FReaction/FRef)’, which is the ratio of the corrected fluorescence intensities of 
the reaction well relative to a reference well. Cluster assembly reaction on 5 µM Rho-IscU 
was performed using 30 µM Fe2+, 0.5 µM IscS, 30 µM cysteine and 10 mM GSH. The 
reaction was repeated in the presence of 40 µM Grx4, 20 µM Fdx and 20 µM HcaC. 
CD spectroscopy. CD spectra were recorded using a 1 cm path length cuvette on a 
Chirascan CD spectrometer (Applied Photophysics). Cuvettes were sealed with a rubber 
septa and electrical tape in a glove box. The assays were run in 50 mM HEPES, 150 mM 
KCl, and 10mM MgCl2 (pH 7.5). 
Cluster assembly assay on IscU and reaction with apo-Fdx. The assay constituted 30 
μM IscU, ,0.5 μM IscS, 400 μM Fe(NH4)2(SO4)2, and 100 μM cysteine. The reaction was 
initiated with 10 mM GSH. The formation of holo-IscU was studied using CD 
spectroscopy via monitoring ellipticity at 330 nm. 40 μM apo-Fdx was added using air-
tight syringe after the level of holo-IscU saturated and the change in the CD signal was 
recorded. 
Cluster transfer from Holo-IscU to apo-Fdx in presence of chaperones. Holo-IscU 
was assembled following the above procedure using 30 μM IscU, 0.5 μM IscS, 400 μM 
Fe(NH4)2(SO4)2, 100 μM cysteine and 10 mM GSH and monitored using CD 
spectroscopy. 40 μM apo-Fdx was then added to the reaction and the spectra was recorded. 
Next, 30 μM HscA and HscB and 3 mM MgATP followed by addition of 2 mM DTT 
using an-air tight syringe. The transfer of cluster from holo-IscU to apo-Fdx was detected 
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by the peak-shift to 355 nm from 330 nm which is characteristic of holo-IscU but has 
minimal contribution for holo-Fdx. 
One pot cluster assembly on apo-Fdx in the presence of chaperones and DTT. The 
assay contained 20 μM IscU, 0.5 μM IscS, 40 μM Grx4, 400 μM Fe(NH4)2(SO4)2, 40 μM 
HscA, 40 μM HscB, 50 μM apo-Fdx and 100 μM cysteine and the reaction is initiated by 
the addition of 10 mM GSH and 3mM MgATP. Cluster formation on apo-Fdx was then 
measured by monitoring the ellipticity at 350 nm over time. The control reactions lacked 
chaperones and MgATP. 
Cluster transfer reaction from Holo-Grx4 to apo-Fdx in presence of chaperones. 
Assay contained 30 μM holo-Grx4 (as isolated from E.Coli), 40 μM HscA and 40 μM 
HscB and 10 mM GSH. The reaction was initiated by addition of 40 μM apo-Fdx and 3 
mM MgATP. The cluster transfer from holo-Grx4 to apo-Fdx was monitored by change 
in ellipticity at 315 nm.  
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CHAPTER VII 
SUMMARY AND CONCLUSIONS 
 
This work has been directed towards achieving a better understanding of the 
mechanism of iron-sulfur cluster biogenesis in the ISC pathway via in-vitro analysis. In 
particular, we first focused on re-examining the traditional in vitro iron-sulfur cluster 
assembly assays and re-optimized them to minimize off-path solution chemistry so that 
they selectively report on physiological processes. We also developed one-pot cluster-
delivery assays on terminal apo-acceptors where the iron-sulfur clusters were assembled 
on scaffold protein followed by transfer to the intermediate carrier and then delivered to 
terminal targets. The assays were not biased in any way by using pre-isolated 
intermediates and hence were more likely to follow the physiological path and report more 
accurately on the effects of different components on the course of reaction. We then used 
these assays and other spectroscopic techniques to study the role of different proteins like 
CyaY, ISCU2(M106I), Grx4 and HscA-HscB in ISC pathway. 
Dithiothreitol (DTT) has been traditionally used as an electron source for in vitro 
iron-sulfur cluster formation assays. DTT was used as an electron source for monitoring 
the cluster assembly on scaffold protein, ISCU2 in the presence of cysteine desulfurase 
complex, SD and allosteric activator, FXN but the nature of cluster formed had not been 
characterized. In chapter II, we used CD spectroscopy and observed that [4Fe-4S]-like 
clusters not bound to proteins were generated under this condition. These species were 
then characterized via Mössbauer spectroscopy as high Molecular Weight Species 
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(HMWS) with spectral character similar to mineral species like pyrites. We identified that 
DTT-mediated generation of sulfide from persulfide-cleavage and interception of other 
[2Fe-2S] cluster-intermediates were the primary pathways that led to the formation of 
HMWS. We re-optimized the assay condition using cysteine as our electron source and 
showed that the clusters generated under the assay condition are [2Fe-2S] bound to 
scaffold protein. Using this assay, we demonstrated that FXN that had been previously 
shown by our group to function as allosteric activator of cysteine desulfurase complex SD 
in presence of scaffold protein ISCU2 also accelerates the rate of cluster-assembly on 
ISCU2. 
In chapter III, we aimed to study the role of CyaY in the process of iron-sulfur 
cluster biogenesis process. CyaY is known to inhibit the rate of iron-sulfur cluster 
assembly on ISCU2 whereas its eukaryotic homolog, FXN, functions as an allosteric 
activator of cysteine desulfurase. However, the mechanism of this inhibition is not yet 
known. Moreover, there have not been any studies conducted to test if the inhibitory effect 
of CyaY translates to a slower delivery of clusters on apo-proteins.  Using stopped flow 
experiments, we demonstrated that CyaY inhibits the rate of cluster-formation on IscU by 
inhibiting the rate of persulfide transfer from IscS to IscU. We also used one-pot cluster 
formation assay to show that CyaY slows down the rate of cluster delivery on 
glutaredoxin. We confirmed the inhibition to be a downstream effect of slow cluster 
assembly on IscU by showing that CyaY has no effect on cluster transfer from holo-IscU 
to apo-Grx4 in a separate experiment. 
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Frtataxin (FXN) functions as an allosteric inhibitor of cysteine desulfurase. A 
genetic mutation that lowers expression of frataxin causes Friedreich’s ataxia, a recessive 
autosomal disease that results in progressive damage to nervous system. An interesting 
breakthrough was made with the discovery that a point mutation on scaffold protein, 
ISCU2(M106I) could bypass the FXN deletion in yeast under in-vivo conditions. In 
chapter II, we demonstrated that FXN accelerates the cluster assembly on scaffold protein, 
ISCU2 by accelerating the sulfur transfer step but the molecular details were still not 
understood. The mechanistic understanding of the activation would facilitate rational drug 
design for Friedreich’s ataxia. Evaluation of the effect of M106I mutation on ISCU2 under 
in-vitro conditions for human system would also contribute towards the same goal. In 
chapter IV, we studied the mechanism of FXN activation and FXN-bypass by 
ISCU2(M106I). Using a novel persulfide assay and stopped flow experiments, we 
demonstrated that FXN accelerates the formation of persulfide on cysteine desulfurase 
(NFS1) as well as sulfur transfer to ISCU2 by accelerating cys-aldimine formation and 
quinonoid decay respectively. Using CD spectroscopy, we carried out one-pot cluster 
assembly assays on GRX5 with FXN and ISCU2(M106I) respectively and found the rates 
to be comparable and hence confirmed ISCU2(M106I) can bypass FXN under in-vitro 
conditions for human system. We demonstrated that mechanism of FXN bypass to be 
accelerated rate of cluster transfer from holo-ISCU2 to GRX5 and concluded that 
ISCU2(M106I) and FXN activate different steps of cluster biogenesis, contrary to current 
model in literature. We further confirmed the observation using one-pot cluster delivery 
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assay on GRX5 in presence of both FXN and ISCU2(M106I) and found the rate to be 
higher than either for FXN or ISCU2(M106I) taken individually. 
In chapter V, we studied the role of monothiol glutaredoxin in the process of cluster 
transfer using a combination of one-pot cluster assay and novel fluorescence quenching 
assay developed in our group. We were able to demonstrate that the cluster transfer from 
IscU to apo-Fdx was accelerated in the presence of Grx4 and show that Grx4 can act as 
an intermediate cluster carrier in cluster transfer from IscU to apo-acceptors like Fdx and 
HcaC with rate constants for transfer that proceed through Grx4 being comparable or 
larger than the rate constants for direct cluster transfer from IscU to apo-protein. 
Chaperones accelerate the direct cluster transfer from IscU to Fdx in ATP-
dependent manner. They are also shown to accelerate the cluster transfer from IscU to 
Grx4.  In chapter VI, we tested if the chaperone-based direct cluster transfer from IscU to 
apo-Fdx is an alternative pathway to the glutaredoxin mediated cluster transfer that we 
observed in chapter V. We observed that the chaperone-dependent accelerated cluster 
transfer from IscU to apo-Fdx was DTT dependent and concluded that DTT acts as a 
mimic to glutaredoxin in that reaction. We demonstrated that the chaperone-accelerated 
cluster transfer rate from IscU to apo-Fdx is independent of DTT in presence of 
glutaredoxin. We also studied the effect of chaperones on cluster transfer steps 
downstream to that of glutaredoxin and observed that the rate of cluster transfer from holo-
Grx4 to apo-Fdx is unchanged in the presence of chaperones. Hence, we conclude that the 
chaperone-based acceleration of cluster delivery to terminal apo-acceptors like Fdx is a 
result of faster cluster assembly on the intermediate cluster carrier, Grx4.  
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To conclude, in spite of all the recent discoveries made in the field of iron-sulfur 
cluster biosynthesis pathways, a lot of questions regarding the mechanism of cluster 
formation and transfer remain unanswered. In particular, there is very little known about 
the 4Fe-4S cluster synthesis and delivery pathways including the mechanism for 
partitioning of 2Fe-2S and 4Fe-4S cluster synthesis. Though, IscA had been shown to be 
able to bind 4Fe-4S cluster, the result needs re-evaluation in the light of recent findings. 
Further studies are also required to confirm the generality of monothiol glutaredoxins in 
the process of cluster transfer to various targets and its involvement, if any, in transfer of 
4Fe-4S iron-sulfur clusters. It would also be interesting to study how IscR, transcriptional 
regulator of iron-sulfur cluster biosynthesis in mitochondria represses the cluster 
synthesis. A combination of different in vivo and in vitro techniques would be required to 
address these questions. 
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